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Systems Biology Approach to Identifying Host Interactive Pathways Modulating
the Severity of Streptococcal Sepsis
Abstract
Clinical outcomes of infectious diseases are controlled by complex interactions between the host and the
pathogen. Epidemiological, genetic and molecular studies in my mentor’s laboratory provided evidence
that in invasive Group A streptococcal (GAS) infections, genetic variations in both bacteria and patients
influenced the severity of GAS sepsis. Allelic variations in class II human leukocyte antigens (HLA)
contributed significantly to differences in the severity of group A streptococcal sepsis caused by the
same virulent strain of the bacteria. HLA class II molecules present streptococcal superantigens (SAgs)
to T cells, and variations in HLA class II molecules can strongly influence SAg responses. However, the
bacteria produce a very large number of additional virulence factors that participate in the pathogenesis
of this complex disease, and it is likely that host genes besides HLA class II molecules are also
participating in modulating the severity of GAS sepsis. The main focus of this Ph.D. project was to identify
additional host genes and pathways that may be modulating the severity of GAS sepsis.
To achieve this goal I applied a systems genetics approach, involving genome wide association studies
(GWAS) of GAS sepsis in the Advanced Recombinant Inbred (ARI) panel of BXD mouse strains. We used
this panel of ARI-BXD strains as a genetically diverse reference population to study differential severity of
GAS sepsis as ARI-BXD strains diversity mimics the genetic diversity of human population. We assessed
several traits associated with differential host responses to GAS sepsis, and analyzed variations in these
traits in the context of mice genotypic variability, using genome-wide scans and the sophisticated
analysis tools of WebQTL. This allowed us to map quantitative trait loci (QTL) associated with modulating
susceptibility to severe GAS sepsis on chromosome (Chr) 2 and Chr X. The mapped QTLs strongly
predicted disease severity (accounting for 25–30% of variance), and harbored highly polymorphic genes
known to play important roles in innate immune responses. Based on linkage analyses, gene ontology, cocitation networks, and variations in gene expression, we identified interleukin 1 (IL1) and prostaglandin E
(PGE) pathways as prime candidates associated with modulating the severity of GAS sepsis.
To further investigate mechanisms underlying differential host susceptibility, we analyzed genome-wide
differential gene expression in blood and spleens of uninfected vs. infected mice belonging to highly
resistant or susceptible BXD strains, at selected times post infection. Our transcriptional analyses
revealed common pathways between susceptible and resistant strains associated with innate immune
response, e.g. Interferon signaling pathway.
Since our data has pointed to a strong association of differential response to GAS with innate immune
responses, we explored if differences in the numbers of relevant immune cells among the BXD strains
played a role in their differential susceptibility to GAS. We found no significant differences in numbers or
percentages of immune cell populations between susceptible and resistant strains under normal,
uninfected conditions. However, depletion of neutrophils and/or macrophages significantly increased the
severity of GAS sepsis in both resistant and susceptible strains. Taken together, our data suggested that
differences in mobilization and /or function of these cells between susceptible and resistant strains might
play a role in modulating differential severity of GAS sepsis.
In conclusion, we found that variations in the severity of GAS sepsis have a strong genetic component
that is complex and multigenic. Different combinations of genetic variants influenced theonset,
progression, and severity of GAS sepsis and disease and ultimate outcome. Our overall approach of
systems genetics, where we systematically dissected genetic, molecular, cellular and functional
differences that may be associated with differential host susceptibility to GAS provided us with
tremendous insight into disease mechanism. The knowledge gained can help the development of better

diagnostics and means to predict disease severity based on a set of genetic and prognostic biomarkers
to help customize patient care, to apply effective and more targeted therapeutic interventions and
improve disease outcomes in septic patients.

Document Type
Dissertation

Degree Name
Doctor of Philosophy (Medical Science)

Program
Biological Science

Research Advisor
Malak Y. S. Kotb, Ph.D.

Keywords
Advanced Recombinant Inbred (ARI) BXD Mice Genome-wide Association Studies Immunogenetics of
Infectious Diseases QTL Mapping Streptococcus pyogenes (GAS) Sepsis Systems Genetics

Subject Categories
Biological Phenomena, Cell Phenomena, and Immunity | Genetic Processes | Medical Genetics | Medical
Sciences | Medicine and Health Sciences

Comments
Two year embargo expired May 2012.

This dissertation is available at UTHSC Digital Commons: https://dc.uthsc.edu/dissertations/5

SYSTEMS BIOLOGY APPROACH TO IDENTIFYING HOST INTERACTIVE
PATHWAYS MODULATING THE SEVERITY OF STREPTOCOCCAL SEPSIS

A Dissertation
Presented for
The Graduate Studies Council
The University of Tennessee
Health Science Center

In Partial Fulfillment
Of the Requirements for the Degree
Doctor of Philosophy
From The University of Tennessee

By
Nourtan Fatthy Abdeltawab
May 2010

Chapter 2 © 2007 by the Nature Publishing Group.
Chapter 3 © 2008 by Public Library of Science.
All other materials © 2010 by Nourtan Fatthy Abdeltawab.
All rights reserved.

ii

DEDICATION
To all my teachers, to whom I am forever indebted to, starting with my parents, and
to my dissertation readers, I wish you would enjoy it as much as I did.

iii

ACKNOWLEDGMENTS
I am grateful to everyone who helped me in the process of achieving my Ph.D.
degree. To start with, I would like to express my deep gratitude to Dr. Malak Kotb, who
is not only my mentor; but also a dear friend who I am privileged to have. I have enjoyed
my journey in her laboratory with all its ups and downs. I cannot thank her enough for
her heartfelt dedication as a mentor that was fundamental to my scientific development
and maturation. I am forever grateful for her everlasting support; she has taught me
priceless lessons in my scientific and social life.
I would like to thank my committee members; each and every member has been
crucial towards my scientific development. Their critiques and suggestions towards better
dissecting the mechanisms of the studied sepsis model have been tremendously
constructive. I would like to especially thank Dr. Robert Williams and his research team
with whom I enjoyed working closely as a collaborating student throughout my Ph.D.
research project.
I would like to extend a special thanks to Dr. Kotb’s research team, present and
previous members, as with the extensive animal experiments done in this dissertation, I
could not have ever done it on my own. While working with Dr. Kotb laboratory
members, I have learned something valuable from each and every one of them. I would
like to thank all my co-authors on my publications. I would like to extend a special
thanks to Dr. William Taylor for sharing his experience with me during my gene
expression analysis studies. I am forever grateful to Dr. Yan Jiao for our various
collaboration studies that will result in multiple manuscripts to be soon published.
On a personal level, I would like to thank all my friends along this journey. There
are too many to mention everyone, they all have been very supportive. I would like to
especially thank Mrs. Sarah Rowe Hasty, who has been a great asset to my success; she is
a living example of sincerity and devotion. She is a genuinely dedicated scientist that I
enjoyed learning from and working with. I will always cherish the time we spent together
whether in the lab or outside it, as she has been a wonderful second mother to me.
Words cannot express enough my deep gratefulness to my parents, my father,
Prof. Dr. Fatthy M. Abdeltawab and my mother, Prof. Dr. Maie F. Ali. They have been
tremendously supportive throughout my Ph.D. journey. Last but not least, I would like to
thank my brother, Amr and his beautiful wife Samah, and their cute daughter Rose, who
lightens up my days with her cute playful giggles.
Finally, I am grateful to various funding agencies that supported this work. These
agencies include Medical Research Service, Department of Veterans Affairs (Merit
Award to M.K.), the U.S. Army Medical Research Acquisition Activity (W81XWH-051-0227 to M.K), AI40198-06 grant from NIH, National Institute of Allergy and
Infectious Diseases (NIAID, to M.K.). Development and maintenance of Gene Network
and the BXD Colony is partly supported by INIA and Human Brain Project funded

iv

jointly by the NIMH, NIDA, and NIAAA (P20-DA 21131, U01AA13499 to R.W.W.),
NCI MMHCC (U01CA105417 to R.W.W.), and the Biomedical Informatics Research
Network (BIRN), NCRR (U24 RR021760 to R.W.W.). Parts of this work were awarded
ASM Student travel award, funded by Richard and Mary Finkelstein grants (ASM award
to N.F.A.).

v

ABSTRACT
Clinical outcomes of infectious diseases are controlled by complex interactions
between the host and the pathogen. Epidemiological, genetic and molecular studies in my
mentor’s laboratory provided evidence that in invasive Group A streptococcal (GAS)
infections, genetic variations in both bacteria and patients influenced the severity of GAS
sepsis. Allelic variations in class II human leukocyte antigens (HLA) contributed
significantly to differences in the severity of group A streptococcal sepsis caused by the
same virulent strain of the bacteria. HLA class II molecules present streptococcal
superantigens (SAgs) to T cells, and variations in HLA class II molecules can strongly
influence SAg responses. However, the bacteria produce a very large number of
additional virulence factors that participate in the pathogenesis of this complex disease,
and it is likely that host genes besides HLA class II molecules are also participating in
modulating the severity of GAS sepsis. The main focus of this Ph.D. project was to
identify additional host genes and pathways that may be modulating the severity of GAS
sepsis.
To achieve this goal I applied a systems genetics approach, involving genome
wide association studies (GWAS) of GAS sepsis in the Advanced Recombinant Inbred
(ARI) panel of BXD mouse strains. We used this panel of ARI-BXD strains as a
genetically diverse reference population to study differential severity of GAS sepsis as
ARI-BXD strains diversity mimics the genetic diversity of human population. We
assessed several traits associated with differential host responses to GAS sepsis, and
analyzed variations in these traits in the context of mice genotypic variability, using
genome-wide scans and the sophisticated analysis tools of WebQTL. This allowed us to
map quantitative trait loci (QTL) associated with modulating susceptibility to severe
GAS sepsis on chromosome (Chr) 2 and Chr X. The mapped QTLs strongly predicted
disease severity (accounting for 25–30% of variance), and harbored highly polymorphic
genes known to play important roles in innate immune responses. Based on linkage
analyses, gene ontology, co-citation networks, and variations in gene expression, we
identified interleukin 1 (IL1) and prostaglandin E (PGE) pathways as prime candidates
associated with modulating the severity of GAS sepsis.
To further investigate mechanisms underlying differential host susceptibility, we
analyzed genome-wide differential gene expression in blood and spleens of uninfected vs.
infected mice belonging to highly resistant or susceptible BXD strains, at selected times
post infection. Our transcriptional analyses revealed common pathways between
susceptible and resistant strains associated with innate immune response, e.g. Interferon
signaling pathway.
Since our data has pointed to a strong association of differential response to GAS
with innate immune responses, we explored if differences in the numbers of relevant
immune cells among the BXD strains played a role in their differential susceptibility to
GAS. We found no significant differences in numbers or percentages of immune cell
populations between susceptible and resistant strains under normal, uninfected
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conditions. However, depletion of neutrophils and/or macrophages significantly increased
the severity of GAS sepsis in both resistant and susceptible strains. Taken together, our
data suggested that differences in mobilization and/or function of these cells between
susceptible and resistant strains might play a role in modulating differential severity of
GAS sepsis.
In conclusion, we found that variations in the severity of GAS sepsis have a
strong genetic component that is complex and multigenic. Different combinations of
genetic variants influenced the onset, progression, and severity of GAS sepsis and disease
and ultimate outcome. Our overall approach of systems genetics, where we
systematically dissected genetic, molecular, cellular and functional differences that may
be associated with differential host susceptibility to GAS provided us with tremendous
insight into disease mechanism. The knowledge gained can help the development of
better diagnostics and means to predict disease severity based on a set of genetic and
prognostic biomarkers to help customize patient care, to apply effective and more
targeted therapeutic interventions and improve disease outcomes in septic patients.
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CHAPTER 1. INTRODUCTION
Pathogenesis Mechanisms of Streptococcus pyogenes
Streptococcus pyogenes is an important human pathogen that can cause a wide
spectrum of diseases with varying degrees of severity (reviewed in [Cunningham, 2000;
Kotb et al., 2003]). These diseases range from mild sore throat or skin infections to
severe and often deadly ones, such as streptococcal toxic shock syndrome (STSS) and
necrotizing fasciitis (NF), known as flesh-eating disease, giving the bacteria its nickname
as the flesh-eating bacteria. Certain individuals develop post-streptococcal nonsuppurative sequelae that include glomeronephritis, acute rheumatic fever, poststreptococcal arthritis, and neurological disorders collectively known as pediatric
autoimmune neuropsychiatric disorders associated with streptococcal infections
(PANDAS).
The wide range of diseases associated with Streptococcus pyogenes infections and
their varying degrees of severity has intrigued us and other researchers to study the basis
for the variable outcomes of the infection. Research groups have long debated over which
is more vital towards the final outcome of streptococcal diseases, the bacteria or the host,
with evidence supporting each side. Lately, it has become evident that interactions
between host factors, which are influenced by their genetic background, and
environmental factors, and the bacterial arsenal of virulence factors shape the final
outcome of group A streptococcal (GAS) infection. I will briefly review the bacteria
virulence factors and then elaborate on host genes associated with modulating the
susceptibility to infectious diseases and sepsis.
Streptococcal Arsenal of Virulence Factors
Streptococcus pyogenes expresses multiple virulence factors that are tailored to
their human host. Not all of these factors are expressed at the same time as Streptococcus
pyogenes (also known as (GAS)) senses its environment and accordingly restructures its
community to where mutants that are best fit for specific host environment are selected.
These mutants have distinct genetic expression patterns. Examples of GAS virulence
factors are shown in Figure 1-1. Some virulence factors are secreted and others are
surface bound, of note, superantigens (SAgs), which are a large group of secreted
proteins (exotoxins) and are associated with severe GAS sepsis and STSS. GAS produces
virulence factors that specifically impair host mechanisms of bacterial killing; for
example, GAS interferes with host signals for neutrophil chemotaxis, migration and
function. Streptococcal chemokine protease A (ScpA), also known as the complement 5a
(C5a) peptidase, degrades host C5a an important chemoattractant. Meanwhile,
streptococcal chemokine protease C (ScpC), also known as interleukin 8 (IL8) degrading
enzyme, degrades host IL8 thus impairing one of neutrophil chemotaxis factors (Sjolinder
et al., 2008; Gleich-Theurer et al., 2009). Streptococcal inhibitor of complement (SIC)
inhibits complement membrane attack complex and was also recently associated with
inhibition of several of the human innate immune machinery namely, lysozyme, secretory
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Figure 1-1. An overview of group A streptococcal main virulence factors.
GAS displays multiple virulence factors depending on site and stage of infection, shown
are selected virulence factors. Each of these virulence factors has been tailored to
counteract one or more of the host defenses. For example, ScpA (streptococcal
chemokine protease A, also known as C5a peptidase) degrades host C5a, and ScpC
(streptococcal chemokine protease C) degrades interleukin 8 (IL8), with a net result of
hindering the recruitment of neutrophils to site of infection (Hidalgo-Grass et al., 2006;
Sjolinder et al., 2008; Zinkernagel et al., 2008). Streptococcal inhibitor of complement
(SIC) as its name suggests, inhibits complement membrane attack complex and was also
recently associated with inhibition of four more proteins of the human innate immune
machinery namely, lysozyme, secretory leukocyte proteinase inhibitor, human α-defensin
1 and LL-37 (Johansson et al., 2008; Minami et al., 2009). M protein binds and
counteracts host’s counter-regulatory factors e.g. host fibronectin. Streptokinase (Ska)
degrades human plasminogen into plasmin thereby, dissolving blood clots. EndoS,
endoglycosidase S; FBP54, fibronectin-binding protein 54; Mac, Mac1-like protein;
MHC, major histocompatibility complex; PFBP, pyogenes fibronectin-binding protein;
Sfb, streptococcal fibronectin-binding protein; SlaA, streptococcal phospholipase A2;
cytotoxins streptolysin O (SLO) and streptolysin S (SLS); Spe, streptococcal pyogenic
exotoxin (aka superantigens (SAgs)); Smez, streptococcal mitogenic exotoxin Z; SSA,
streptococcal superantigen A; GRAB, G-related α2-macroglobulin-binding protein;
NADGH, Nicotine adenine dinucleotide (NAD) glycohydrolase; and TCR, T-cell
receptor. Source: Adapted with permission. Mitchell, T.J. (2003) The pathogenesis of
streptococcal infections: from tooth decay to meningitis. Nat Rev Microbiol 1: 219-230.
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leukocyte proteinase inhibitor, human α-defensin 1 and LL-37 (Johansson et al., 2008;
Minami et al., 2009). Another example of GAS interfering with neutrophil killing
mechanisms is Sda1, a potent DNase produced by M1T1 (GAS strain under study). Sda1
dissolves neutrophil extracellular traps (NETs), which are DNA filaments produced by
neutrophils and contain histones and antimicrobial peptides, allowing the bacteria to
escape the entrapment and on mechanism of killing by neutrophil (Aziz et al., 2004b;
Buchanan et al., 2006; Walker et al., 2007).
According to site and stage of infection, GAS virulence factor genes are turned on
or off to survive the host immune response and adapt to its environment. How the
bacterium does that is not completely understood, but it is postulated that according to the
environmental pressure, GAS selects for the most-fit mutants, sacrificing even the wild
type. This has been shown in several recent studies by our group and others (Buchanan et
al., 2006; Walker et al., 2007) and reviewed by (Aziz and Kotb, 2008; Bessen, 2009)
In the studies discussed in this dissertation, I used a hypervirulent clonal GAS
strain, designated M1T1. This hypervirulent M1T1 clonal strain, along with M3, M18,
and M28 strains, has been associated with the resurgence of the severe GAS sepsis in the
1980s (Johnson et al., 1992; Hoge et al., 1993). M1 and M3 GAS strains have displayed
highest associations with severe GAS sepsis (STSS) and NF (Hauser et al., 1991;
Johnson et al., 1992). Our research focus has been on the M1T1 strain, which has been
consistently isolated over the past 20 years from patients with both noninvasive and
invasive disease displaying varying degrees of severity (Chatellier et al., 2000; Johnson
et al., 2002; Ikebe et al., 2007). The hypervirulence of this strain is believed to be due to
the acquisition of virulence factors through horizontal gene transfer, recombination and
mutations (reviewed in [Aziz and Kotb, 2008]).
Streptococcal Sepsis as a Model of Host-pathogen Interactions
In studies presented in this dissertation, our focus was to determine the basis for
differential host susceptibility to one of the most severe GAS invasive diseases,
streptococcal toxic shock syndrome (STSS). STSS is an invasive disease of GAS, where
bacteria reach an otherwise sterile site in the body, e.g. blood, and the patient has
hypotension, plus two or more of the following clinical symptoms that are indicative of
multiple organ failure: renal impairment, coagulopathy, hepatic involvement or
respiratory distress. A STSS case is classified as probable if GAS is isolated from a nonsterile site or fluid, e.g. throat, and the patient displays hypotension and two or more of
the above-mentioned symptoms (Lappin and Ferguson, 2009).
The pathophysiology of STSS has multiple aspects and is associated with host
interactions and response to the bacterial arsenal of virulence factors including
superantigens (SAgs). The Kotb research group has found, through epidemiological
studies, that the severity of GAS sepsis is associated with allelic variations in human
leukocyte antigen (HLA) class II (Kotb et al., 2002). Patients with GAS sepsis expressing
HLA class II (DR15/DQ6) haplotype were protected from severe GAS sepsis, whereas
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those with HLA class II (DR14/DQ5) haplotype were at high risk for developing severe
and often fatal forms of the disease (Kotb et al., 2002; Norrby-Teglund et al., 2002; Nooh
et al., 2007). Ensuing studies, in vitro and in vivo, dissected the molecular mechanisms
underlying these differential responses and helped to dissect the role of GAS SAgs in
severe GAS sepsis and their interactions with HLA-II (Kotb et al., 2002; Norrby-Teglund
et al., 2002; Welcher et al., 2002; Kotb et al., 2003; Kotb, 2004; Nooh et al., 2007).
Whereas HLA-II allelic variations clearly influenced disease severity, it was clear
that other host factors must also be participating in the pathogenesis of GAS sepsis
because different inbred mice that do not express HLA-II were also found to display
differential susceptibility to GAS sepsis (Medina et al., 2001).This observation was
interesting because mice are normally less susceptible to GAS SAgs because they have
an inherent poorer affinity of MHC-II to GAS SAgs. Therefore, other bacterial virulence
factors, other than SAgs, and hence other host factors, other than HLA-II, are also likely
to modulate differential severity to GAS sepsis. Moreover, the bacteria produce a number
of additional, important virulence factors that must also participate in the pathogenesis of
GAS sepsis. The overall aim of my study was to identify additional host factors
modulating susceptibility to severe GAS sepsis and to identify host genes and pathways
involved in this disease (Aziz et al., 2007; Abdeltawab et al., 2008).
Infectious Diseases as Complex Traits that Require a Systems Approach to Better
Understand Them
It is now established that infectious diseases are a manifestation of complex traits
modulated by the interaction of host factors and genetic background with the pathogen
virulence factors and other environmental factors. Complex interactions between the
pathogen virulence factors and host immune-related genetic makeup determine the
progression and outcomes of the infection. Host genetic variations modulating
differential response to infectious diseases have long been studied (Hornef et al., 2002;
Fortin et al., 2007; Carvalho et al., 2009; Chai et al., 2009; Deghmane et al., 2009; Ko et
al., 2009; Zhang et al., 2009a). Variations in host response can be attributed to variations
in pathogen recognition, prior exposure and preexisting immunity, immune regulation
and/or quantitative differences in the immune response mounted to the infectious agents
(reviewed in [Frank, 2002]). Variation in host recognition of pathogens and their
virulence components can arise from a number of factors, including variations in many
immune genes, including genes encoding pattern recognition receptors (PRR), and major
histocompatibility complex (MHC) molecules. Also, variations in genes involved in
immune regulation can strongly affect the host response to the infection. An added level
of host immune response variability arises from polymorphisms of key immune-related
genes.
Two main approaches have been employed to identify host genetic
polymorphisms associated with infectious diseases. The first approach is to examine a
candidate gene or genes for polymorphisms and analyze the distribution of these
polymorphisms in patients or infected subjects vs. a normal group. The hypotheses are
usually based on plausible associations based on the mechanism of diseases studied and
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prior reports in the literature. The second approach employed is genome-wide association
studies (GWAS). In GWAS no assumptions are made as to which gene might be involved
and a scan of associations of phenotype with genotypes is performed. Such approaches
have been widely applied in animal models and moving forward with using human
subjects, as more projects like the human haplotype map (HapMap) (Frazer et al., 2007)
and the Wellcome Trust Case Control Consortium (2007) are establishing genomic
repositories for case-control studies of common diseases.
Systems Genetics Approach – Definition and Tools
Systems genetics is an approach that studies the effects of multiple genes on
modulating disease phenotypes. Instead of the classical one gene, one disease approach,
systems genetics attributes variations in phenotypes of a trait to a network of genes or
loci that are in turn affected by environmental conditions (Sieberts and Schadt, 2007).
Instead of looking at one gene, systems genetics explores one or more quantitative trait
loci (QTL) associated with a given disease or complex trait. QTLs are regions within the
genome whose genetic variation modulates quantitatively a phenotype characteristic of
the particular trait under study (Lynch and Walsh, 1998). Determining the association
between variations in specific disease phenotypes or a trait, with variations in genotypes
of a reference population can be used to locate a QTL. One of the methods used for
mapping QTLs associated with complex traits is genetic markers-trait association.
Genetic markers associated with certain loci can be inherited in linkage disequilibrium.
Generating populations with linked loci in disequilibrium is achieved though either
crosses between inbred lines, or use of the out-bred populations. In this study we used
recombinant inbred mouse strains that are fully genotyped as a genetic reference
population for mapping QTLs.
Recombinant inbred (RI) and advanced RI (ARI) mice are a genetically diverse,
segregating reference population that affords a powerful tool for systems genetics
approaches (Williams et al., 2001; Peirce et al., 2004; Tsaih et al., 2005). RI and ARI
strains have been successfully used to map quantitative trait loci (QTLs) associated with
various phenotypes and diseases (Hardy et al., 2001; Grizzle et al., 2002; Chesler et al.,
2005; Miyairi et al., 2007; Abdeltawab et al., 2008). RI and ARI strains of mice are the
progeny of two ancestral inbred strains. For example, BXD strains are progeny of mating
C57Bl/6J (B6) and DBA/2J (D2). B6 was mated with D2 to give F1 mice; all F1 progeny
are identical, yet heterozygous, with one allele from the B6 parent (B) and the other from
the D2 parent (D). Those F1 hybrids were then crossed to generate an F2 progeny, each
with random patterns of recombination. Pairs of F2 mice were designated as “parents” of
an RI line, and are then sib-mated for > 20 generations to achieve homozygosity for each
genetically distinct RI line (Figure 1-2). This breeding strategy accumulates
recombinations and random assortment of polymorphic loci. The breeding scheme used
for generation of ARI strains is slightly different from RI strains and was adopted to
increase recombination events per ARI strain, resulting in roughly double the number of
recombinations per strain compared to a conventional RI strain (Williams et al., 2001;
Tsaih et al., 2005; Shifman et al., 2006). ARI breeding scheme involves random matting
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Figure 1-2. Breeding scheme used for generation of RI strains of mice.
BXD strains are an example of recombinant inbred mice strains (RI). In this Figure, a
scheme of crossing C57Bl/6J (B6 carrying B allele) female to a DBA/2J (D2 carrying D
allele) male is shown. A representative one chromosome is shown. The parental strains
chromosomes are homozygous and when crossed, their F1 progeny are identical and
each chromosome pair is heterozygous carrying BD alleles. F1 mice are crossed to
generate F2 progeny with random recombinations. Randomly assigned F2 pairs are
designated as parents for a BXD strain, and are sib-mated for ≥ 20 generations to
achieve homozygosity. Advanced RI (ARI) strains are bred using a slightly different
scheme, where at the F2 stage, mice are randomly mated till generation 9 or 11
(according to the adopted breeding scheme (Peirce et al., 2004)) avoiding sib mating
and even cousin mating to increase the number of recombinations and diversity of the
genetic pool. There are currently > 80 ARI-BXD strains available for genome-wide
association studies.
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of F2 mice till generation 9 or 11 avoiding sib mating and even cousin matting to increase
the recombinations and hence diversity of the genetic pool. After reaching generation 9 or
11, pairs of mice are set as parental for a designated BXD strain and are sib matted for
~20 generations or until each chromosome become homozygous (Peirce et al., 2004).
The net result in both cases is a mosaic chromosomal pattern of both ancestral parents,
B6 and D2.
In the studies presented in this dissertation, we used the BXD panel of RI and ARI
strains. We had found that parental strains of BXD mice, B6 and D2 strains, showed
differential response to GAS severe sepsis. We found that D2 were susceptible to severe
GAS sepsis showing high mortality and bacterial loads in blood while B6 were relatively
resistant. This differential response of the BXD ancestral strains to GAS sepsis motivated
us to use ARI-BXD strains to parse out genes associated with differential response to
GAS sepsis. Figure 1-2 shows the breeding scheme used to generate the BXD RI panel
(explained above). The BXD strains are derived from B6 and D2 strains and consisting of
homozygous, inbred lines, each of which is genetically distinct. There are now more than
80 BXD strains. Each strain is a clone, as the recombinations become fixed after
approximately 20 generations of sib matting, so each strain is renewable and the number
of mice that can be tested per strain can be infinite with high reproducibility of results.
This is in contrast to using F2 crosses, which have recombinations and have been used in
mapping studies, however, F2 crosses recombinations are random, and therefore, it may
be not possible to reproduce results obtained using these mice. In contrast, each BXD
strain has a unique set of recombinations different from the other BXD strains and is
renewable, where we can test the same BXD strain several times (n = ∞) with highly
reproducible results. The high number of recombinations of each ARI-BXD strain makes
these strains genetically diverse, thus mimicking the genetic diversity of the human
population (Williams et al., 2001; Churchill, 2007; Peters et al., 2007). The use of BXD
strains as a reference population is facilitated by the fact that BXD strains have been
heavily genotyped with approximately 580,000 SNP and microsatellite markers
(Churchill and Doerge, 1994; Shifman et al., 2006). In addition, the genomes of the B6
and D2 parental strains have been fully sequenced with 4.5 million SNPs, 450,000 indels,
copy number variants, and inversions, facilitating the dissection of mapped genetic loci.
All taken together makes the BXD panel of ARI strains a very powerful tool as a
genetically diverse reference population for genome-wide association studies.
Overview of Aims, Results, and Organization of the Dissertation
Aims of the Studies
The overall aim of this dissertation was to analyze the role played by host
immunogenetic variability in influencing differential susceptibility to severe GAS sepsis.
To accomplish this overall aim, we first wanted to discover loci associated with
differential genetic susceptibility to severe GAS sepsis. This was done by performing
genome-wide scans for mapping QTLs associated with differential survival of a panel of
recombinant inbred (RI) mice. These scans revealed multiple QTLs on mouse
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chromosomes (Chr) 2 and X. Next, steps were taken to fine tune and explore additional
and interactive QTLs modulating severity of GAS sepsis. We fine-tuned the mapped
QTLs to narrow down the list of candidate genes at mapped QTLs. To narrow down the
candidate genes within individual mapped QTLs, we used additional BXD RI strains;
chosen based on strains haplotypes also known as strain distribution patterns (SDP) of all
BXD in the region of the mapped QTLs.
We then applied bioinformatics tools including linkage, gene ontology, cocitation networks, polymorphism analyses and pathway analyses to prioritize our
candidate genes list. Next we aimed to identify genes and pathways modulating host
response to GAS sepsis and validate those specific genes. This was accomplished by
multiple approaches. We first compared the gene expression profiles of resistant and
susceptible strains pre- and post- infection and validated differentially expressed gene
identified with quantitative real time PCR analyses that revealed multiple pathways
involved in modulating differential susceptibility to GAS sepsis. We then validated these
pathways by studying the kinetics of soluble biomarkers, both cytokines and lipid
mediators, associated with these pathways. We then aimed to analyze the cellular
populations modulating differential response to severe sepsis and identify cellular
mechanisms of differential response to severe GAS sepsis. The results of the studies are
outline below including organization of the dissertation.
To identify correlates for survival, we explored additional independent and/or
interactive traits associated with severity of GAS sepsis. Accordingly, we assessed
variations in the number of bacteria in blood as well as dissemination of bacteria to
various organs. Interestingly, both traits mapped to the same QTLs on Chr 2 associated
with modulating survival but not with the one on Chr X. Additionally we found that there
were interactions (epistatic effects) between two mapped QTLs on Chr 2. We also found
interactions between Chr 2 QTLs and the Chr X QTL.
Results and Organization of the Dissertation
In Chapter 2 of this dissertation, I will discuss the establishment of the mouse
model of GAS sepsis where we analyzed genetic, environmental and non-genetic
covariates that might be contributing to the measured phenotypes. We standardized our
model so that the observed phenotypes were mainly due to genetic differences of the
strains (heritability) rather than any of the underlying covariates. The covariates studied
included mice age, sex, and body weight, in addition to bacterial inoculate. This study is
crucial, as phenotypes associated with complex traits can be affected by interactions with
environment and/or other covariates, thus masking the actual gene networks associated
with the trait under study. Chapter 2 was published as a peer-reviewed manuscript: Aziz,
R.K., Kansal, R., Abdeltawab, N.F., Rowe, S.L., Su, Y., Carrigan, D., Nooh, M.M., Attia,
R.R., Brannen, C., Gardner, L.A. et al (2007) Susceptibility to severe Streptococcal
sepsis: use of a large set of isogenic mouse lines to study genetic & environmental
factors. Genes Immun. 8(5): 404–415.
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In the next chapter (Chapter 3), I will present how we analyzed disease
phenotypes in the context of the mice genotypes which mapped two quantitative trait loci
(QTLs) on Chromosome (Chr) 2. One QTL, between 22–35 Mb, that strongly predicts
disease severity and accounts for 25%–30% of variance (calculated using hereditary
tests) was highly significant (likelihood ratio statistic (LRS) 34.2 i.e. P < 0.0000001). We
also mapped disease severity to a second QTL on Chr 2 (LRS 12 P < 0.001). Both QTLs
harbor several polymorphic genes known to regulate immune responses to bacterial
infections. Candidate genes within these QTLs were evaluated using multiple parameters
that included linkage, gene ontology, and variation in gene expression. We identified
interleukin 1 (IL1) and prostaglandin E synthases pathways as key networks involved in
modulating GAS sepsis severity. Chapter 3 was published as a peer-reviewed manuscript:
Abdeltawab, N., Aziz, R.K., Kansal, R.K., Rowe, S., Su, Y., Gardner, L.A., Brannen, C.,
Nooh, M., Attia, R., Abdelsamed, H. et al. (2008). An Unbiased Systems Genetics
Approach to Mapping Genetic Loci Modulating Susceptibility to Severe Streptococcal
Sepsis. PLoS Pathog. 4(4):e1000042.
In Chapter 4, I will present our attempts to identify molecular and soluble
biomarkers associated with differential susceptibility at multiple stages of infection. I
explored changes in the genome-wide expression levels, where we examined differential
gene expression at early stages of infection in resistant and susceptible strains and
compared it to late stages of infection. In addition, we sought to examine patterns of
cytokines, as soluble biomarkers, associated with late and early stages. Chapter 4 is a
manuscript in preparation: Abdeltawab, NF, Kansal, R, Mukandan, S., Bangar, H.,
Aronoff, D., Senn, T., Jordan, M., Williams, RW, & Kotb, M. Genomic & soluble
biomarkers associated with different outcomes of Group A streptococcal sepsis reveal
underlying mechanisms of differential host susceptibility.
Next, in Chapter 5 we wanted to examine the role of these genes and pathways at
the cellular level. We immunophenotyped selected resistant and susceptible BXD strains
where we examined and characterized the relative percentages of blood and spleen
cellular populations at normal uninfected selected resistant and susceptible strains. We
concluded that migratory and functional differences rather than cellular availability might
be a possible mechanism of resistance. Subsequently, we wanted to dissect and confirm
the cellular response in our model by depleting neutrophils, which are known to be
associated with susceptibility to GAS infection. We blocked Gr-1 receptors, which are
receptors expressed on the surface of neutrophils and some populations of monocytes and
dendritic cells, this rendered resistant strains susceptible. This led us to more experiments
on analyzing the role of neutrophils and the associated host pathways modulating this
response. Chapter 5 is a manuscript in preparation: Abdeltawab, NF, Bangar, H., Kansal,
R., Williams, RW, & Kotb, M. Host-pathogen interactions in Group A streptococcal
sepsis: role of macrophages & neutrophils.
Finally, I will discuss and summarize the results of the studies done in this
dissertation in Chapter 6, in addition to future directions of this project.
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CHAPTER 2. SUSCEPTIBILITY TO SEVERE STREPTOCOCCAL SEPSIS: USE
OF A LARGE SET OF ISOGENIC MOUSE LINES TO STUDY GENETIC AND
ENVIRONMENTAL FACTORS 
Summary
Variation in responses to pathogens is influenced by exposure history,
environment, and the host’s genetic status. We recently demonstrated that HLA class II
allelic differences are a major determinant of the severity of invasive group A
streptococcal (GAS) sepsis in humans. While in-depth controlled molecular studies on
populations of genetically well-characterized humans are not feasible, it is now possible
to exploit genetically diverse panels of recombinant inbred (RI) BXD mice to define
genetic and environmental risk factors. Our goal in this study was to standardize the
model and identify genetic and nongenetic covariates influencing invasive infection
outcomes. Despite having common ancestors, the various BXD strains (n strains = 33, n
individuals = 445) showed marked differences in survival. Mice from all strains
developed bacteremia but exhibited considerable differences in disease severity, bacterial
dissemination, and mortality rates. Bacteremia and survival showed the expected negative
correlation. Among nongenetic factors, age—but not sex or weight—was a significant
predictor of survival (p = 0.0005). To minimize nongenetic variability, we limited further
analyses to mice ages 40–120 days and calculated a corrected relative survival index
(cRSI) that reflects the number of days an animal survived post-infection normalized to
all significant covariates. Genetic background (strain) was the most significant factor
determining susceptibility (p ≤ 0.0001), thus underscoring the strong effect of host
genetic variation in determining susceptibility to severe GAS sepsis. This model offers
powerful unbiased forward genetics to map specific quantitative trait loci and networks of
pathways modulating the severity of GAS sepsis.
Introduction
There is now overwhelming evidence that specific genetic factors influence a
host’s susceptibility or immunity to many infectious agents, and modulate severity and
outcome of infectious diseases (reviewed in [Skamene, 1983; Roy and Malo, 2002;
Frodsham and Hill, 2004; Kotb, 2004]). Infection with group A streptococcus (GAS or
Streptococcus pyogenes) represents an ideal model for studying effects of host genetics
on disease. This human pathogen causes a wide variety of conditions ranging from sore
throat to invasive life-threatening diseases (reviewed in [Cunningham, 2000]), and the
same strain of pathogen leads to different outcomes in different individuals (Chatellier et
al., 2000). Our laboratory provided direct evidence that the highly polymorphic human



Source: Reprinted with permission. Aziz, R.K., Kansal, R., Abdeltawab, N.F., Rowe, S.L., Su,
Y., Carrigan, D., Nooh, M.M., et al. (2007) Susceptibility to severe Streptococcal sepsis: use of
a large set of isogenic mouse lines to study genetic and environmental factors. Genes Immun 8:
404-415.
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leukocyte antigen (HLA) genes confer high risk or protection in rheumatic heart disease
(Guedez et al., 1999) as well as in streptococcal toxic shock (STSS) and necrotizing
fasciitis (NF) (Kotb et al., 2002; Kotb et al., 2003). In GAS sepsis, allelic variation in
HLA class II molecules plays a major role in modulating infection severity, primarily
because they serve as binding and signaling receptors for superantigens (Kotb, 1992;
Kotb, 1995), which are the primary trigger of the severe inflammatory responses that can
lead to organ failure and shock (Norrby-Teglund et al., 2001; Proft et al., 2003).
To systematically identify additional gene variants that modulate susceptibility to
severe GAS sepsis and to elucidate how they influence disease outcome, we sought a
robust experimental model of the disease with attributes that incorporate roughly the
same level of genetic variation as that of human populations. Small numbers of
conventional inbred mouse strains have been used previously to study differential
susceptibility to GAS infection (Medina et al., 2001; Goldmann et al., 2003, 2004b);
however, these models are limited in their genetic variability and cannot be used to map
modifier loci. HLA transgenic mice are appropriate models for GAS sepsis (Nooh et al.,
2007) but these too are generated on the genetic background of conventional inbred
laboratory strains.
The genetically diverse mouse reference population of recombinant inbred (RI)
strains, which can be likened to an immortal population of human monozygotic twins, is
an ideal model for our studies. RI strains are generated by the crossing of two inbred
strains followed by ≥ 20 consecutive generations mating among siblings (Bailey, 1971;
Taylor, 1978). These types of strains are frequently used for studying genetic variation
and mapping quantitative trait loci (QTL) influencing disease (Peirce et al., 2004; Chesler
et al., 2005). The BXD strains were used recently to study variation in the pathogenicity
of bovine spongiform encephalopathy and to uncover genes modulating anthrax and pox
lethality (Benjamin et al., 1986; Melvold et al., 1990; Watters et al., 2001)
Among the different panels of RI strains, we selected the BXD set produced from an
intercross of C57BL/6J and DBA/2J. The parental strains are known to differ in response
to many pathogens (Plant and Glynn, 1976; Anthony et al., 1989; Boyartchuk et al.,
2001; Mahler et al., 2002). The other notable advantage of this particular panel of RI
strains is that both parental strains have been sequenced (Waterston et al., 2002). This
makes it possible to use reverse genetic methods to test modifier genes (Williams, 2006).
We have 80 BXD strains that are being extensively phenotyped and genotyped.
As a first step in exploiting the BXD strains to study the genetics of GAS
susceptibility, we have studied the influence of differences in sex, age, body weight,
inoculum titer, and genetic factors on disease development. Our main objective has been
to develop a protocol that can be applied uniformly across the entire BXD set of 80. Our
second objective has been to measure heritability and evaluate prospects of mapping
modifier loci. We show the genetic and nongenetic factors that determine whether a
mouse is protected from or susceptible severe GAS sepsis, we evaluate the contribution
of each of these factors using multivariate analysis, and we discuss the proper measures
that should be followed to design experiments using this novel and promising mouse
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model in other infectious disease and for elucidating the complex events of host-pathogen
interactions.
Results
The main purpose of this study was to adapt and standardize the BXD RI model
to investigate the genetic and molecular mechanisms associated with susceptibility to
severe invasive GAS sepsis, to determine the nongenetic environmental factors affecting
the model, and to test whether the genetic variations among these mice would affect the
progression and severity of invasive GAS disease. We used 717 mice in the study: 218
mice in the preliminary phase, 445 for the initial statistical analysis, 307 of which were
selected for the final analysis as detailed below, and 54 for the time-course experiments.
Survival Scores Show Differential Susceptibility to Severe GAS Sepsis
To assess the phenotype ‘susceptibility or resistance of mice to severe GAS
sepsis,’ we calculated a survival score for each animal as a quantitative trait: among 445
mice tested in six experiments, a notable variability was observed in survival scores
measured as days post-infection. Interestingly, the distribution of the survival scores was
not normal but multimodal, showing three groups (Figure 2-1-A), the largest of which
represented animals (n = 208) that died early (in less than 2.5 days). Another group
included an intermediate population (n = 125) that survived between 2.5 and 4.5 days and
the third group (n = 112) survived for more than 5 days and up to the entire 7-day
observation period. This pattern of survival was highly reproducible and predictable from
one experiment to another with slight variability in the boundaries separating the three
clusters in each experiment.
Bacterial Loads in Blood and Organs Show Various Degrees of Bacteremia and
Tissue Dissemination
The bacterial load in blood (calculated as ‘bacteremia index,’ BI = log CFU/ml
blood sampled 24 h post-infection) was measured for 396 of 445 mice used in six
experiments. *In contrast to the survival scores, bacterial load followed a normal
distribution (Figure 2-1-B). With the exception of a few mice (n = 6) whose blood was
sterile (possibly due to injection failure), all mice had bacteremia with counts ranging
from 125 CFU/ml (BI = 2.097) to 1.72 x 109 CFU/ml (BI = 9.236), the mean BI ± SE was
5.2 ± 0.07 reflecting a highly symmetrical distribution. Correlation analysis showed an
inverse relation between survival scores and BI. The Pearson product moment-correlation
factor of –0.430 (Figure 2-1-C) indicates that the BI accounts for 20 – 30 % of variance
in mortality.

*

In some cases, mice died before their blood was sampled and in other cases, the bacteria were
too numerous to be counted by the plate dilution technique.
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Figure 2-1. Distribution and correlation of survival scores and bacteremia indices.
Histograms showing the frequencies of survival scores (A) and log CFU/ml blood, or
bacteremia indices, BI (B). A. The distribution of the survival scores of 445 animals
from six experiments was multimodal, showing three clusters representing a susceptible,
an intermediate, and a resistant population. Bars representing the intermediate population
are shaded in grey. B. The distribution of BI for 396 was unimodal and symmetric, with
the exception of six animals having sterile blood (leftmost bar). C. A scatter plot
showing the negative correlation between survival scores and BI. Pearson productmoment correlation factor is indicated.
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In addition to counting bacteria in blood, in some experiments we determined the
bacterial dissemination in different systemic organs (mainly spleen, but also liver and
lung) to estimate invasiveness of the disease. Among 335 mice with confirmed
bacteremia, only 14 had sterile spleens while the remaining mice had bacterial counts
ranging from 102 to 3x1010 CFU/spleen, with a median count of 1.3x108 CFU/spleen.
Bacterial loads in liver and lung were determined for 77 mice, and the median counts
were 3.16x109 CFU/liver and 2x109 CFU/lung, with a wide range of variation.
Statistical Analysis Evaluates the Confounding Factors Affecting Mice Survival
The variability in animal mortality and extent of bacteremia is not surprising and
matches that reported in human infection (Davies et al., 1996; Basma et al., 1999; Muller
et al., 2003) and in mice strains (Medina et al., 2001). However, in this particular set of
experiments, it was necessary to determine whether this variability reflects genetic
differences between different BXD strains or is it mere biological variability caused by
confounding factors like sex, body weight, animal age, or experiment-to-experiment
variability (due in part to differences in inoculum size or other experimental error). The
large number of animals used and the availability of replenishable inbred BXD lines
made such analysis possible and efficient.
First, we examined the effect of inoculum size. In preliminary experiments, we
conducted a dose-response study in which we exposed animals to bacterial inocula
ranging from 105 to 108 CFU/ml to find an optimal dose that would kill animals rapidly
but would also discriminate between susceptible and resistant strains (data not shown).
We chose an inoculum size of 107 CFU/ml because it showed clear differences between
the parental strains (C57BL/6J and DBA/2J). However, because it is difficult to
reproduce the inoculum titer in every experiment, and because precise counts could only
be determined after injection, it was important to examine whether the inter-experimental
differences in inoculum size had an effect on survival. Slight variation in inoculum size
had an insignificant effect on survival (r2 = 0.1%, p = 0.533) Figure 2-2-A.
We tested whether sex had an effect on survival. Male mice (n = 235) had a mean
survival of 3.49 ± 0.12 days and a median of 3 days, slightly higher than female mice (n
= 206) that had a mean of 3.25 ± 0.12 days and a median of 2.3 days. This difference did
not achieve statistical significance (p = 0.153) Figure 2-2-B.
Subsequently, we tested the effect of animal body weight and age on survival, and
each of the two factors, independently, showed positive association with survival scores
(Figure 2-2-C and 2-2-D). Whereas weight had a correlation of 0.29, age has a stronger
correlation (factor = 0.44). It is noteworthy that weight was directly proportional with
animal age between the ages of 40–120 days. Based on these findings, we decided to use
animals in the age range of 40–120 days and to correct for age effects using a General
Linear Model (GLM).
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Figure 2-2. Effect of non-genetic factors on the survival of BXD mice and their
parental strains.
Scatter plots showing the effect of the inoculum size (A), the mice body weight (C), and
their age (D) on their survival. The effects of these confounding factors were evaluated
by linear regression and Pearson product-moment correlation analyses, and the values
of r2 and correlation factors are shown when necessary. B. Box plots of animal sex
versus animal survival in days post-infection. The significance of the effect of sex was
tested by the student-t test, and the p-value is shown. D. Vertical dashed lines show the
range of animals selected for further analysis.
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Analysis of Covariates Underscores the Role of Genetic Background in Determining
Animal Susceptibility to GAS
Having determined the effect of several major cofactors on survival scores, we set
out to determine the complex interaction between these covariates and the genetic factor
(i.e., the mouse strain). At this stage of the analysis, we filtered our data set to exclude
mice that were outside the 40–120 days age range (see above) and we selected BXD
strains that had been used in at least two experiments. Table 2-1 lists mice selected for
final analysis. We took advantage of the multimodal distribution of survival scores
detailed above (see Figure 2-1-A) to define a survival index (SI): animals were given a
score ranging from 0.25 to 3, with increments of 0.25 (0.25 for most susceptible and 3.0
for most resistant). The use of SI was superior to survival scores as it normalized the data
across experiments and minimized the unavoidable experiment-to-experiment variance in
survival scores caused by slight differences in inoculum size and other systematic sources
of error.
Finally, we performed GLM analysis of covariates using ordinary least squares
ANOVA to determine the relative effect of covariates, including mouse strain, on
survival (Table 2-2). This analysis revealed that strain was the most significant predictor
(p ≤ 0.0001), followed by age (p = 0.0005), and weight (p = 0.02). As shown in Figure 22-B, sex remained an insignificant factor in the final analysis (Table 2-2). From the
GLM, we estimate the main effect attributable to strain (a measure of heritability) to be
25–30% (42.21/152.44, see Table 2-2). This GLM analysis was not only helpful in
assessing effects of several factors, but it also allowed us to generate a corrected relative
survival index (cRSI), which was used to compare the strains and determine their relative
susceptibility—correcting for differences in age and weight (Figure 2-3).
BXD Strains Exhibited Phenotype Variability Outside the Range of the Parental
Strains
The comparison of cRSI values between different strains (Figure 2-3) reveals the
stark effect that the genetic background plays in predicting how long a mouse will
survive after being exposed to a high dose of GAS. Some strains have very low mean
cRSI (e.g., BXD66, BXD97, and BXD61) and are highly susceptible, whereas others are
almost completely resistant (e.g., BXD87, BXD92, and BXD69). The difference between
the cRSI values of parental strains, shown on the two extreme sides of the bar chart
(Figure 2-3), was more modest than the variation displayed by the different BXD strains.
This finding underscores the complexity of the trait we are measuring (susceptibility/
resistance) and highlights the fact that the survival phenotype is modulated by multiple
loci.
Following the same method of building a GLM for covariate analysis, we
corrected the BI and the log CFU/spleen by calculating the coefficients that express the
contribution of ‘mouse strain’ as a predictor for BI and for spleen dissemination (Figure
2-4). As shown with the inverse correlation between survival score and BI (Figure
2-1-C), most strains that were judged susceptible based on their cRSI (e.g. BXD60,
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Table 2-1. Mouse strains used in the final analysis of this study.
Strain

N
11
12

Age
(Mean ± SE)
75.55 ± 3.76
88.92 ± 3.79

Body Weight
(Mean ± SE)
21.98 ± 0.90
23.74 ± 0.59

C57BL/6J
DBA/2J
BXD43
BXD44
BXD45
BXD51
BXD60
BXD61
BXD62
BXD64
BXD66
BXD69
BXD70
BXD73
BXD74
BXD75
BXD85
BXD87
BXD89
BXD90
BXD92
BXD97

11
11
20
16
13
9
14
12
7
14
17
14
14
22
16
8
23
17
14
12

91.45 ± 5.05
75.09 ± 7.96
80.00 ± 4.48
74.00 ± 4.39
68.38 ± 6.31
57.67 ± 0.53
62.14 ± 2.26
96.67 ± 2.38
90.57 ± 6.30
73.93 ± 5.63
82.00 ± 4.83
86.14 ± 2.01
77.00 ± 7.14
74.36 ± 4.16
78.69 ± 4.97
89.00 ± 3.78
87.22 ± 4.48
83.71 ± 5.09
81.86 ± 1.82
98.33 ± 4.24

23.92 ± 0.77
22.67 ± 1.88
24.10 ± 0.72
23.32 ± 0.89
24.28 ± 1.63
20.13 ± 0.64
20.70 ± 0.71
22.46 ± 0.77
23.66 ± 1.19
21.48 ± 0.70
24.11 ± 0.81
22.40 ± 1.24
21.53 ± 0.97
23.69 ± 0.74
26.72 ± 1.42
19.50 ± 0.74
23.71 ± 0.56
27.40 ± 0.81
27.48 ± 1.66
26.68 ± 1.09

Total Cases

307

80.33 ± 1.123

23.66 ± 0.240

Table 2-2. Analysis of Variance for Survival Index.
Source

df*

Const
Wt
Sex
Age
Strain
Error

1
1
1
1
21
282

Sums of
Squares
937.56
1.73
0.19
3.97
42.21
90.80

Total

306

152.44

Mean
Square
937.56
1.73
0.19
3.97
2.01
0.32

* df: Number of degrees of freedom.
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F-ratio
2911.80
5.37
0.58
12.32
6.24

Probability
≤ 0.0001
0.0212
0.4452
0.0005
≤ 0.0001

Figure 2-3. Differential susceptibility of BXD strains to invasive GAS.
A bar chart showing the mean values of corrected relative survival indices (cRSI) for
different BXD strains, arranged in ascending order. Parental strains (C57Bl/6J and
DBA/2J) are shown on the two extremities of the X-axis. Error bars represent the
standard errors of the means. The total number of animals (n) used per strain is indicated.
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Figure 2-4. Variation in bacteremia and spleen dissemination in different BXD
strains.
Bar chart showing the mean values of corrected bacteremia indices, cBI, (A) and
corrected loc CFU/spleen (B) for different BXD strains, arranged in ascending order.
Parental strains (C57Bl/6J and DBA/2J) are shown on the two extremities of the X-axis.
Error bars represent the standard errors of the means.

21

BXD66, and BXD75) had higher cBIs, and vice versa (e.g. BXD69 and BXD73).
However, there were exceptions, e.g., BXD44 had a negative cRSI and a negative cBI as
well, and BXD92 was one of the most resistant strains but showed intermediate, rather
than low, bacteremia (Figure 2-4-A). Additionally, when examining the bacterial
dissemination in spleens of different strains (Figure 2-4-B), most susceptible strains had
high dissemination and vice versa, again with exceptions, e.g. BXD69. Conversely, the
parental strains were this time clearly on two sides of the spectrum, with DBA/2J having
the highest spleen dissemination and C57BL/6J having one of the lowest values.
Collectively, the data suggest the existence of different mechanisms leading to mortality.
Controlled Time-course Experiments Show the Kinetics of Bacterial Spread and
Confirm Results of Population-based Experiments
Having generated data with large number of mice and with strong statistics, we
moved to confirm the population-based study through time-course experiments that
would clarify the kinetics of bacterial dissemination or clearance in the early hours of
infection. In one representative experiment, we selected animals from six strains
predicted to have the following descending order of susceptibility BXD61, BXD60,
BXD51, BXD73, BXD89, BXD69 (Figure 2-3-A) and we infected them with the same
dose of bacteria, then sacrificed three mice per strain at 18 h, 36 h, and 60 h. Overall, the
results were as expected: All mice developed bacteremia, and their organs (spleen, lung,
and liver) were positive for bacterial dissemination, but the kinetics of bacterial
dissemination/ clearance were quite different. Strains BXD60 and BXD61, predicted as
the most susceptible in this experiment, behaved as expected with highest bacterial loads
in their spleens and highest rate of bacterial invasiveness, estimated from the slopes of
bacterial dissemination in their organs over time (Figure 2-5 and Table 2-3). BXD69 was
the most resistant strain to bacterial dissemination, with the lowest bacterial loads in
organs and a tendency to clear bacteria rapidly (note the negative slopes in Figure 2-5-B
and 2-5-C); this behavior matches its rank as having one of the lowest cRSI (Figure 2-3)
and cBI (Figure 2-4-A). A similar pattern was displayed by BXD51, an intermediate
strain that tends to have lower bacterial counts in blood and spleen (Figure 2-4). More
interesting, however, was the behavior of BXD73 and BXD89 strains, both of which are
resistant strains that showed delayed bacterial clearance in the first 60 h. While BXD73
had bacterial dissemination in organs an order of magnitude lower than BXD60 and
BXD61, BXD89’s counts seemed to follow the pattern of a susceptible rather than a
resistant strain. This underscores the dissociation between the speed of bacterial
dissemination and animal mortality as separate traits. A possible explanation is that
BXD89 has an attenuated immune system that may delay bacterial clearance but that
does not harm the host.
Preliminary Quantitative Trait Loci Mapping
To provide accurate QTL mapping, we are conducting a more extensive study
with more strains and more mice per strain. However, with the current number of strains
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Figure 2-5. Kinetics of bacterial dissemination in lung, liver, and spleen of six BXD
strains.
Scatter plots of the bacterial dissemination during the first 60 h of an active infection in
spleens (A), livers (B), and lungs (C) of mice from 6 strains with different
susceptibility to GAS sepsis. Color regression lines indicate the rate and extent of
change in log CFU bacteria/organ versus time for each strain.
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Table 2-3. Extent of invasiveness in time-course experiments, as measured by
bacterial loads in spleen, liver, and lung.
Strain
BXD51
BXD60
BXD61
BXD69
BXD73
BXD89

Mean ± SE Log CFU/Spleen
18h
36h
60h
5.19 ± 0.12 5.44 ± 0.50 3.91 ± 2.39
4.29 ± 0.35 7.22 ± 0.24 7.50 ± 1.26
4.26 ± 0.37 4.57 ± 0.35 8.64 ± 0.32
2.31 ± 1.19 4.10 ± 0.67 2.79 ± 1.41
3.48 ± 0.48 3.74 ± 1.87 5.11 ± 0.32
4.78 ± 0.31 6.16 ± 0.13 6.27 ± 0.96

Regression
r2
p
6.80%
0.466
47.90%
0.039
81.40%
0.001
0.60%
0.84
14.60%
0.35
29.50%
0.131

Strain
BXD51
BXD60
BXD61
BXD69
BXD73
BXD89

Mean ± SE Log CFU/Liver
18h
36h
60h
5.71 ± 0.13 6.43 ± 0.54 4.06 ± 2.53
4.45 ± 0.39 7.92 ± 0.26 8.03 ± 1.25
5.64 ± 0.27 6.20 ± 0.74 8.39 ± 0.06
4.22 ± 0.13 5.31 ± 0.58 3.31 ± 1.67
2.24 ± 2.24 4.24 ± 2.12 5.49 ± 0.38
5.21 ± 0.33 6.92 ± 0.16 7.74 ± 0.96

Regression
r2
p
9.60%
0.385
49.00%
0.036
72.70%
0.004
6.80%
0.499
23.80%
0.22
56.50%
0.02

Strain
BXD51
BXD60
BXD61
BXD69
BXD73
BXD89

Mean ± SE Log CFU/Lung
18h
36h
60h
4.60 ± 0.33 5.43 ± 0.38 3.01 ± 3.01
3.97 ± 0.28 6.55 ± 0.13 6.93 ± 1.09
4.62 ± 0.33 2.68 ± 1.40 8.26 ± 0.29
2.83 ± 1.42 4.13 ± 0.65 1.26 ± 1.26
2.50 ± 2.50 2.74 ± 1.52 5.01 ± 0.90
3.90 ± 0.28 5.77 ± 0.16 6.66 ± 1.50

Regression
r2
p
7.00%
0.46
52.20%
0.028
39.00%
0.072
12.70%
0.346
19.10%
0.327
42.00%
0.059
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and mice we used the WebQTL tools on the GeneNetwork web site
(http://www.genenetwork.org) and were able to exclude certain sites that could have
possibly contributed to the modulation of GAS sepsis severity. For example, our human
genetic association studies in patients with severe GAS sepsis revealed a strong
association with HLA class II haplotypes (Kotb et al., 2002). It was therefore interesting
to determine whether any QTLs map to the H2 locus. Although the parental strains
differed in their H2 types (the C57/BL6 mice are H2-b while the DBA/2J mice are H2-d),
we could not find any hint for significant QTLs in the H2 region on chromosome 17.
Instead, our preliminary mapping results suggest two significant QTLs on chromosome 2
that we are currently verifying and fine-tuning using additional mice and strains. The
insignificant contribution of the mice H2 locus was not entirely surprising because the
HLA class II association in humans is related to the role of these molecules in presenting
GAS superantigens to T-cells. While superantigens play a crucial role in the human
disease and in HLA-transgenic mice (Nooh et al., 2007), they have little contribution in
the BXD mouse model because GAS superantigens are poorly presented by mouse H2.
Discussion
The Strength of the BXD Recombinant Inbred Population Model
Clinical and epidemiological observations provide evidence of strong differences
in human susceptibility to GAS infections and the severity and outcomes of diseases
caused by the same strain of bacteria (Hoge et al., 1993; Davies et al., 1996; Kaul et al.,
1997; Johnson et al., 2002; Kotb, 2004). For example, we have previously demonstrated
a dominant effect of HLA class II allelic polymorphisms in severe GAS sepsis (Kotb et
al., 2002; Kotb et al., 2003). We also provided biological confirmation of these
associations with HLA both in vitro (Kotb et al., 2002; Norrby-Teglund et al., 2002) and
in vivo (Nooh et al., 2007). Despite this strong association with HLA class II
polymorphic alleles, we realize that sepsis is a complex disease affected by multiple
interactive pathways. To identify additional pathways and polymorphisms contributing to
the stark difference in the severity of GAS sepsis, we explored several animal models that
may be suitable for this genetic study. While non-human primates represent an alternative
to study human GAS infections (Virtaneva et al., 2003; Virtaneva et al., 2005), their use
in immunogenetic population studies is expensive and impractical due to their slow
breeding pattern and small progeny, high cost, and ethical issues. Meanwhile, regular
laboratory mice, which share ~85% gene content with humans (Jackson, 2001), are not
sensitive to invasive GAS infections (Miethke et al., 1992; Welcher et al., 2002) just as
certain human populations are not good models for certain human diseases because of
their genetic resistance. This natural resistance of mice to severe GAS sepsis can be
overcome by the use of high infectious doses, less resistant strains, or transgenic mice
carrying human HLA class II (Nooh et al., 2007) or human plasminogen (Sun et al.,
2004; Cole et al., 2006).
Despite this, successful attempts were made with standard inbred mouse lines,
e.g., BALB/c, C3H/HeN, and CBA/J, C57BL/10 (Medina et al., 2001), and DBA/2 and
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C57BL/6 (Kansal and Kotb, submitted); whereas these studies were quite informative,
conventional mouse models are limited in their genetic pool, and thus one may miss
important genotype-trait relations. Our choice was thus to use one of the genetically
diversified mouse reference populations generated by the international Complex Trait
Consortium (CTC). The CTC strategy, known as the Collaborative Cross (CC), is to
construct a very large set of RI strains from a genetically diverse set generated by
intercrossing conventional inbred mice (Vogel, 2003; Churchill et al., 2004; Peirce et al.,
2004).
RI strains are an ideal resource for systems biology research as they provide a
reproducible, highly varied, and diversified yet controlled set of genetic backgrounds for
functional genomics, QTL mapping, and identification of interactive gene networks
modulating disease phenotype (Valdar et al., 2006). Being inbred, RI strains are
perpetually renewable, and have many advantages over F2 or backcross populations.
Experiments performed with RI mice can be repeated in different laboratories and at
different times with expected reproducibility. This adds high statistical power. Because
the ancestral parents are fully sequenced, the genotyped RI strains afford a powerful tool
for identifying genes within QTLs and are particularly useful for mapping multiple and
epistatic genetic effects underlying complex phenotypes, including those seen in
infectious diseases (Caron et al., 2002; Churchill et al., 2004; Peirce et al., 2004; Ouburg
et al., 2005; Roy et al., 2006).
Among the different RI sets of mice, we found the BXD panel more suitable for
us than other series (e.g., the AXB set) as the BXD series is much larger, almost 3-times
more than used in any other series of experiments and because both parental strains
(C57BL/6J and DBA/2J) have been fully sequenced (Waterston et al., 2002), and have
been shown to differ in their response to many pathogens (Hormaeche, 1979b, a; Mitsos
et al., 2000; Boyartchuk et al., 2001; Boyartchuk and Dietrich, 2002; Mitsos et al., 2003),
including GAS (Kansal and Kotb, personal communication).
The Complexity of the Phenotype
Susceptibility to a particular bacterial infection and disease severity are complex
phenotypes likely to be contributed by more than one genetic factor, and by networks and
pathways modulated by gene products. Our attempt to attribute one or two sets of genetic
loci that predispose mice to or protect them from certain infections could be misleading if
we fail to take the complexity of the phenotype into consideration. In this study, we
explored the response of a panel of 20 BXD RI mice (plus the two parental strains) to
infection with the same dose of GAS and monitored them over a week post-infection. To
quantify the animals’ susceptibility to GAS and the severity of sepsis, we measured three
variables: animal survival, bacteremia, and dissemination in systemic organs (spleen,
liver, and lung). Our results provide solid evidence of the complexity of our phenotype.
One manifestation of this complexity is that BXD strains exhibited a much wider range of
variability in survival (Figure 2-3) and bacteremia (Figure 2-4-A) than the parental
strains; yet, the two ancestral strains were on the two extreme sides of the panel of
bacterial dissemination in spleen (Figure 2-4-B). This behavior is likely a result of the
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random assortment of many polymorphic loci that accentuate resistance or susceptibility
to infection depending on the pattern by which they are inherited from the parental strains
to the offspring. Another consequence of the trait complexity is that the different strains
did not show identical patterns for the different measured variables (Figures 2-3 and 2-4).
There was a significant correlation between survival and bacteremia (Figure 2-1-C), but it
only explained 25% of the variance. Differences in the kinetics of bacterial dissemination
to organs of BXD strains in the first 60 h of disease (Figure 2-5 and Table 2-3) highlights
the uniqueness of each strain, and shows the importance of following the course of
infection at multiple time points.
Our analysis indicates that bacteremia and dissemination to organs were major
predictors of disease severity and mortality; however, it is likely that other factors
contribute to mortality including severe toxicity and inflammatory responses in blood and
organs.
The Power of Statistical Analysis
A major part of our study was dedicated to the optimization and standardization
of this novel mouse model. We conducted preliminary experiments to optimize the
inoculum size and volume, the number of mice to be used per strain, and the best
randomization scheme for injecting mice and recording the data. Subsequently we
generated a large data set from 445 mice, and we used this data set to estimate the effect
of independent confounding factors like sex, age, body weight, and inoculum size (Figure
2-2) as well as the combined effects of these covariates (Table 2-2). As a result of these
analyses, we filtered our data set, bringing the number of analyzed cases to 307, after
excluding animals from strains that were tested only once, and those that did not fall in
the age range where age and weight were colinear. The analysis of covariates also helped
us to estimate the contribution of each factor in predicting susceptibility to the severe
form of GAS sepsis therein allowing us to correct the measurable traits (SI, BI, and Log
CFU/spleen) for significant covariates. Correction for age, for example, was a vital
alternative to age-matching all animals, which is not feasible because the breeding
scheme of 20 strains cannot be synchronized practically. The ability to use a large
number of strains and to repeat experiments using the same strains added power to the
statistical analysis. Combining the genetic diversity of the RI strains with statistical
analysis allowed the dissection of many factors contributing to infection phenotype using
relatively small numbers of animals and a large number of strains.
The Preliminary Quantitative Trait Loci Mapping Results
It is rather risky to attempt to identify QTLs using only 20 BXD strains, and this
was not the intention of this study, which focused on developing the model and
identifying significant covariates affecting the severity of GAS sepsis. Nonetheless, we
were able to exclude plausible regions as major contributors to GAS sepsis severity. For
example, we can comfortably exclude any contribution from the H2 region on
chromosome 17. Although our previous studies showed strong association with HLA
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class II genes (Kotb et al., 2002; Nooh et al., 2007), it was not surprising that the mouse
H2 allelic variation does not contribute to GAS sepsis severity because the mouse H2
molecules are very poor presenters of GAS superantigens that are pivotal in mediating
the pathogenesis of the human disease. The BXD model allows us now to map QTLs and
identify additional bacterial virulence strategies involved in the pathogenesis of sepsis.
The latter are usually masked by the overwhelming effects of superantigens in human
studies and the HLA-transgenic mouse model (Kotb et al., 2002; Nooh et al., 2007).
Preliminary mapping studies pointed to two regions on mouse chromosome 2, which
harbor many genes of relevance to immune modulation. Ongoing studies using additional
strains are expected to confirm and narrow down these QTLs.
Conclusion
The BXD RI strains afforded a good model for the analysis of traits that
contribute to severe GAS sepsis. The genetic diversity of these strains exaggerates or
suppresses traits seen in the parental strains. Having standardized the model and set major
criteria for selecting the animals to be used and analyzed, we will continue generating
data by using more BXD strains and bioinformatics tools to map QTLs and determine the
genetic basis for the large differences in disease susceptibility among these animals.
Mapping QTLs is likely to identify gene variants (polymorphisms, SNPs, or mutations)
that underlie the remarkable individual differences that are a hallmark of host-GAS
interactions; however, our long-term goal is to generate a disease roadmap by revealing
the networks involved in these inter-strain differences.
Materials and Methods
Mice
The BXD strains are completely inbred strains generated by repeated mating
between siblings starting from F2 intercross progeny between C57BL/6J and DBA/2J
(Taylor, 1978; Taylor et al., 1999; Williams et al., 2001; Peirce et al., 2004). In this
study, we used 717 mice belonging to a set of 33 BXD strains along with the parental
strains, C57BL/6J (B6) and DBA/2J (D2). Among these mice, 218 were used in the
preliminary experiments for optimization of inoculum size and experimental conditions,
445 were used in the population-based experiments, and 54 were used in the controlled
time-course experiments. The animals chosen for final statistical analysis of the
population-based experiments (n = 307) were those that satisfied all the conditions
determined in the study (see Results) and that belonged to a BXD strain that was used in
at least two experiments.
The animals were mated and housed in a pathogen-free colony on hardwood chip
bedding in microisolator cages at the VA Medical Center and the University of
Tennessee Health Science Center, Memphis, TN. They were maintained on a 12 h lightdark cycle, in a room kept at 23 °C with 50–60% relative humidity and were given tap
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water and sterile irradiated rodent chow (Harlan Teklad, Madison, WI) ad libitum. All
protocols were approved by the Institutional Animal Care and use Committees of
Veterans Affairs Medical Center and The University of Tennessee.
Bacteria and Culture Media
We used the clinical isolate, GAS-5448 (Kansal et al., 2000), representative of the
clonal M1T1 strain that has globally disseminated since the mid 1980s and was
associated with severe and non-severe GAS infections (Chatellier et al., 2000; Aziz et al.,
2005). The bacteria were incubated in Todd Hewitt Broth (DIFCO, Detroit, MI) supplied
with 1.5% of yeast extract (DIFCO, Detroit, MI), or THY, for 17 h, washed twice with
sterile phosphate-buffered saline solution, PBS (GIBCO, Carlsband, CA), then diluted to
the final inoculum size with sterile PBS. The original isolate had been aliquoted in THY
stocks containing 15% glycerol (Sigma, Saint Louis, MO) at –80˚C. Before each use, the
bacteria were spread on blood agar plates (Becton Dickenson, Franklin Lakes, NJ) for
colony isolation and sterility checking.
Experimental Design and Infection Scheme
Before the start of each experiment, we randomized animals to avoid bias in the
order of injection, weighing, or sampling. We kept males and females in different cages.
Animals were infected via the tail vein injection with a 2 ± 1 x107 CFU/mouse (unless
otherwise stated). Twenty-four hours post-infection, blood was sampled for bacteremia:
20 ml was drawn from the tail vein and diluted 10-fold in sterile saline (SS). During the
observation period (7 days), animals were weighed twice a day (8:00 a.m., 4:00 p.m.) and
checked for survival three times a day (8:00 a.m., 4:00 p.m., and at midnight). We
dissected spleens, livers, and lungs from mice that were sacrificed at specified time
points, as well as animals that expired prior to sacrifice, and we homogenized these
tissues using a rotor stator homogenizer (Omni International, Marietta, GA) in SS, and a
sample was used to estimate bacterial loads.
Design of Controlled Time-course Experiments
Time-course experiments were designed to investigate the kinetics of bacterial
dissemination in the early stages of the infection. These experiments were performed
following the same procedure as the population-based experiments (see experimental
design and infection scheme), except that equal numbers of animals belonging to each
strain (typically 3 animals per strain per time point) were sampled for blood, spleen, liver,
and lung at 18 h, 36 h, and 60 h post-infection. Regardless of the specified sampling time,
all animals were bled through the tail vein (20-50µl) for determination of bacteremia at
18 h. At each time point, the animals were dissected, and their organs (spleens, livers,
and lungs) were homogenized in 10 ml SS each.
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Bacterial Loads in Blood and Organs
To determine bacterial loads in blood and organ homogenates, we diluted 10 ml
of either sample (tail vein blood or homogenate) serially (up to 10-7) and plated 10 ml of
each dilution (as well as the original sample) on the surface of blood agar plates (Becton
Dickenson, Franklin Lakes, NJ). After 24 h incubation, all plates were counted, and the
number of colony forming units (CFU) per ml or per organ was calculated (CFU/organ =
CFU/ml homogenate x 10).
Data Handling and Statistical Analysis
Results were recorded three times daily (or whenever an animal died). Data were
reviewed for accuracy and consistency at the end of every experiment by a different set
of investigators. We dedicated a considerable amount of time to data recording, error
checking, and filtration after each experiment. Mice lost due to factors unrelated to
infection were flagged in the database and excluded from the final analysis. We
performed all primary calculations and sorting operations using simple features and
functions of Microsoft Excel. Excel files were later exported to Data Desk (version 6.2)
software (Data Description, Inc., Ithaca, NY; www.datadesk.com), which we used for all
statistical analyses and tests, including clustering, correlation analysis, linear regression,
multiple regression, and general linear model (GLM) analysis by ordinary least squares
analysis of variance (OLS ANOVA).
Preliminary Quantitative Trait Loci Mapping
For QTL mapping, we used the web-based complex trait analysis platform,
WebQTL (Wang et al., 2003) available on the GeneNetwork web site
(http://www.genenetwork.org). WebQTL evaluates potential QTL at regular intervals and
estimates the significance at each location with a graphical representation of the
likelihood ratio statistics (LRS).

31

CHAPTER 3. AN UNBIASED SYSTEMS GENETICS APPROACH TO MAPPING
GENETIC LOCI MODULATING SUSCEPTIBILITY TO SEVERE
STREPTOCOCCAL SEPSIS 
Summary
Striking individual differences in severity of group A streptococcal (GAS) sepsis
have been noted, even among patients infected with the same bacterial strain. We had
provided evidence that HLA class II allelic variation contributes significantly to
differences in systemic disease severity by modulating host responses to streptococcal
superantigens. Inasmuch as the bacteria produce additional virulence factors that
participate in the pathogenesis of this complex disease, we sought to identify additional
gene networks modulating GAS sepsis. Accordingly, we applied a systems genetics
approach using a panel of advanced recombinant inbred mice. By analyzing disease
phenotypes in the context of mice genotypes we identified a highly significant
quantitative trait locus (QTL) on Chromosome 2 between 22–34 Mb that strongly
predicts disease severity, accounting for 25–30% of variance. This QTL harbors several
polymorphic genes known to regulate immune responses to bacterial infections. We
evaluated candidate genes within this QTL using multiple parameters that included
linkage, gene ontology, variation in gene expression, co-citation networks, and biological
relevance, and identified interleukin1 alpha and prostaglandin E synthases pathways as
key networks involved in modulating GAS sepsis severity. The association of GAS sepsis
with multiple pathways underscores the complexity of traits modulating GAS sepsis and
provides a powerful approach for analyzing interactive traits affecting outcomes of other
infectious diseases.
Introduction
Infectious diseases, like most human diseases, are modulated by complex traits.
Susceptibility and clinical outcomes of infections are often a manifestation of interactions
between the host’s complex traits and the pathogen’s virulence components.
Identification of genes and molecular networks that influence host responses to infectious
agents can provide a disease road map that would focus the discovery of effective
diagnostics and therapeutics.
Group A streptococci (GAS) are classified on the basis of surface M protein
antigens into more than 100 serotypes, but recent studies showed a high degree of
diversification within a serotype that is driven primarily by horizontal gene transfer (Aziz
et al., 2005; Sumby et al., 2005; Walker et al., 2007). It is widely believed that such
events are responsible for the emergence of highly virulent strains in the 1980s, including
a hypervirulent M1T1 clonal strain, coinciding with the resurgence of severe invasive


Source: Reprinted with permission. Abdeltawab, N.F., Aziz, R.K., Kansal, R., Rowe, S.L., Su,
Y., Gardner, L., Brannen, C., et al. (2008) An unbiased systems genetics approach to mapping
genetic loci modulating susceptibility to severe streptococcal sepsis. PLoS Pathog 4: e1000042.

32

GAS infections associated with streptococcal toxic shock syndrome (STSS) and
necrotizing fasciitis (NF), also known as the “flesh eating” disease (Low et al., 1997). We
showed that this hypervirulent M1T1 clinical strain can cause sore throat or mild
bacteremia and erysipelas in some patients, while in others it can cause STSS and NF
(Chatellier et al., 2000). These findings suggested a strong role for host factors in
modulating the outcome of infection by this highly virulent strain. Indeed, we found that
allelic variations in host HLA class II haplotypes are associated with markedly different
outcomes of GAS sepsis in humans (Kotb et al., 2002; Kotb et al., 2003). We confirmed
these associations using HLA transgenic mice that were expressing different HLA class II
alleles (Nooh et al., 2007). Inasmuch as STSS pathogenesis is largely mediated by
streptococcal superantigens (Strep SAgs), and because HLA class II molecules serve as
SAg receptors, such an association was expected. However, GAS is rich in many other
virulence factors, and we believe that some of those virulence factors, beside SAgs, may
also interact with additional host factors to modulate host responses to GAS infections.
To identify additional host factors involved in GAS severity we needed an
approach that allowed us to uncover the effect of interactions between complex,
polymorphic genetic traits that may modulate sepsis outcomes. Previous animal models
for GAS sepsis included various regular conventional inbred mouse strains (Medina et
al., 2001; Goldmann et al., 2004b), congenic strains (Goldmann et al., 2005a), and HLA
transgenic mice (Welcher et al., 2002; Nooh et al., 2007). These models confirmed that
host genetic variability can have a strong effect on infection outcome. Despite their
significant utility, these mouse models do not offer the genetic diversity that is
characteristic of the human population.
In this study, we used a panel of advanced recombinant inbred (ARI) mice as a
genetically diverse, segregating reference population that affords a powerful tool for
systems genetics approaches. Recombinant inbred (RI) strains have been successfully
used to map quantitative trait loci (QTLs) associated with various phenotypes and
diseases (Hardy et al., 2001; Rosen and Williams, 2001; Grizzle et al., 2002; Peirce et al.,
2003; Chesler et al., 2005; Mountz et al., 2005; Aziz et al., 2007; Miyairi et al., 2007).
We used the BXD panel of ARI mice derived from C57BL/6J (B6) and DBA/2J (D2)
strains and consisting of homozygous, inbred BXD lines, each of which is genetically
distinct. Using this genetically diverse BXD panel, we mapped QTLs modulating GAS
sepsis severity, and identified candidate genes within these QTLs that were parsed into
pathways likely to modulate the severity of this complex infectious disease.
Results
Variable Susceptibility to Severe GAS Sepsis in Genetically Distinct Mice
Our initial studies (Aziz et al., 2007) demonstrated that there is considerable
variability among BXD strains with respect to susceptibility to severe GAS sepsis. To
quantify differences among strains in this study, we used three main quantitative traits,
namely animal survival, bacteremia, and bacterial dissemination to spleen.
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We infected mice (n = 5–26 mice per strain), belonging to 32 strains (30 different
BXD strains and their parental strains, B6 and D2), intravenously (i.v.) with the same
bacterial dose (2  1.5 x 107 CFU/mouse). Survival was expressed as normalized
corrected relative survival indices (cRSI) calculated for each of the 32 strains as detailed
in materials and methods. We observed significant difference in relative susceptibility to
GAS sepsis across the BXD panel (P ≤ 0.0001), Figure 3-1-A. This wide range of
susceptibility across the various strains, together with the finding that some of the strains
showed phenotypes considerably more exaggerated than the parental strains (B6 and D2),
is an illustration of how different combination of polymorphic genes can manifest quite
differently according to the overall genetic context.
Similarly, we determined bacterial load in blood (log CFU/ml blood), 24 h postinfection and found considerable variation across the strains. In general there was an
inverse correlation between mice survival and extent of bacteremia (r = – 0.471, P ≤
0.0001, R2 = 22.2%), Figure 3-1-B. Bacterial dissemination to spleen also varied across
the strains, showing a stronger inverse correlation with mice survival (r = – 0.717, P ≤
0.0001, R2 = 51.4%), Figure 3-1-C.
Although these inverse correlations between mice survival and bacterial load in
blood and spleen made biological sense because it is anticipated that susceptible strains
would have higher bacterial load than in resistant strains, there were several exceptions.
For example, although strains BXD44 and BXD45 are ranked susceptible based on their
survival, they showed low bacterial load in blood and spleen. Similarly, BXD43 and
BXD85 strains, which are ranked resistant, had a high bacterial load in their spleen.
Another interesting observation was that, in general, susceptible strains survival was
better correlated with bacterial load in blood and spleen than resistant strains. Together,
these findings confirm that there is more than one mechanism modulating differential
susceptibility or resistance to severe GAS sepsis (Aziz et al., 2007).
Genome-wide Scans for Mapping GAS Susceptibility Quantitative Trait Loci
We used bioinformatics tools available through Gene Network (GN) to link
measured phenotypes to strains genotypes. Each of the quantified phenotypes was
analyzed in the context of the studied mice genotypes and single nucleotide
polymorphism (SNPs) using 3795 SNPs and microsatellite markers for BXD strains.
Significant QTLs modulating survival, bacteremia 24 h post-infection and bacterial
dissemination to spleen mapped to mouse Chromosome (Chr) 2.
The strongest QTL modulating mouse survival (cRSI) mapped to mouse Chr 2
between 22–34 Mb, with an likelihood ratio statistic (LRS) of 34.2 (P ≤ 0.0000001),
Figure 3-2-A. A second less significant QTL was also mapped on the same chromosome
between 125–150 Mb with an LRS of 12 (P ≤ 0.001), and a third QTL on Chr X, Figure
3-2-A. The QTLs for bacteremia and bacterial dissemination to spleen overlapped with
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Figure 3-1. Differential susceptibility to GAS sepsis among different BXD strains
and their parental strains.
(A) Rank-ordered bar chart of survival expressed as mean values of coefficient of mean
corrected relative survival indices (cRSI) across 30 different BXD strains and their
parental strains (DBA/2J and C57Bl/6J). N = 489 belonging to 32 strains; number of
mice used per strain is indicated.(B) Bar chart of GAS bacteremia expressed as
coefficient of mean values of corrected log blood CFUs 24 h post injection (corrected log
CFU/ml blood). (C) Bar chart of GAS dissemination to spleen expressed as coefficient of
corrected bacterial load in spleen (log CFU/spleen). B and C Strains are ordered by their
corrected relative survival indices with the parental strains at the two extremes of the Xaxis. Error bars represent the standard errors of the means. Statistical test is two-way
ANOVA (with correction to covariates) P ≤ 0.0001.
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Figure 3-1. (Continued).
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Figure 3-2. Genome-wide scan for mice susceptibility to GAS sepsis showing
mapped QTL on Chr 2.
Interval mapping of survival (expressed as corrected relative survival index, cRSI),
showing a significant QTL (based on 1000 permutation tests) on Chr 2 between 22–34
Mb with LRS of 34.2 (P ≤ 0.0000001), and a suggestive QTL between 125–150 Mb with
LRS of 12 (P ≤ 0.001). (B) Whole genome interval mapping of GAS bacteremia using
bacterial load 24 h post injection expressed as corrected log CFU/ml blood, showing two
QTLs on Chr 2: first QTL between 22–34 Mb with LRS of 24.5 (P ≤ 0.00001) and a
second with LRS of 17 (P ≤ 0.0001) between 125–150 Mb. (C) Whole genome mapping
of GAS sepsis using tissue dissemination of GAS expressed as corrected log CFU/spleen
with QTL between 125–150 Mb with LRS of 15 (P ≤ 0.0001). Red line indicates
significant LRS, while grey line indicates suggestive LRS. Upper x-axis shows mouse
chromosomes, and lower x-axis shows physical map in mega bases, y-axis represents
linkage in LRS score.
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those for survival, with slight difference in significance. The first QTL modulating
bacteremia mapped to Chr 2 between 22–34 Mb with an LRS of 24.5 (P ≤ 0.00001),
Figure 3-2-B. The second QTL mapped to the same chromosome between 125–150 Mb
with an LRS of 17 (P ≤ 0.0001), Figure 3-2-B. A QTL modulating bacterial
dissemination to spleen also mapped to Chr 2 between 125–150 Mb with LRS of 15 (P ≤
0.001), Figure 3-2-C.
To further investigate and narrow down the mapped region on Chr 2, we resorted
to haplotype maps of BXD strains to select additional strains that may be informative in
validating, and further confirming mapped QTLs.
In silico Prediction of BXD Susceptibility to Severe GAS Sepsis
Our mapped QTLs directed us to select more strains for survival experiments
based on differences in their haplotypes within the QTLs. For example, we selected
BXD100 with a D haplotype at Chr 2 between 22–34 Mb region, Figure 3-3-A, and
found it to be susceptible. Similarly, we tested BXD87 with a B haplotype in the same
region and this strain as predicted, exhibited a resistant phenotype. To further narrow
down the mapped QTLs, we chose strains with breakage in the mapped interval, i.e. with
recombination at Chr 2 region 22–34 Mb for further survival testing (Figure 3-3-A).
BXD34 with a B haplotype at Chr 2 between 24–33.15 Mb region was resistant, while
BXD60 with a B haplotype at Chr 2 between 20–23.27 Mb region was susceptible, Figure
3-1-A and 3-3-A. This narrowed down the relevant susceptibility region to Chr 2 between
23.27–33.15 Mb. Using more strains with recombination at this narrowed region, we
found BXD51, 64, and 79 to be quite interesting as they showed intermediate resistance
suggesting that genes at this region are candidate modulators of the mapped QTL, Figure
3-3-B. Another interesting strain was BXD94 that we found susceptible to infection, yet
has a heterozygous genotyping, suggesting that D allele exhibited dominance, Figure
3-3-B.
Similarly, we inspected haplotypes of studied BXD strains at the second QTL
between 125 –150Mb (Figure 3-3-C), the majority of susceptible strains had D alleles,
while resistant strains had B alleles with some exceptions, for example BXD77 is a
susceptible strain, yet had B alleles. It was interesting to find that the susceptible strain
BXD44 had B alleles at this QTL (Figure 3-3-C), suggesting that observed lower
bacterial load in blood compared to other susceptible strains (Figure 3-1-B) might be
modulated by B allele in the second QTL. Meanwhile, BXD48, a resistant strain, has a
breakage at 135.9 Mb (Figure 3-3-C) with D alleles suggesting that its relatively higher
bacterial load in blood (Figure 3-1-B) might be modulated by the second QTL.
Collectively, these findings suggest that both loci modulate different observed
phenotypes of GAS sepsis severity.
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Figure 3-3. Recombinant inbred BXD strain distribution patterns at region of
interest on Chr 2.
(A) Haplotype maps of the first QTL on Chr 2 between 20–34 Mb showing available

BXD strains. Haplotype maps were used for in silico selection of strains for survival
studies based on the strain distribution patterns, where B allele (blue bars) inherited from
the resistant parent C57Bl/6J and D alleles form the susceptible parent DBA/2J, beige
bars indicate strains that are heterozygous at this region, resembling an F1. Arrows
indicate BXD strains 34, 51, 60, 64, 79, 94, and 100. Recombinant inbred BXD strain
distribution patterns at region of interest on Chr 2. (B) Haplotype maps of the first QTL
region on Chr 2 between 20—34 Mb across BXD strains used in the population-based
survival experiments showing the pattern of alleles inherited from each parent at region
of interest on Chr 2. The different BXD strains are rank-ordered according to their
susceptibility to GAS sepsis from susceptible to more resistant. Resistant strains show a
pattern of accumulation of alleles inherited from resistant parent (B) C57Bl/6J (blue bars)
while the susceptible strains show a pattern of alleles from susceptible parent (D)
DBA/2J (red bars), with the exception of BXD94 strain, heterozygous (beige bars) at the
QTL region. (C) Haplotype maps of the second QTL region on Chr 2 between 125—150
Mb across BXD strains used in the population-based survival experiments showing the
pattern of alleles inherited from each parent at region of interest on Chr 2. The different
BXD strains are rank-ordered according to their susceptibility to GAS sepsis from
susceptible to more resistant. BXD genotype data set can be downloaded from
www.genenetwork.org/genotypes/BXD.geno.
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Figure 3-3. (Continued).
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Mining for Candidate Genes and Pathways in Mapped Loci
Based on our in silico strain selection and QTL validation by experimental
assessment, we evaluated candidate genes within the mapped QTLs, taking into
accountlinkage, gene ontology analyses, co-citation networks, and biological relevance.
To categorize genes and transcripts in the mapped QTLs into functional pathways, we
performed functional analyses using Ingenuity Pathways Analysis (IPA)
(www.ingenuity.com). We parsed our genes into 50 functional networks; the most
relevant networks involved those associated with immune response, cell signaling,
cellular assembly and organization, and lipid metabolism. From these interrelated
pathways, we selected 37 representative genes to study their role in GAS susceptibility
QTL by quantitative analysis of their expression levels in selected resistant and
susceptible strains (groups) pre- and post-infection (Appendix A. Table A-1).
We found that 28 out of a representative 37 genes were differentially expressed
post- infection (Appendix A. Table A-2), of those 14 genes were down regulated in the
resistant group while up regulated in the susceptible group post-infection. Nine genes
were down regulated in both groups post-infection, and five were up regulated in both
groups post-infection (Appendix A. Table A-2). Fourteen of the 28 differentially
expressed genes showed significant change post-infection in both resistant and
susceptible strains (Table 3-1 and Figure 3-4). In general, susceptible strains showed an
increase in the relative expression levels post-infection (19 genes) of both pro and antiinflammatory genes, e.g. interleukin1 alpha (Il1), and Il1 receptor antagonist (Il1rn)
respectively. By contrast, in the resistant BXD strains, most of the tested genes showed a
decrease (23 genes) in expression levels post-infection with few exceptions (five genes)
e.g. TNF receptor associated factor 1 (Traf1) (Figure 3-4 and Appendix A. Table A-2).
Differentially expressed genes were associated with both innate and early adaptive
immune response. Among those associated with early immune response, Il1a, Il1rn,
prostaglandin E synthase (Ptges), and Ptges2 were up regulated in susceptible strains,
whereas their levels decreased in resistant strains. Several of the differentially expressed
genes show polymorphisms as SNPs between the parental strains B6 and D2, suggesting
that these polymorphic genes modulate differential response to infection (Appendix C).
The differential expression of IL1 was confirmed at the protein level (data not shown).
We parsed the differentially expressed genes into pathways, using IPA, IL1 and
prostaglandins were key early response molecules modulating susceptibility to severe
GAS sepsis in two of the mapped networks, which are shown merged in Figure 3-5. The
first network (P <10–27) comprised of genes related to lipid metabolism and innate
immunity, e.g. Il1a, Il1rn, Ptges, while the second network (P < 0.01) contained genes
modulating nucleic acid metabolism, energy production and host responses to injury e.g.
Ectonucleoside triphosphate diphosphohydrolase 2 (Entpd2) (Figure 3-5).
Discussion
It has been established that networks of multiple pathways, rather than a single
gene, modulate traits and affect susceptibility and outcomes of virtually all diseases. The
44

Table 3-1. The relative expression levels of candidate genes post infection in resistant and susceptible strains expressed as ratio
of post/pre infection in susceptible and resistant strains.
Gene ID

Gene

Genes down regulated in resistant group while up regulated
in susceptible group
Anaphase promoting complex subunit 2
Anapc2
Interleukin 1 a
Il1
Interleukin 1receptor antagonist
Il1rn
Prostaglandin E synthase
Ptges
Prostaglandin E synthase 2
Ptges2
SH2 domain containing 3C
Sh2d3c
Genes down regulated in both resistant group and
susceptible groups
Ectonucleoside triphosphate diphosphohydrolase 2
Entpd2
Endothelial differentiation-related factor 1
Edf1
GTPase activating RANGAP domain-like 3
Garnl3
Nuclear factor of activated t-cells, cytoplasmic,
Nfatc2
calcineurin-dependent 2
Phosphohistidine phosphatase 1
Phpt1
Proteasome (prosome, macropain) 26S subunit,
Psmd5
non-ATPase 5
Protein phosphatase 2A regulatory subunit B
Ppp2r4
Genes up regulated in both resistant group and
susceptible group
TNF receptor associated factor 1
Traf1
a

Resistant
Strains

P-value a

Susceptible
Strains

P-value

0.551
0.739
0.851
0.417
0.913
0.162

0.022 *
0.010 *
0.680
0.001 *
0.774
0.055 †

1.475
44.525
54.687
6.363
1.456
1.009

0.509
0.062 †
0.221
0.028 *
0.005 *
0.980

0.359
0.349
0.601
0.178

0.010 *
0.095 †
0.142
0.095 †

0.654
0.470
0.674
0.693

0.064 †
0.014 *
0.070 †
0.208

0.229
0.644

0.077 †
0.006 *

0.714
0.963

0.233
0.652

0.902

0.256

0.734

0.091 †

1.826

0.300

5.995

0.066 †

Significance based on t-test, * P < 0.05, † P = 0.06–0.08
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Figure 3-4. Patterns of differential gene expression levels of candidate genes post
infection in susceptible and resistant strains.
Quantitative PCR results showing levels of gene expression of 14 genes with
significant (P = 0.05–0.08) change post-infection in susceptible and resistant strains,
expressed as Log10 fold differences in gene expression level post-infection. Genes are
grouped to three groups, a) genes up regulated in susceptible strains post-infection and
decreased in resistant strains post-infection, b) genes down regulated in both
susceptible and resistant strains post-infection, and c) genes up regulated in both
susceptible and resistant strains post-infection. Susceptible strains are represented as
solid black bars, we used two highly susceptible strains BXD61 and BXD90, and
resistant strains as dashed bars, we used two highly resistant strains BXD 73 and
BXD87. The bars represent 2–4 biological replicates run in three technical replicates
each and significance is based on t-test. Anapc2, anaphase promoting complex subunit
2; Entpd2, ectonucleoside triphosphate diphosphohydrolase 2; Edf1, endothelial
differentiation-related factor 1; Garnl3, GTPase activating RANGAP domain-like 3;
Il1a, interleukin 1 alpha; Il1rn, interleukin 1 receptor antagonist; Nfatc2, nuclear factor
of activated t-cells, cytoplasmic, calcineurin-dependent 2; Phpt1, phosphohistidine
phosphatase 1; Ptges, prostaglandin E synthase; Ptges2, prostaglandin E synthase 2;
Psmd5, proteasome (prosome, macropain) 26S subunit, non-ATPase 5; Ppp2r4,
Protein phosphatase 2A regulatory subunit B; Sh2d3c, SH2 domain containing 3C;
Traf1, TNF alpha receptor associated factor.
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Figure 3-5. Functional network of genes modulating GAS QTL.
Graphical representation of the molecular relationships between differentially expressed
genes, showing the central role of IL1, IL1rn, PTGES, and PTGES2 in modulating
response to GAS sepsis and their indirect interactions with IFN and IL2 networks in
modulating bacterial sepsis. Genes are represented as nodes, and the biological
relationship between two nodes is represented as line, solid lines represent direct
interactions, dashed lines represent indirect interactions. Oval shapes represent
chemical or drug, squares represent cytokines, diamond shapes represent enzymes,
concentric circles represent group of family, and triangles represent phosphatases. Blue
lines and arrows represent expression levels of resistant strains, while red lines and
arrows represent susceptible strains expression levels. Apyrase, ATP
diphosphohydorlase; ANAPC2, anaphase promoting complex subunit 2; CDC20 cell
division cycle homolog 20; CXCL14, chemokine (c-x-c motif) ligand 14; ENTPD2,
ectonucleoside triphosphate diphosphohydrolase 2; EDF1, endothelial differentiationrelated factor 1; JUN jun oncogene; IL1A, interleukin 1 alpha; IL1RN, interleukin
1receptor antagonist; IFNG interferon gamma; IL2 interleukin2; PDCD1LG2,
programmed cell death ligand 2; PTGES, prostaglandin E synthase; PTGES2,
prostaglandin E synthase 2; PSMC3 proteasome (prosome, macropain) 26S subunit
ATPase 3; PSMD5, proteasome (prosome, macropain) 26S subunit, non-ATPase 5;
PPP2R4, protein phosphatase 2A regulatory subunit B; RBM39, RNA binding protein
39; SH2D3C, SH2 domain containing 3C; SLC6A6, solute carrier family 6; TP53
tumor protein p53; TP53RK, TP53 regulating kinase; VTCN1, V-set domain containing
T cell activation inhibitor 1.
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ARI strains used in this study afford one of the best unbiased forward genetics
approaches to determine how different combinations of polymorphic genes interact to
shape disease phenotypes. Using ARI-BXD panel as a genetically diverse reference
population, we were able to map QTLs modulating specific phenotypes associated with
severe GAS sepsis.
GAS causes a wide range of diseases depending on multiple factors including site
and route of infection, interplay of the pathogen virulence factors with host immune
defenses that are affected by the host immune status and difference in the genetic makeup
of the host (Kotb et al., 2002). Thus, these bacteria represent a good model to explore the
impact of host complex traits on susceptibility to infections. Previous studies have shown
that host-pathogen interactions modulate the severity of GAS sepsis (Chatellier et al.,
2000; Medina et al., 2001; Kotb et al., 2002; Goldmann et al., 2004b), and we found that
patients with GAS sepsis expressing HLA class II DRB1*15/DQB1*06 (DR15/DQ6)
haplotype are protected from severe GAS sepsis, whereas those with HLA class II
DRB1*14/DQB1*05 (DR14/DQ5) haplotype are at high risk for developing severe and
often fatal forms of the disease (Kotb et al., 2002). The strong association between
disease severity and HLA class II allelic polymorphism is primarily related to the
differential ability of HLA class II alleles to present SAgs to T cells, where presentation
of Strep SAgs by the protective HLA class II alleles results in a significantly attenuated
response as compared to their presentation by the neutral or high-risk alleles (Kotb et al.,
2002; Norrby-Teglund et al., 2002; Nooh et al., 2007). While this association made
perfect biological sense based on the known central role of SAgs in the human disease,
mice are not susceptible to SAgs due to an inherent lower affinity of mouse MHC class II
molecules to GAS SAgs. The role of GAS SAgs can be well investigated in HLA class II
transgenic mice as others and we have reported (Leder et al., 1998; Andersen et al., 1999;
Welcher et al., 2002; Nooh et al., 2007). However, due to the overwhelming response to
SAgs in these mice, it is difficult to use them to dissect host response to other GAS
virulence factors in the disease process. For this reason, our present ARI mouse model of
sepsis is ideal for identifying host genetic variations, besides the MHC class II antigens,
that may also contribute to differences in GAS sepsis severity.
We invested time and effort to standardize the GAS infection model using a large
number of BXD mice (n = 717) and this allowed us to optimize infection dose and
identify significant covariates (e.g. age and sex) needed to be accounted for in our final
analysis (Aziz et al., 2007). Although GAS strains can vary considerably with regards to
virulence, we showed that the same virulent strain could cause diseases with starkly
different severity in humans (Chatellier et al., 2000; Kotb et al., 2002). The strain used in
this study is a hypervirulent derivative of the M1T1 clonal strain that emerged in the
1980s at the same time that the severe forms of the invasive GAS infections resurged
(Kazmi et al., 2001; Aziz et al., 2004a; Buchanan et al., 2006; Walker et al., 2007).
Initial studies (Aziz et al., 2007) identified an optimal infection dose of 2 ± 1 x107
CFU/mouse, and indicated the need to use mice with an age range of 40–120 days for
linear correlation with survival. In addition, these pilot studies determined that sex has
insignificant effect in this GAS sepsis model (Aziz et al., 2007) and revealed a stark
variation among various BXD strains used with respect to their susceptibility to severe
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sepsis. However, precise mapping of QTLs required that we study more BXD strains and
include more mice per BXD strain to obtain statistical power.
With a total of 30 BXD strains and an average of 15 mice per strain, we mapped
QTLs on Chr 2 that modulate severity to GAS sepsis, measured by comparing mice
survival post-infection, bacterial load in blood, and bacterial dissemination to spleen
across the BXD strains. Inasmuch as the BXD strains are heavily genotyped with more
than 3600 genomic markers, identifying QTLs is relatively straightforward. The mapped
QTLs on Chr 2 harbor a relatively large number of candidate genes associated with
various functional networks and signaling pathways including nuclear factor- kappa B
(NF-KB) and p38 mitogen activated protein kinases (MAPK) pathways, proliferation of
immune cells, and eicosanoid signaling. Such output is typical of unbiased genome-wide
analysis studies, and required further analyses to determine which of these genes are the
key modulators of the studied trait.
To narrow down the gene list to a handful of genes that can be experimentally
validated, we used multiple methods including linkage, gene ontology, and differential
gene expression analyses. Our quantitative PCR analysis of 37 representative candidate
genes showed that 28 genes were differentially expressed in selected susceptible and
resistant strains post-infection. These differentially expressed genes fell into three main
categories, genes associated with innate and adaptive immune response, and genes
associated with apoptosis. Differentially expressed genes associated with innate immune
response were both pro- and anti-inflammatory as well as adaptive immune response
genes associated with T and B cell proliferation and differentiation, cell signaling and
antigen processing and presentation.
Differentially expressed genes associated with innate immune response were
either related to pro- or anti-inflammatory responses. Both pro- and anti-inflammatory
associated genes were up-regulated in the selected susceptible strains post-infection, and
this is in agreement with a recent study by Goldmann, et al. (2007) who showed a mixed
pro- and anti-inflammatory response belonging to M1 and M2 macrophage phenotypes in
response to GAS infection. This increase in both pro- and anti-inflammatory response
could be attributed to homeostatic mechanisms where, for example, the increase in Il1
levels in the susceptible strains was accompanied by an increase in its endogenous
antagonist Il1rn. This was not the case in the resistant strains that showed decreased
levels of expression of pro- and anti-inflammatory related genes both pre- and postinfection. These findings suggest that susceptibly to GAS sepsis is associated with an
overzealous innate immune response as observed in susceptible BXD strains only. These
results mirror previous findings in humans, where association of exaggerated
inflammatory responses, including IL1, with susceptibility to GAS sepsis was detected
(Norrby-Teglund et al., 2000; Norrby-Teglund and Kotb, 2000; Kotb et al., 2002).
However, unlike what we found in this mouse model, human responses are dominated by
high levels of IFN and TNFß, presumably because the human disease is driven primarily
by SAgs (Norrby-Teglund et al., 1997; Norrby-Teglund et al., 2000).
In general, differentially expressed genes associated with early adaptive immune
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responses showed a pattern of decrease in expression levels in both susceptible and
resistant strains with the exception of anaphase promoting complex subunit 2 (Anapc2)
that was slightly increased in susceptible strains post-infection (Figure 3-5). By contrast,
several genes associated with pro- and anti-apoptotic response were differentially
expressed in the selected susceptible and resistant strains post-infection (Figure 3-5).
Apoptosis in streptococcal pathogenesis is affected by interacting factors including,
context of infection (Marriott and Dockrell, 2006), cells undergoing apoptosis
(Kobayashi et al., 2003; Nakagawa et al., 2004; Miyoshi-Akiyama et al., 2005), for
example, apoptosis aids in the clearing of infection if macrophages are undergoing
apoptosis, while it would be harmful to the host if lymphocytes are undergoing apoptosis.
Other factors include, whether the bacteria is internalized or extracellular (Cywes Bentley
et al., 2005) and accordingly the type of apoptosis pathways activated (Klenk et al.,
2005). In our murine GAS sepsis model, we have measured expression levels in whole
spleens, which involved the response of various cells including macrophages, T and B
lymphocytes, dendritic and endothelial cells etc. Consequently, we expected to observe a
mixed response; however, in our ongoing studies, we are examining possible alterations
in splenic population profiles post-infection in the various BXD strains to determine
which cell types are responsible for the major differences in cytokine levels seen postinfection and to dissect the role of different cell populations in this GAS sepsis model.
Another interesting observation was that the relative expression level of genes
measured in the selected resistant strains showed a pattern of decrease post-infection,
with the exception of five genes, heat shock 70KDa protein 5 (Hspa5), Traf1, Traf2,
Notch gene homolog 1 (Notch1), and signal-regulatory protein alpha (Sirpa). It is worthy
to note the link between these genes, as they are involved directly and indirectly with
activation of early adaptive response. Hspa5 is an Hsp70, which is associated with
cytoprotection, anti-apoptosis, and anti-inflammation (Kiang and Tsokos, 1998; Yenari et
al., 2005; Kim et al., 2006), and has been associated with immune response to sepsis
(Kustanova et al., 2006; Singleton and Wischmeyer, 2006). Notch1 has been associated
with the signaling involved in regulation of lymphocytes development and activation to
effector cells (Minato and Yasutomo, 2005), natural killer cells development (van den
Brandt et al., 2004; Garcia-Peydro et al., 2006; Rolink et al., 2006) and recently Notch1
was associated with macrophage activation (Monsalve et al., 2006).We took into
consideration in our experimental design that stress might alter the expression of stress
related genes especially heat shock proteins and chemokines, therefore, we subjected
control mice to the same stress as infected mice by injecting control mice with saline, so
that any change in expression levels would be accounted to GAS sepsis.
Among the differentially expressed genes, four genes, Il1, Il1rn, Ptges, and
Ptges2, showed marked up regulation in susceptible strains, while they showed no change
or slight decrease in levels in resistant strains post-infection (Figure 3-5). Increase in
expression of Ptges and Ptges2 genes is induced by the increased levels of Il1 (Bream et
al., 2000), which is an indirect effect of the activation of IFN (Figure 3-5). Ptges and
Ptges2 are prostaglandin synthases for the lipid inflammatory mediators PGE2, which
along with platelet activating factor and leukotrienes; mediate vasodilatation in the early
response to inflammation (Harris et al., 2002; Mosca et al., 2007). Vasodilatation in turn
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leads to hypotension, a hallmark of STSS. Although the role of prostaglandins in
inflammation and immune response has long been studied, their role in the immune
response to infectious diseases has been lately pursued (Ruiz et al., 1998; Maloney et al.,
2000; Smith et al., 2002; Chen et al., 2004; Jobin et al., 2006; Woolard et al., 2007).
Increased production of prostaglandins has been associated with various Gram positive
bacterial infections including Streptococcus suis (Jobin et al., 2006), group B
streptococcal (Maloney et al., 2000), and GAS skin infections (Ruiz et al., 1998).
In conclusion, our holistic approach of studying the genetic basis of differential
susceptibility to GAS sepsis revealed loci on Chr 2 that harbor major immune
modulators. In the present study, we examined the interactions of pathogen multiple
virulence factors with the host immune system in an in vivo model of sepsis using a
genetically diverse reference population. This shed light on a network of host genes
modulating variation in GAS severity, which includes cytokines, pro- and antiinflammatory mediators, and genes associated with apoptosis and early adaptive immune
response. Our ongoing detailed studies to identify interactive molecular pathways
contributing to the complex trait of GAS sepsis will undoubtedly help us dissect the
various mechanisms by which the host interacts with the bacteria in vivo, resulting in
resistance or increased susceptibility to severe GAS sepsis.
Materials and Methods
Mice
We generated the BXD advanced recombinant inbred (ARI) mice at UTHSC by
crossing B6 and D2 mice to generate F1 hybrids, which were crossed to generate F2
progeny, each with random patterns of recombination. Random crossing of F2 mice
generated F3 and so on, till F11 generation, after which we designated pairs of F11
hybrids as parents of each BXD line, and inbred them by sib mating for >20 generations
to achieve homozygosity for each genetically distinct BXD line. This breeding scheme
was done to increase recombination events resulting in roughly double the number of
recombinations per strain compared to conventional RI strains (Williams et al., 2001;
Peirce et al., 2004).
The genomes of the B6 and D2 parental strains have been sequenced and a
database of their SNPs is available at the Gene Network (GN) web site
(www.genenetwork.org/webqtl/snpBrowser.py). Simple sequence length polymorphism
(SSLP) markers were typed for all BXD RI strains as previously described (Williams et
al., 2001). The BXD progeny is genotyped at 13377 SNPs and microsatellite markers
(Shifman et al., 2006), a selected subset of 3795 SNPs and microsatellite markers used by
GN BXD genotype dataset for mapping traits, can be downloaded at
www.genenetwork.org/genotypes/BXD.geno.
We recently standardized the model of BXD ARI mice for use in GAS infection
studies (Aziz et al., 2007). In the current study, a total of 696 mice were used, from
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which 183 flagged mice were excluded based on predetermined criteria as previously
detailed in (Aziz et al., 2007). All procedures involving mouse tissues were approved by
the institutional animal care and use committee at the UTHSC.
Experimental Design
Population-based experiments
Groups of 5–26 mice from a total of 30 BXD lines and their parental strains (B6
and D2) were injected via tail vein with 2  1.5 x 107 CFU/mouse of a hypervirulent form
of the clinical isolate GAS 5448 (M1T1) (Chatellier et al., 2000; Aziz et al., 2004a; Aziz
et al., 2004b) as detailed previously (Aziz et al., 2007). Mortality and weight loss were
recorded every 8 h for the ensuing 6 days. To normalize across experiments, we inspected
survival days distribution clusters for each experiment and determined multimodal
distribution and boundaries of each cluster for a total of three clusters: susceptible,
intermediate, and resistant. Survival days within each cluster were then converted into a
survival index ranging from 0.25–1, 1.25–2, and 2.25–3 for susceptible, intermediate, and
resistant clusters respectively. The survival index was assigned to each mouse
irrespective of its strain. Indices for each strain, across experiments were then corrected
for significant covariates (age, sex, body weight, and inocula) using multiple regression
analyses.
Phenotype assessment experiments
We designed experiments for the assessment of survival, bacteremia, and bacterial
dissemination to spleen. We assessed relative mice survival and bacteremia in the same
experiment. We measured bacteremia as CFU/ml by culturing serial dilutions of blood
drawn from mice tails 24 h post-injection. We determined bacterial load in spleen by
homogenizing spleens of expired mice using tissue homogenizer, TH (Omni
International, Marietta, GA). Each tissue homogenate was serially diluted 10 folds to 10-6
fold, and each dilution was cultured for determination of bacterial load in spleens
(CFU/ml) that was then normalized to spleen weight and expressed as CFU/spleen.
Quantitative Trait Loci Mapping
We performed QTL mapping using web-based complex trait analysis available on
the GN website and the mapping module which analyzes phenotypes in context of mouse
genotypic differences. Interval mapping evaluates potential QTL at regular intervals and
estimates the significance at each location using 1000 permutation tests (Churchill and
Doerge, 1994). We performed three sets of analyses using strain means for the following
three variables: (1) corrected relative survival index, described earlier, (2) log bacterial
load in blood 24 h post injection, and (3) log bacterial load in spleen at expiration.
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Quantitative PCR Analysis for Target Genes Expression
We investigated the differential expression of target genes in spleen of infected
vs. control PBS-injected mice at selected time points; we selected strains based on their
susceptibility, BXD61 and 90 representing susceptible strains, and BXD73 and 87,
representing resistant strains. We performed 2–3 biological replicates of each set of
paired susceptible and resistant (n = 6–8 per strain). Mice were sacrificed 40 h post i.v.
injection with 2 ± 1.5 x 107 CFU/mouse of clinical isolate GAS 5448 (M1T1) and RNA
from individual mice was extracted from spleens. Bacteremia was determined as
described above. We isolated RNA using RNA-STAT 60 method and when necessary,
we purified RNA samples using RNeasy mini kit clean up columns (Qiagen, Valencia,
CA). We pooled RNA samples per strain with A260/280 ratios  1.8 for cDNA synthesis
with SuperScript III reverse transcriptase kit (Invitrogen, Carlsbad CA) using oligo dT
primers. We designed real time PCR assays, hydrolysis probes, and gene specific primers
that span long introns to distinguish cDNA from genomic DNA using primer design
online software universal probe library (UPL) at www.roche-appliedscience.com/sis/rtpcr/upl/index.jsp. We performed quantitative TaqMan PCR on light
cycler LC480 (Roche Applied Science, Indianapolis, IN). We used the mouse
housekeeping gene, hypoxanthine guanine phosphoribosyl transferase (Hprt1) as an
endogenous control to which we normalized gene expression data. Primer sequences are
listed in Appendix A Table A-1. Samples were analyzed in triplicates for each of 2–4
biological replicates. We used delta delta Ct (threshold cycle) method for calculating
relative expression levels expressed as fold differences between pre- and post-infection
values for each gene analyzed. Student t-test was used to assess statistical significance.
Identification of Differentially Expressed Genes in the Mapped Interval and
Bioinformatics Functional Pathways Analyses
We generated functional analyses of genes within the QTLs using Ingenuity
pathways analysis (IPA) (www.ingenuity.com). Each data set containing gene identifiers
was uploaded into the online application, and each gene was overlaid onto a molecular
network developed from information contained in the ingenuity pathways database.
Networks of genes were then generated based on their connectivity, and we chose the top
50 significant networks. The significance of the association between the data set and the
pathways was measured in two ways: (1) the ratio of the number of genes from the data
set that map to the pathway divided by the total number of genes that map to the
pathway; and (2) by Fischer’s exact test with P < 0.001.
Statistical Analysis
We used the DataDesk 6.2 (www.datadesk.com) to calculate mean survival
indices, corrected survival indices, and correlation coefficients. Covariates association
was evaluated for significant associations by Spearman correlation as described
previously (Aziz et al., 2007). Fischer exact test was used to analyze association of the
analyzed differentially expressed genes with specific pathways.
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Web Site URL
Our data sets stored in WebQTL can be found at Gene Network
(www.genenetwork.org) under BXD published phenotypes record ID 10836.
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CHAPTER 4. IDENTIFICATION OF SOLUBLE AND GENETIC BIOMARKERS
ASSOCIATED WITH DIFFERENT OUTCOMES OF GAS SEPSIS REVEALS
UNDERLYING MECHANISMS OF DIFFERENTIAL HOST SUSCEPTIBILITY
Summary
Individuals infected with the same group A streptococcal (GAS) strain can
develop starkly different disease progression and outcomes. My mentor’s laboratory have
shown that the same GAS strain can cause a wide range of diseases, from mild
bacteremia and erysipelas to streptococcal toxic shock syndrome (STSS) and necrotizing
fasciitis (NF) (Chatellier et al., 2000). Difference in disease severity was associated with
differences in the profile and magnitude of cytokine responses, where overzealous
inflammatory cytokine responses, triggered mainly by streptococcal superantigens
(SAgs), were associated with severe disease, including STSS and NF (Norrby-Teglund et
al., 2000). Our group has found that HLA class II allelic variations contributed to the
differences in cytokine responses in these patients, where individuals with DR14/DQ5
HLA class II haplotypes, produced high levels of inflammatory cytokines and were at
risk of developing severe systemic disease and STSS. Whereas, we found that patients
who had DR15/DQ6 haplotype mounted moderate cytokine responses and experienced
mild sepsis and/or cellulitis (Kotb et al., 2002; Norrby-Teglund et al., 2002).
The HLA-II association was related to interactions of GAS SAgs with the host
where GAS SAgs forced interactions of HLA-II on antigen presenting cells and T cell
receptors on T helper cells stimulating both types of cells to mount cytokine responses
which differed based on HLA-II alleles as described above. However, GAS is rich in
many other virulence factors that are likely to engage other host defense mechanisms.
Indeed, we have recently shown that additional host factors, other than HLA- II, are
modulating host differential responses to GAS infections. Employing genome-wide
association studies, we mapped differential susceptibility to severe GAS sepsis to QTLs
on mouse Chr 2 and X (Abdeltawab et al., 2008). We found that within these QTLs most
significant association with differential susceptibility to GAS sepsis was that of
interleukin 1 and prostaglandin E pathways. We validated our results based on genomewide association studies (GWAS) using multiple bioinformatics tools and quantitative
gene expression analyses (as detailed in chapter 3). However, we aimed to perform
genome-wide expression analyses to study patterns associated with differential responses
to GAS sepsis at early stages of infection. In the current chapter, we aimed to further
dissect the mechanisms of the discovered pathways (discussed in chapter 3) and how they
are associated with differential susceptibility. In the studies covered in this chapter, in
addition to analyzing genome wide (GW) gene expression patterns, we also analyzed
soluble biomarkers that are associated with pathways identified by both GW mapping and
GW expression analyses.
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Results and Discussion
Comparison of Genome-wide Differential Expression in Blood between Susceptible
and Resistant Strains at Selected Times Post Infection
In studies outlined in this dissertation, our overall aim was to investigate
mechanisms underlying differential response to GAS sepsis. We employed genome-wide
association studies (GWAS) adopting systems genetics approach as discussed in chapters
2 and 3. Using these genome-wide association studies, we identified interleukin 1 and
prostaglandin pathways as candidate pathways associated with modulation of differential
susceptibility to severe GAS sepsis (chapter 3 and Abdeltawab et al. 2008). In this
chapter, we sought to characterize and further dissect genetic and soluble biomarkers
associated with differential susceptibility to GAS sepsis. To do so, we first aimed to
characterize differential gene expression patterns associated with differential
susceptibility to GAS sepsis. We compared global gene expression differences (genetic
biomarkers) and differences in a selected set of cytokines associated with sepsis (soluble
biomarkers) between uninfected vs. infected mice of selected highly resistant and highly
susceptible strains at 8, 12, and 24 hours post infection.
In our global gene expression analyses, we aimed to profile patterns associated
with differential susceptibility to severe GAS sepsis. To achieve this aim, we compared
infected mice at different stages of infection (8 and 12hours post GAS infection) to
uninfected group of mice (0hrs) (experimental design illustrated in Figure 4-1). We used
groups of ARI-BXD strains that displayed marked differences in response to severe GAS
sepsis as characterized in studies outlined in chapters 2 and 3 of this dissertation and Aziz
et al. 2007 and Abdeltawab et al 2008. We designed our experiments so that there were
multiple levels of replication. First at the level of ARI-BXD strains used, we selected
three highly susceptible ARI-BXD strains (BXD97, 100, and 77) * to represent the most
susceptible side of strains (see gradient of differential susceptibility in Figure 3-1).
Similarly for the resistant group, we chose to use three most resistant ARI-BXD strains
(BXD48, 73, 87) †. In doing so, there were replicas on the level of both susceptible and
resistant groups, instead of one strain representing the susceptible group; we collected
data from three extremely susceptible strains and similarly for resistant strains as
illustrated in Figure 4-1. Within each of these selected representative six strains, we
collected and pooled blood from three mice per strain. Each pool of blood represented
one strain at a selected time point; this represented biological replica (3 mice per strain).
To guard against effects of stress due to multiple bleedings of the same mouse, we used
three different sets of mice (3 different mice per set) to analyze each of the studied time
points whether pre infection or at different stages of infection (Figure 4-1).
*

According to our studies outlined in chapter 3 as illustrated in Figure 3-1, BXD94 and BXD90
are among the extremely susceptible strains; however we did not use BXD94 and BXD90 as
BXD94 is now extinct, while BXD90 has been recently difficult to breed in our hands.
†
Similarly for resistant strains, we used strains that exhibit extreme resistance as illustrated in
Figure 3-1 (BXD48,, BXD73 and BXD87), however, we did not use BXD92 which is also
extremely resistant as it has become extinct.
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Figure 4-1. Experimental design to test gene expression differences associated with
differential susceptibility to severe GAS sepsis at selected stages of infection.
Illustration of experimental design used for the assessment of patterns of differential
gene expression in blood associated with differential susceptibility to GAS sepsis at
early stages of infection (8 and 12 hours post infection). We selected mice belonging to
highly resistant strains (BXD48, 73 and 87) and highly susceptible strains (BXD100. 97
and 77). Strains were chosen based on our previous differential susceptibility results
detailed in chapter 3 of this dissertation. At each time point, 0 h representing uninfected
mice and 8 and 12 hours post infection, we sacrificed three mice per strain and collected
blood that was later pooled per strain, representing certain strain at a certain time point
(e.g. BXD48 in the illustration, where RNA1 represents BXD48 0 h and RNA2
represents BXD48 8h, each RNA sample was prepared from pooled blood of 3 mice).
The same design was repeated for each and every strain. We extracted RNA from these
pooled blood samples and hybridized purified high quality RNA to Illumina WG-6 V2.0
mouse arrays (see methods for details of arrays processing). We compared differentially
expressed genes in the resistant group (as a whole) at 8 and 12 hours post infection to
uninfected mice, and obtained a list of differentially expressed genes, denoted as A and
B for resistant strains at 8 and 12 h respectively. Similarly, gene lists C and D for
susceptible strains at 8 and 12 hours respectively as shown. We then parsed these
differentially expressed gene lists associated with resistance and those with
susceptibility into pathways. These pathways are shown in Figures 4-2 and 4-3, and
methods used to generate these pathways are detailed in methods section.
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We adopted the design (illustrated in Figure 4-1) to allow us to investigate
patterns of differentially expressed genes associated with differential susceptibility to
severe GAS sepsis. In addition we wanted to investigate stage-specific differential gene
expression patterns associated with differential susceptibility.
We chose blood for our current analyses of early stage of infection as our
genome-wide association studies revealed association of differential susceptibility to the
innate immune cells, neutrophils and monocytes. In addition, blood is the main organ that
mounts the first line of defense to this blood borne pathogen. Nonetheless, we also
collected data for differentially expressed genes in the spleens of above-mentioned
selected highly susceptible and highly resistant strains at multiple times post infection
representing different stages of infection. We chose to also investigate genome-wide
differential gene expression in the spleen due to the spleen role as one of the main
secondary lymphoid tissues involved in clearance of extracellular blood borne bacteria. In
future studies to be performed in the laboratory, we plan to also investigate differential
gene expression in lungs of these differentially susceptible and resistant strains, as the
lung is one of the main organs involved in the severe outcome of GAS sepsis associated
with high mortality in clinical settings manifested by acute respiratory distress syndrome.
In our genome-wide differential gene expression analyses of blood, we aimed to
analyze stage-specific patterns of resistant strains and susceptible strains compared to
their uninfected control (Figure 4-1). For example gene expression levels at 8 hours post
infection from three resistant strains compared to 0 hr (uninfected mice) of the same
strains. Similarly for susceptible strains at 8 hours vs. 0 hours and also we performed
similar analyses for 12hrs compared to 0 hrs for both resistant and susceptible groups
(Figure 4-1).However, our current design allows us to analyze the data we generated in
multiple ways asking different questions. For instance, we can ask the question of what
are the patterns of different mechanisms of resistance by comparing the sets of
differentially expressed genes of each of the tested three resistant strains, and similarly
for susceptible strains. Another question we would like to address is: what are the
differences in gene expression in blood cells between susceptible and resistant group preinfection (0h). This will help us address the question of possible predisposition to severe
sepsis prior to GAS infection.
We compared global gene expression in blood at 8 hours vs. 0 hours and found
that 232 genes were differentially expressed in resistant strains, while 322 genes were
differentially expressed in blood cells of susceptible strains (Figure 4-1, 4-2 and Table
4-1). Comparing these two differentially expressed gene lists, we found that there were
91 genes that were shared (common) between differentially expressed gene sets of
susceptible and resistant strains (Figure 4-2). These shared genes fell into multiple
pathways, including interferon signaling and interferon regulatory factor activation
pathway. Both pathways were upregulated in both susceptible and resistant strains
(Figure 4-2 and Table 4-1). However, there were quantitative differences between
susceptible and resistant strains in this upregulation (Table 4-1). For example, interferon
induced protein with tetratricopeptide repeats 3 (Ifit3) was upregulated at 8 h vs. 0 h in
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Figure 4-2. Pathways associated with differentially expressed genes at 8 hours post
infection in peripheral blood of resistant and susceptible strains compared to
uninfected (0hr) mice of respective strains.
Panel A. Venn diagram of differentially expressed genes in blood of resistant and
susceptible strains, showing common (shared) and unique genes. Resistant strains had
232 genes differentially expressed within these, 141 genes were unique to resistant
strains while 91 genes were shared with susceptible strains. A total of 322 genes were
differentially expressed in susceptible strains within these genes, 231 genes were unique
to susceptible strains. These lists of differentially expressed genes were parsed into
pathways using ingenuity pathway analysis tool (IPA) as detailed in methods section.
Shown are the most significant pathways. We parsed common (shared) differentially
expressed genes in both resistant and susceptible strains into pathways shown in panel B.
The significant pathways associated with genes that are differentially expressed only in
resistant strains are shown in panel C, while those associated only with susceptible
strains are shown in panel D. Whether the genes within a pathway are up or down
regulated is denoted in words and as arrows beside each pathway. The x-axis displays
significance in (–log (p-value)) where the higher the number (the longer the blue bar) the
more likely the association of the differentially expressed genes with the noted pathways
is not by chance, this significance is also expressed as p-values on each bar. For each
pathway we calculated a ratio (orange squares, and decimal number associated with it),
the ratio is the number of differentially expressed genes divided by total number of
molecules in the specified pathway.
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A Venn diagram of differentially expressed genes at 8 h
post infection in blood of resistant and susceptible
strains, showing common (shared) and unique genes

B Pathways of differentially expressed genes shared (common)
between resistant and susceptible strains at 8 h post infection
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C Pathways of differentially expressed genes
associated with resistant strains at 8 h post infection

D Pathways of differentially expressed genes associated only
with susceptible strains at 8 h post infection

Figure 4-2. (Continued).
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Table 4-1. Differentially expressed genes in peripheral blood of resistant and susceptible strains at 8 hrs post GAS infection.
Pathways and Genes/Transcripts
Top pathways associated with differentially
expressed genes shared between susceptible
and resistant strains
Interferon signaling and activation of IRF by
cytosolic pattern recognition receptors
Ifit3
Ifit2
Stat2
Zbp1
Dhx58
Oas1
Top pathway associated with differentially
expressed genes in resistant strains (8h vs. 0h)
IL10 signaling
Arg2
Ikbke
Il1b
Il1rn
Tnf
Jun

Gene/Transcript Description

Fold Change
Susceptible Resistant

Interferon-induced protein with tetratricopeptide
repeats 3 (Ifit3)
Interferon-induced protein with tetratricopeptide
repeats 2 (Ifit2)
Signal transducer and activator of transcription 2
(Stat2)
Z-DNA binding protein 1 (Zbp1)
DEXH (Asp-Glu-X-His) box polypeptide 58 (Dhx58)
2'-5' oligoadenylate synthetase 1G (Oas1 gamma)

19.83

29.42

5.58

9.57

4.04

3.42

4.13
8.50
12.14

3.93
8.79
11.48

Arginase, type II
Inhibitor of kappa light polypeptide gene enhancer in
B-cells, kinase epsilon
Interleukin 1, beta
Interleukin 1 receptor antagonist
Tumor necrosis factor (TNF superfamily, member 2)
Jun oncogene (Jun)
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3.78
3.79
5.99
9.49
4.63
2.23

Table 4-1 (Continued).
Pathways and Genes/Transcripts

Gene/Transcript Description

Top pathway associated with differentially
expressed genes in susceptible strains (8h vs. 0h)
Role of PKR in Interferon induction
Inhibitor of kappa light polypeptide gene enhancer in
Ikbk
B-cells, kinase gamma
Mitogen-activated protein kinase kinase 3
Map2k3
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Fold Change
Susceptible Resistant
-2.03
-2.53

susceptible group by ~20 folds vs. 29 folds in resistant group (Table 4-1). Similarly other
quantitative differences between susceptible and resistant group were observed.
However, we didn’t observe this quantitative difference between resistant and susceptible
group at 12 hours post-infection (Table 4-1 and 4-2). Further studies, which are beyond
the scope of this dissertation, are needed to elucidate if and how these observed
quantitative differences relate to differential susceptibility to GAS sepsis.
Among the top pathways (pathways with highest significance) associated with
differentially expressed genes in resistant strains (8 vs. 0 hours) was IL10 signaling
pathway (Figure 4-2 and Table 4-1). We found that most of the differentially expressed
genes in IL10 signaling pathway were upregulated (Table 4-1).Of note was the
upregulation of arginase II (Arg II) in resistant strains at 8 h post infection (Table 4-1).
Arg II and nitric oxide synthase (NOS) compete for the same arginine pool with the
production of L-ornithine or nitric oxide (NO) respectively. Therefore, upregulation of
Arg II in resistant strains might reflect a plausible mechanism of resistance, where
upregulation of Arg II might regulate the production of NO in endothelial cells by
decreasing the bio availabity of arginine. This suggested that resistant strains might be
upregulating Arg II to control a possible over production of NO. Over production of NO
can lead to an increase in vascular permeability and leakage, leading to increase loss of
fluids from vascular vessels, leading to hypotension which leads to shock, and
consequently STSS.
In addition, association of upregulation of IL10 signaling pathway with resistance
(Figure 4-2) suggested that resistance might be initiated early on in infection with known
involvement of IL10 signaling pathway in induction of tissue repair and its
immunomodulatory responses. However, in our analyses, we did not find upregulation of
Il10 gene itself upregulated; although its signaling pathway was upregulated. In addition
to IL10 signaling pathway, multiple pathways associated with tissue development, cell
proliferation, activation of macrophages, pattern recognition activation were associated
with resistance (Figure 4-2). We also found that pathways associated with bacterial
killing and reactive oxygen species (ROS) production were among pathways associated
with differentially expressed genes in resistant strains only. It seems contradictory that
we found that resistant strains had upregulation of both Arg II (associated with regulation
of NO production) and ROS production pathways. However, it might be that these
resistant strains exert an active suppression of over production of such ROS but not ROS
production per se. Since overproduction of NO is associated with tissue damage and
shock, resistant strains guard against these deleterious effects by using up arginine pools
(Arg II upregulation), meanwhile adequate production of ROS is induced to control the
bacterial infection.
In susceptible strains, we found that 231 genes were differentially expressed at 8 h
post infection compared to 0 h (Figure 4-1 list C and 4-2). The top pathways associated
with these differentially expressed genes were role of protein kinase receptor (PKR)
interferon induction and CD40 signaling. Most of the differentially expressed genes
belonging to both pathways were downregulated. This observed downregulation of PKR
induced interferon signaling in susceptible strains at 8 hrs is in contrast to resistant strains
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that manifested upregulation of the same pathway at same time point.CD40 signaling
pathway is involved in a multitude of immune responses ranging from induction of proinflammatory cytokines to activation of cell survival and was associated in the production
of IL1 and IL8 from vascular endothelial cells, in addition, it is involved in the induction
of prostaglandin endoperoxide synthase 2 (Ptgs2) and subsequent production of PGE2
(Elgueta et al., 2009). The observed downregulation of genes associated with CD40
signaling and PKR induction of interferon signaling in susceptible strains might be
associated with the lack of mounting appropriate response to GAS infection.
Next, we examined differential gene expression patterns at 12 hours post
infection; we found that 380 genes were differentially expressed in resistant strains at 12
h compared to uninfected mice, out of which 268 genes were unique to resistant strains
and 112 genes were shared with susceptible strains (Figure 4-3).Again similar to 8 h, the
shared (common) differentially expressed genes between resistant and susceptible strains
(112 genes) fell into pathways that included interferon signaling. However, the
quantitative differences between susceptible and resistant strains were more towards
higher levels in susceptible than resistant strains, while the reverse was true at 8h, e.g.
Ifit3 levels at 8 vs. 12 hrs (common genes Table 4-1 and 4-2).The 268 genes
differentially expressed in resistant strains only, fell into interferon signaling pathway and
activation of interferon signaling by pattern recognition receptors and PKR signaling. We
observed this upregulation of genes associated with interferon signaling at both 8 and 12
hours in both susceptible and resistant strains however, the mechanism of induction was
different and there was a down regulation of PKR induced interferon signaling in
susceptible strains at 8 h. Further detailed studies might help in elucidating the details of
mechanisms of interferon in modulating differential susceptibility.
Meanwhile, pathways associated with differentially expressed genes in the blood
of susceptible strains at 12h post infection were mainly associated with induction of
mitochondrial enzymes, induction of apoptosis and oxidative phosphorylation. Genes
within these pathways were upregulated; this upregulation of mitochondrial pathways
might be associated with bacterial induced mitochondrial injury and bioenergetic failure
thus leading to sepsis-associatated multiple organ failure. This is further supported by our
finding that in susceptible strains mitochondrial oxidative phosphorylation enzymes e.g.
NADH dehydrogenase and succinate dehydrogenase were upregulated at both 8 and 12 h
post infection (Figure 4-2, 4-3 and Table 4-2), suggesting that mitochondrial oxidative
phosphorylation is upregulated to counteract the ROS produced. Furthermore,
mitochondrial apoptosis related enzymes e.g. caspase 8 and cytochrome C-1, as well as
pathways associated with induction of apoptosis were upregulated in only the susceptible
strains at 12h (Figure 4-3 and Table 4-2). This simultaneous upregulation of electron
transport chain (ETC) enzymes and mitochondrial-induced apoptosis signaling could be
explained in terms of possible positive feedback between the cascades of oxidative
phosphorylation provided by ETC to enhance apoptotic pathway. This fits with a recent
report that showed that GAS can induce mitochondrial permeability leading to
bioenergetic and redox damage. Thus evading host immune defense and causing
inflammatory programmed cell death in monocytes (Goldmann 2009). Furthermore, it
results have been recently reported that GAS streptolysin S and O virulence factors
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Figure 4-3. Pathway analysis of differentially expressed genes at 12 hrs post
infection in peripheral blood of resistant and susceptible strains compared to
uninfected (0hr) mice of respective strains.
Panel A. Venn diagram of differentially expressed genes in blood of resistant and
susceptible strains, showing common (shared) and unique genes. Resistant strains had
380 genes differentially expressed within these, 268 genes were unique to resistant
strains while 112 genes were shared with susceptible strains. A total of 650 genes were
differentially expressed in susceptible strains within these genes, 538 genes were
unique to susceptible strains. These lists of differentially expressed genes were parsed
into pathways using ingenuity pathway analysis tool (IPA) as detailed in methods
section. Shown are the most significant pathways. We parsed common (shared)
differentially expressed genes in both resistant and susceptible strains into pathways
shown in panel B. The significant pathways associated with genes that are differentially
expressed only in resistant strains are shown in panel C, while those associated only
with susceptible strains are shown in panel D. Whether the genes within a pathway are
up or down regulated is denoted in words and as arrows beside each pathway. The xaxis displays significance in (–log (p-value)) where the higher the number (the longer
the blue bar) the more likely the association of the differentially expressed genes with
the noted pathways is not by chance, this significance is also expressed as p-values on
each bar. For each pathway we calculated a ratio (orange squares, and decimal number
associated with it), the ratio is the number of differentially expressed genes divided by
total number of molecules in the specified pathway.
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A Venn diagram of differentially expressed genes at 12 h B Pathways of differentially expressed genes shared (common)
post infection in blood of resistant and susceptible
between resistant and susceptible strains at 12 h post infection
strains, showing common (shared) and unique genes
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C Pathways of differentially expressed genes associated
with resistant strains at 12 h post infection

D Pathways of differentially expressed genes associated only
with susceptible strains at 12 h post infection

Figure 4-3. (Continued).
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Table 4-2. Differentially expressed genes in peripheral blood of resistant and susceptible strains at 12 hrs post GAS infection.
Pathways and Genes/Transcripts
Top pathways associated with differentially
expressed genes shared between susceptible and
resistant strains
Interferon signaling and LXR/RXR signaling
pathways
Ifit3
Tap1
Oas1
Il18
Il1rn
Nr1h3
Tlr4
Top pathway associated with differentially
expressed genes in resistant strains (12h vs. 0h)
Interferon signaling pathway
Stat1
Stat2
Top pathway associated with differentially
expressed genes in susceptible strains (12h vs. 0h)
Mitochondrial dysfunction
App
Casp8
Cyc1

Gene/Transcript Description

Fold Change
Susceptible Resistant

Interferon-induced protein with tetratricopeptide
repeats 3 (Ifit3)
Transporter 1, ATP-binding cassette, sub-family B
(MDR/TAP)
2'-5' oligoadenylate synthetase 1G (Oas1 gamma)
Interleukin 18
Interleukin 1 receptor antagonist, transcript variant 1
Nuclear receptor subfamily 1, group H, member 3
Toll-like receptor 4

22.93

22.31

4.21

2.78

15.54
6.84
5.41
17.61
2.59

11.54
5.03
5.75
15.80
2.67

Signal transducer and activator of transcription 1
Signal transducer and activator of transcription 2

Amyloid beta (A4) precursor protein
Caspase 8, apoptosis-related cysteine peptidase
Cytochrome c-1
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4.00
2.82

8.51
2.84
2.61

Table 4-2 (Continued).
Pathways and Genes/Transcripts

Gene/Transcript Description

Htra2
Ndufa8

HtrA serine peptidase 2
NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex 8, 19 kDa
NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex 9, 39 kDa
NADH dehydrogenase (ubiquinone) Fe-S protein 2,
49 kDa
NADH dehydrogenase (ubiquinone) Fe-S protein 3,
30 kDa
NADH dehydrogenase (ubiquinone) Fe-S protein 7,
20 kDa
NADH dehydrogenase (ubiquinone) Fe-S protein 8,
23 kDa
Succinate dehydrogenase complex, subunit B, iron
sulfur (Ip)
Succinate dehydrogenase complex, subunit C
Ubiquinol-cytochrome c reductase core protein 1
Xanthine dehydrogenase

Ndufa9
Ndufs2
Ndufs3
Ndufs7
Ndufs8
Sdhb
Sdhc
Uqcrc1
Xdh
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Fold Change
Susceptible Resistant
4.17
3.96
3.91
2.45
2.98
2.45
2.76
3.39
2.24
2.92
6.20

specifically interfere with killing mechanisms by induction of mitochondrial dysfunction
(Aikawa et al., 2010). Nonetheless, these previous studies did not elucidate the exact
mechanisms and role of mitochondrial dysfunction in modulating severity of GAS sepsis.
Therefore, more detailed studies with more time points focusing on the role of
mitochondrial dysfunction in inducing multiple organ failure are required to further
elucidate our results.
In general, our global gene expression studies comparing differential gene
expression in blood of infected vs. uninfected susceptible and resistant strains at multiple
times post infection gave us insight into some aspects of how the host might be
modulating differential immune response to GAS sepsis. Our data suggested that the
involvement of multiple pathways in modulating differential susceptibility, where starting
as early as 8h post infection, IL10 signaling pathways were upregulated only in resistant
strains. In addition, pathways associated with bacterial killing and resolution of infection
were triggered in resistant strains at that early stage. It was noteworthy that genes and
pathways involved in macrophage and neutrophils killing mechanisms were also
associated with these discovered pathways.
Next, we analyzed change in gene expression in spleen at 8, 12, 16, 24 and 36h
post infection following the same design as blood microarrays studies detailed in Figure
4-1. However, we chose to start by analyzing the 36 h post infection differential gene
expression arrays, to investigate immune response after allowing enough time for the
bacteria to disseminate to the spleen. Analysis of the differentially expressed genes in
spleens of resistant and susceptible ARI-BXD strains revealed the engagement of the
same pathways suggested by the systems genetics genome-wide association studies.
These pathways encompass many of the genes located within all 3 survival QTLs,
including the one on Chr X. In those studies, we infected susceptible and resistant ARIBXD strains with M1T1 GAS, uninfected control mice from the same strains were
injected with saline. The data revealed significant changes in the expression of highly
relevant genes in both susceptible and resistant mice, both pre- and post infection (Figure
4-4). Many of those genes are located within our 3 mapped QTLs (e.g. Il1α, Il1β, and
Il1rn) on Chr 2, in addition to Irf1 on Chr X. These genes and pathways are likely to
contribute to the pathogenesis and differential severity of GAS sepsis. However, this
spleen microarray data is very preliminary, with further analyses and more samples
needed to be done for obtaining a clearer picture of mechanisms of differential
susceptibility.
Soluble Biomarkers Associated with Differential Susceptibility in Select Susceptible
and Resistant Strains at Multiple Time Series Post-infection
Next, we wanted to dissect soluble biomarkers associated with differential
response. Therefore, we aimed to analyze the kinetics of selected cytokines levels in
plasma of uninfected vs. infected resistant and susceptible strains at selected time points
post infection. We analyzed differences in the levels of selected cytokines that are known
to be associated with modulation of differential severity of GAS sepsis and were
associated with differential gene expression analyses detailed in the first section of
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Figure 4-4. Pathways associated with differentially expressed genes in spleens of uninfected versus infected resistant and
susceptible ARI-BXD strains at 36h post GAS infection. *
We infected selected highly susceptible and highly resistant ARI-BXD strains (n = 3–4 strains in each group, 3–5 mice per strain
per time point) with M1T1 GAS strain. In parallel, a control group of mice was injected with saline. Differentially expressed
genes in spleen at 36h post infection were parsed into pathways, shown are the most significant pathways in resistant and
susceptible group. The x-axis displays significance in (–log (P-value)) where the higher the number the more likely the association
is not by chance. Matching pathways shown were connected with arrows in light blue.
*

Data represented in this Figure is preliminary, as we are planning to do more analysis aswell as more time points that we have already collected
samples, these samples represent earlier stages of infection. We are continuing to analyze these data to elucidate mechanisms associated with
differential response.
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Chapter 4. We investigated selected pro-inflammatory cytokines, interleukin 6 (IL-6),
interferon gamma (IFNγ) and tumor necrosis factor alpha (TNFα) and anti-inflammatory
cytokine, IL10 at selected time points post-infection (0, 8, 12 and 24 hours).
We first aimed to analyze stage specific differences within each group, i.e.
susceptible group at different time points post infection and similarly resistant group. We
found that in susceptible strains TNFα showed significant increase in plasma levels at 8
hours post infection, followed by a drop in plasma levels at 12 hours to almost the same
levels as “zero” or uninfected control mice, then no changes at 24 h from 12 h (Figure
4-5-A) *. This might suggest that there might be a possible early induction of acute
systemic sepsis manifested by the observed high systemic levels of TNFα at 8 hours in
susceptible strains only. As for the resistant strains studied, we found that levels of TNFα
significantly increase in the plasma only at 24 h post infection (compared to uninfected
mice) (Figure 4-5-B). This might suggest that the release of TNFα at that stage of
infection is more beneficial and induces appropriate response to resolve infection as these
strains are protected against sepsis. However, on comparing TNFα levels in resistant vs.
susceptible group at each of studied stages of infection, there were trends of differences
but none reached significant (Figure 4-5-C).
For IL6 both susceptible and resistant strains showed significant increase in
plasma levels at 12 and 24 hours post infection in comparison to 0 h (uninfected controls)
(Figure 4-6-A and 4-6-B). However, the levels of IL6 in susceptible strains at 24 hours
post infection were almost double that of resistant strains, yet it didn’t reach statistical
significance differences due to the spread of data points (Figure 4-6- C). Collectively,
TNFα and IL6 pro-inflammatory cytokines and crucial mediators of systemic sepsis
didn’t show differences in the levels between susceptible and resistant strains. However,
we realize that this might due to assessing plasma levels of these cytokines, which does
not reflect the actual producing cells; therefore, we plan to perform intracellular cytokine
staining, where we can determine which cells are producing theses cytokines at the
studied stages of infection and hence draw a more definitive conclusion. Yet, our results
indicate that at these early time points, systemic levels of IL6 and TNFα do not differ
between susceptible and resistant strains at the selected time points.
Next we looked at levels of anti-inflammatory cytokine IL10 in susceptible and
resistant strains at multiple stages of infection. We found that both susceptible and
resistant strains showed significantly high levels at 8 and 12 hours post-infection (Figure
4-7-A and 4-7-B). However, levels of IL10 were 2-3 folds higher in resistant strains than
susceptible strains; indeed comparing susceptible to resistant strains, showed that higher
levels of IL10 were associated with resistant strains at as early as 8 and 12 hours post
*

The analyzed data shown in Figures 4-5 to 4-9 are representive of susceptible and resistant
groups, where 2 mice per strain per time point were analyzed, with the exception of:a)
susceptible group, where we used 4 mice at 8 h and 12h for BXD 97 and for BXD77 we used 4
and 6 mice at 12 and 24 h respectively b) Resistant group, we used 4 mice at 8, 12 and 24 h of
BXD87 and one mouse at 8 hours of BXD48. We collected far more plasna samples that are to
be assayed. All other data shown is for 2 mice per strain (3 strains used) per time point (4 time
points analyzed).
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Figure 4-5. TNFα plasma levels profiles across early time points post infection
comparing selected highly susceptible and highly resistant ARI-BXD strains.
We infected three highly susceptible ARI-BXD strains (BXD100, 77 and 97) and
three highly resistant ARI-BXD strains (BXD48, 73 and 87) with 2 X 107
CFU/mouse of hypervirulent M1T1 GAS strain, design of study is similar to
microarray studies shown in Figure 4-1, further details of cytokine measurements in
methods section. We sacrificed and collected plasma for a set of mice per strain at
each time point post infection, 8, 12, and 24 hours, therefore, there were no multiple
bleedings of any of the mice used. In parallel, a control group of uninfected mice
were used for collection of plasma for estimating normal levels of TNFα in these
selected strains. (A). Comparison of medians of levels of TNFα in susceptible mice
showed that levels of TNFα increased significantly at 8 hours post-infection, then
significantly drop back to almost the zero levels at 12 hours post infection. Panel (B).
Resistant strains showed significant increase in levels of TNFα only at 24 hours postinfection. Panel C. We compared TNFα plasma levels in susceptible (red dots) vs.
resistant (blue dots) groups at the analyzed time points. There were differences in
levels of TNFα but none reached statistical significance based on Mann-Whitney test.
We applied Kruskal-wallis test to assess statistical significance of differences in
levels of TNFα between and across time points (stages of infection) (panels A and B).
In general a p value of < 0.05 was considered significant.
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Figure 4-6. IL6 plasma levels profiles across early time points post infection
comparing selected highly susceptible and highly resistant ARI-BXD strains.
We infected three highly susceptible ARI-BXD strains (BXD100, 77 and 97) and three
highly resistant ARI-BXD strains (BXD48, 73 and 87) with 2 X 107 CFU/mouse of
hypervirulent M1T1 GAS strain We sacrificed and collected plasma for a set of mice
per strain at each time point post infection, 8, 12, and 24 hours, therefore, there were
no multiple bleedings of any of the mice used. In parallel, a control group of
uninfected mice were used for collection of plasma for estimating normal levels of IL6
in these selected strains. (A). Comparison of medians of levels of IL6 in susceptible
mice showed that levels of IL6 increased significantly at 12 and 24 hours postinfection compared to pre-infection (zero hour). Panel B. Similarly, resistant strains
showed significant increase in levels of IL6 12 and 24 hours post-infection, however,
the maximum value and hence the range of IL6 levels was higher and wider in
susceptible strains, up to 3500 pg/ml vs. 1800 pg/ml in resistant strains. Panel C. We
compared IL6 plasma levels in susceptible (red dots) vs. resistant (blue dots) groups at
the analyzed time points. There were differences in levels of IL6 but none reached
statistical significance based on Mann-Whitney test. We applied Kruskal-wallis test to
assess statistical significance of differences in levels of IL6 between and across time
points (stages of infection) (panels A and B). In general a p-value of < 0.05 was
considered significant. (For number of samples analyzed please refer to page 65
footnote).
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Figure 4-7. IL10 plasma levels profiles across early time points post infection
comparing selected highly susceptible and highly resistant ARI-BXD strains.
We infected three highly susceptible ARI-BXD strains (BXD100, 77 and 97) and three
highly resistant ARI-BXD strains (BXD48, 73 and 87) with 2 X 107 CFU/mouse of
hypervirulent M1T1 GAS strain We sacrificed and collected plasma for a set of mice per
strain at each time point post infection, 8, 12, and 24 hours, therefore, there were no
multiple bleedings of any of the mice used. In parallel, a control group of uninfected
mice were used for collection of plasma for estimating normal levels of IL10 in these
selected strains. (A). Comparison of medians of levels of IL10 in susceptible mice
showed that levels of IL10 increased significantly at 8 hours post-infection compared to
pre-infection (zero hour), then dropped at 12 and 24 hours with significant drop at 24 to
almost same as “zero” hour. Panel B. Similarly, resistant strains showed significant
increase in levels of IL10 at 8 hours post infection, with a drop at 12 and 24 hours postinfection, however, levels at 12 hours were still significantly higher than zero hour. In
addition, in general the resistant strains had higher levels of IL10 levels than the
susceptible strains. Panel C. We compared IL10 plasma levels in susceptible (red dots)
vs. resistant (blue dots) groups at the selected analyzed time points. We found that IL10
levels were significantly higher in plasma of resistant strains at early time points (8 and
12 hours) however, at 24 hours post infection both susceptible and resistant strains IL10
levels dropped and no statistical differences between their levels. Significance between
susceptible and resistant strains IL10 levels were calculated based on Mann-Whitney
test. We applied Kruskal-wallis test to assess statistical significance of differences in
levels of IL10 between and across time points (stages of infection) (panels A and B). In
general a p-value of < 0.05 was considered significant. (For number of samples analyzed
please refer to page 65 footnote).
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infection (Figure 4-7-C). The association of higher levels of anti-inflammatory IL10
suggested that an active immunosuppressive of the cytokine avalanche might be the
mechanism of resistance and protection against sepsis. While highly susceptible strains
had lower levels of IL10 suggesting an unchecked cytokine response was associated with
higher severity of sepsis.
IFNγ was significantly higher in susceptible strains at 24 hours post infection;
however, in resistant strains there were no significant increase in levels of IFNγ (Figure
4-8-A and 4-8-B). Comparing levels of IFNγ resistant to susceptible strains, again 24
hours susceptible strains had higher levels, this being a biologically relevant time point
for IFNγ actions. (Figure 4-8-C) Collectively, results from pro-inflammatory cytokines,
IL6, TNFα and IFNγ, showed increase in levels in susceptible across time points
suggested that systemic acute response in susceptible strains. However, these increase
were also seen in resistant strains (Figures 4-5, 4-6, and 4-8 panels A and B), yet we
postulated that the increase in these pro-inflammatory cytokines was neutralized or
modulated by anti-inflammatory cytokines in resistant strains. Therefore, we compared
anti- to pro- inflammatory cytokines ratios, as shown in Figure 4-9 comparing IL10/IFNγ
ratios. This comparison reveled that resistant strains had higher levels of IL10/IFNγ ratio
at all time points post infection and even at 0 h prior to infection. Collectively, our data
suggest that susceptibility to severe GAS sepsis is mainly associated with unchecked
production of pro-inflammatory cytokines and mediators at early time points. Meanwhile,
protected mice are better able to down regulate excessive inflammatory responses and
hence are protected against STSS. Our cytokine profiling analyses validated the pathways
discovered through our transcriptome profiling of blood cells from the mice at different
time points post infection in addition to our GWAS mapping results.
Moreover, our findings outlined in chapters 3 and 4 of this dissertation are in
concordance to the clinical disease data; where our recent human ex vivo data showed
that IL10 exerts active suppression of exaggerated immune responses in individuals
carrying protective HLA-II alleles (DR15/DQ6) (Nooh and Kotb in press). Whereas
individuals carrying the STSS high-risk alleles (DR14/DQ5) mounted significantly lower
levels of IL10 and higher levels of IFNγ (Nooh and Kotb in press).Further validation was
done by the addition of exogenous rIL10 to PBMCs isolated from individuals carrying
high-risk HLA-II alleles (DR14/DQ5) decreased SAg-induced T cell proliferation and
cytokine responses (Nooh and Kotb in press). Moreover, the association of higher levels
of IL10 with protection from sepsis was also observed in our human transcriptome
profiles of patients with severe vs. non-severe GAS sepsis (Kanasal and Kotb in final
preparation).
Collectively, our murine in vivo and in vitro data with our human ex vivo data
support our hypothesis that resistance (protection) is actively exerted by the production of
the anti-inflammatory immunomodulatory IL10. In addition, IL10 is highly regulated and
can be produced by a number of innate immune cells, including dendritic cells,
macrophages, and most recently it has been shown to be produced by neutrophils
(Saraiva and O'Garra, 2010).We observed that IL10 in plasma was detected at a rather
early stage of the infection (8 and 12). Therefore, it is likely that innate immune cells are
producing IL10. Interestingly, recent reports indicated that neutrophils can exert
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Figure 4-8. IFNγ plasma levels profiles across early time points post infection
comparing selected highly susceptible and highly resistant ARI-BXD strains.
We infected three highly susceptible ARI-BXD strains (BXD100, 77 and 97) and three
highly resistant ARI-BXD strains (BXD48, 73 and 87) with 2 X 107 CFU/mouse of
hypervirulent M1T1 GAS strain We sacrificed and collected plasma for a set of mice
per strain at each time point post infection, 8, 12, and 24 hours, therefore, there were no
multiple bleedings of any of the mice used. In parallel, a control group of uninfected
mice were used for collection of plasma for estimating normal levels of IFNγ in these
selected strains. (A). Comparison of medians of levels of IFNγ in susceptible mice
showed that levels of IFNγ increased significantly only at 24 hours post-infection
compared to pre-infection (zero hour). In addition, levels at 24 hours were significantly
higher than 12 hours post infection Panel B. Resistant strains showed increase in levels
of IFNγ post-infection, however, none reached statistical significance. Panel C. We
compared IFNγ plasma levels in susceptible (red dots) vs. resistant (blue dots) groups at
the analyzed time points. There were significant differences in levels of IFNγ between
resistant and susceptible strains only at 24 hours, which is the biologically relevant time
point for IFNγ actions. Statistical significance comparing resistant to susceptible groups
was based on Mann-Whitney test. We applied Kruskal-wallis test to assess statistical
significance of differences in levels of IFNγ between and across time points (stages of
infection) analyzed (panels A and B). In general a p-value of < 0.05 was considered
significant. (For number of samples analyzed please refer to page 65 footnote).
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Figure 4-9. Comparison of ratios of anti-inflammatory to pro-inflammatory
cytokines, comparing ratios of medians of IL10/IFNγ plasma levels across early time
points post infection in selected highly susceptible and highly resistant ARI-BXD
strains.
We infected three highly susceptible ARI-BXD strains (BXD100, 77 and 97) and three
highly resistant ARI-BXD strains (BXD48, 73 and 87) with 2 X 107 CFU/mouse of
hypervirulent M1T1 GAS strain We sacrificed and collected plasma for a set of mice
per strain at each time point post infection, 8, 12, and 24 hours, therefore, there were no
multiple bleedings of any of the mice used. In parallel, a control group of uninfected
mice were used for collection of plasma for estimating normal levels of IL10 and IFNγ
in these selected strains. Data for individual cytokines were shown in Figures 4-7 and 48. Shown here are data from Figures 4-7 and 4-8 reanalyzed where medians of each
cytokine at each time point was calculated and ratio of medians of IL10/IFNγ was
calculated. Resistant group showed higher ratio of IL10/IFNγ than susceptible group at
all the compared time points, indicating that anti-inflammatory levels are governing the
immune response in resistant strains, adjusting the pro-inflammatory levels to
appropriate levels and keeping the pro-inflammatory cytokines in check. Higher levels
of IL10 were generally associated with protection, where we postulate that uncontrolled
pro-inflammatory cytokine avalanche leads to sepsis in the current studied GAS sepsis
model. (For number of samples analyzed please refer to matierials and methods
section).

84

85

immunomodulatory effects by secreting IL10 (Cassatella et al., 2009; Zhang et al.,
2009b). These findings are interesting as it agrees with our hypothesis of IL10 exerting
active suppression of exaggerated immune responses and hence high levels of IL10 are
associated with protection. More detailed studies to support or refute this hypothesis are
needed, with further dissection of the causal agent and modulator of IL10 levels, which
we hypothesized to be PGE2 as discussed in the next section. In conclusion, the
association of GAS sepsis severity with cytokines exerting their effects temporally
underscores the complexity of traits modulating severe GAS sepsis.
Analysis of the Role of Prostaglandin at Early Stage of Infection
The QTLs we mapped to Chr 2 have several immune-related genes that are
polymorphic and made biological sense. We narrowed down our QTLs using multiple
bioinformatics tools including linkage analyses, gene ontology analyses, and
polymorphism analyses; at this point we had a candidate gene list that we parsed into
pathways. The resultant pathways were validated by selecting key genes in each pathway
and validating differential levels in susceptible and resistant strains post infection (as
detailed in chapter 3). Real time PCR analyses associated differential susceptibility with
two main pathways, IL1 and prostaglandin E pathways (Abdeltawab et al. 2008 and
chapter 3 in this dissertation). In this section of the dissertation, I am going to focus on
studies we performed to find prostaglandins association with differential susceptibility to
GAS sepsis.
There are a total of five prostaglandins genes located either within our two main
mapped QTLs on Chr 2 or located in their proximity. These genes were differentially
expressed in our quantitative PCR analyses, however, we didn’t detect these differences
in our array data at the time points we selected. The five prostaglandin genes in our QTL
include, prostaglandin D2 synthase (Ptgds), Chr 2 (25.28 Mb), which is a polymorphic
(see Appendix C) gene encoding a lipocalin-type prostaglandin. Over expression of Ptgds
in lung was associated with better outcomes in bacterial pneumonia model (Joo et al.,
2007). Two other prostaglandins are located in the proximity of mapped QTLs,
prostaglandin-endoperoxide synthase 1 (Cox-1) (Chr 2 (36.05 Mb)) and prostaglandin I2
(Ptgis) aka prostacyclin (Chr 2 (166.89 Mb)). Prostacyclin has immunoregulatory
properties similar to PGE2, with immunosuppressive actions on macrophage in infectious
diseases (Aronoff et al., 2007). Of particular interest are prostaglandin E synthases 1
(Ptges) and 2 (Ptges2), on Chr 2, at 30.71 and 32.21Mb, respectively. These two genes
were quite interesting as we found that increased expression levels of Ptges and Ptges2
were associated with increased susceptibility to GAS sepsis (chapter 3 in this dissertation
and (Abdeltawab et al., 2008). Although following Occam’s razor principle one would
postulate that one gene within these QTLs might be the modulator of the differential
susceptibility observed. In addition, it might be that the co-existence of these immunerelated genes is by chance since the QTL is huge (~10Mb in size) allowing co-existence
of multiple immune-related genes. However, we found that these candidate genes were
polymorphic (Appendix C), in addition, pathway analyses revealed that these mapped
genes act together, moreover, our QTL acts as cis-acting QTL.
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Based on our QTL analyses and our quantitative gene expression analyses and
literature associated with other infectious diseases, we hypothesized that exaggerated
production of prostaglandins E2 (PGE2), the product of PTGES, in susceptible strains
might predispose them to severe response to GAS. Meanwhile, controlled amounts of
PGE2 in resistant strains could modulate a balanced response. To test our hypothesis, we
aimed to quantify PGE2 levels in susceptible and resistant strains at early time points post
infection that are more relevant to the quick responses mounted by PGE2. Being a lipid
mediator, PGE2 can exert its actions within few minutes post infection and is crucial in
the first 24 hours of infection (reviewed in [Harris et al., 2002; Bos et al., 2004; Sakata et
al., 2010]). Therefore, we investigated the levels of PGE2 at 30 minutes intervals after
infecting susceptible and resistant strains with the hypervirulent M1T1 GAS strain. We
sacrificed 4 mice per strain at each time point, examining the first 2 hours in 30 minutes
intervals (30, 60, 90 and 120 minutes) following infection (Figure 4-10). We found that
susceptible strains had significantly higher PGE2 levels compared to resistant mice,
especially during the first 60 min post-infection (Figure 4-10). This suggested that our
hypothesis is valid and matched our real time PCR expression data of Ptges and Ptges2,
our mapped QTL, and the association between increased levels of PGE2 and severe of
GAS sepsis. Further studies to elucidate the mechanism of action are undergone in the
laboratory.
Our finding that higher levels of PGE2 association with severe GAS sepsis along
with our finding its synthases in our mapped QTL in our GWAS (Chapter 3, Appendix A
and Abdeltawab et al. 2008). These synthases are polymorphic (Appendix C) and their
levels are differential expressed as observed in our qPCR results (Chapter 3 and
Abdeltawab et al. 2008). Collectively this led us to believe that PGE2 is an excellent
candidate modulator of differential susceptibility, however, the mechanism of modulation
needs further studies especially that PGE2 mechanism of action is complicated by the
fact that it acts as a Janus mediator. PGE2 can act as pro-inflammatory mediator inducing
IL6 production and causing vasodilatation and vascular leakage in inflammatory
responses (reviewed in [Harris et al., 2002; Bos et al., 2004; Sakata et al., 2010]). Both
events are crucial in GAS sepsis severity. In addition, PGE2 can act as an
immunosuppressive, reducing neutrophil migration and bacterial killing by macrophages,
by blocking production of reactive oxygen intermediates (ROI) (Sakata et al. 2010).
Moreover, it has been debated whether PGE2 promotes Th1 or Th2 responses,
however, recent studies show that PGE2 activates its EP2 and EP4 receptors, and
promotes Th1 differentiation and Th17 expansion (Yao et al., 2009)However, the two
faces of PGE2 are not mutually exclusive, as PGE2 actions depend on multiple factors,
including the cells it is exerting its actions on, stage of infection, receptors being
activated and nature of the activation signal, and more importantly the concentration of
PGE2. Where studies have shown that if the fine balance of this mediator is disturbed it
can lead to pathological consequences. For example alterations in the amounts of PGE2
are associated with high risk of infection with HIV, cancer, and malnutrition (Lima et al.,
2006; Anstead et al., 2009; Greenhough et al., 2009).
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Figure 4-10. Analysis of prostaglandin role at early stages of severe GAS sepsis.
Higher levels of PGE2 in susceptible strains at all examined stages of infection were
observed. We used the parental strains of BXD panel, C57Bl/6J (B6) and DBA/2J (D2),
(n = 4 mice per strain per time point). The time points examined were, 0, 30, 60, 90 and
120 minutes post infection. Data shows that D2 (the susceptible parental strain) has
higher levels of PGE2 compared to B6 even before infection (0hr). Following infection
with GAS (2X107 CFU), D2 PGE2 levels remained high throughout the observed 120
min following infection except for a drop at 90 min. Meanwhile, B6 seemed to maintain
a steady level of PGE2 with a trend of slight increase at 30-60 min then back to starting
levels at 90-120 min.
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Excitingly, studies have shown that PGE2 can inhibit production of IL10 from T
cells, and to exacerbate Th17 mediated inflammation (Boniface et al., 2009; Yao et al.,
2009). In the studies outlined in this dissertation we have shown that susceptibility and
poor outcome of sepsis were associated with higher levels of PGE2 (Figure 4-10), and
IFN (Figure 4-8) and lower levels of IL10 (Figure 4-7). Therefore, we hypothesis that
PGE2 can act as a “switch”, where in susceptible strains PGE2 can inhibit IL10
production, and increase IFN levels, thereby promoting Th17 mediated inflammation.
Meanwhile, we believe that in resistant strains PGE2 is produced in controlled levels,
allowing Th1 and Th17 polarization and subsequent containment of infection. We are
even more interested in this interactive role of PGE2 and IL10 as our recent in vitro
human studies showed that IL10 mediates protection against severe GAS sepsis
(discussed above). In addition, our mouse genome-wide expression pathway analyses
identified IL10 pathways to be upregulated in resistant strains at early time points (8h)
(Figure 4-2) associating high levels of IL10 with resistance to GAS sepsis and better
outcomes of infection.
Conclusion
Our genome-wide transcriptional analyses of infected vs. uninfected resistant and
susceptible strains revealed differentially expressed genes that belong to innate immune
response pathways that matched our mapped QTLs pathways. Moreover, our analyses of
secreted soluble biomarkers (cytokines and prostaglandins) at the studied time points
validated the pathways identified through GWAS and GW expression analyses. This
shows the power of the systems genetics approach in identifying disease mechanisms,
biomarkers and pathways that are associated with differential susceptibility to severe
GAS sepsis. Importantly our pathway discovered in mouse matched our findings from
clinical studies. This showed that pathways to pathways comparisons between mouse and
human can be more readily translated than comparing gene to gene.
Materials and Methods
Bacteria and Infection Studies Using Mice
We used hypervirulent M1T1 GAS strain clinical isolate GAS 5448 (Chatellier et
al., 2000). Bacterial culture and inoculum used in infection studies were prepared as
detailed previously (Aziz et al., 2007). The institutional animal care and use committee
(IACUC) at the University of Cincinnati, OH approved all procedures involving mice and
mice tissues described in current study.
Experimental Design of Time Series Infection Studies
To study the kinetics of cytokines and differential gene expression post GAS
sepsis, we designed time course (series) experiments. In these experiments, we infected a
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group of mice belonging to selected highly resistant and highly susceptible ARI-BXD
strains and sacrificed the mice at selected time points post infection. In parallel, we
injected saline to control group of mice belonging to those selected strains as above. At
each time point, we sacrificed the mice, collected blood, using cardiac puncture
procedure, and harvested spleens. Blood was used to isolate plasma for cytokine analyses
and reconstituted blood (with nuclease-free saline) and preserved blood in RNALater for
blood RNA purification at a later stage. Harvested spleens were immediately
homogenized in RLT buffer and frozen at -80ºC till further purification of spleen RNA.
Processing of Blood and Spleen Samples and Purification of RNA
We investigated the global gene expression in spleen and blood of infected vs.
control groups of mice at selected time points. We selected highly susceptible strains
(BXD97, BXD100, and BXD77) and highly resistant strains (BXD87, BXD48, and
BXD73) for our analyses. We performed 2–3 biological replicates (experiments) for each
selected highly susceptible and highly resistant strains, n = 3 mice per strain per time
point (Figure 4-1). Data represents 7 different experiments with the use of the same
strains overlapping multiple cohorts and comparing expression from same strain used in
different experiments. We isolated spleen RNA using RNeasy mini (Qiagen, Valencia,
CA) and isolated blood RNA using Mouse RiboPure kit (Ambion, Austin, Texas)
according to manufacturer’s protocol. We pooled RNA samples per strain using RNA
samples that passed our quality control testing of integrity and purity as detailed below.
Globin mRNA was removed from all blood RNA using GlobinClear kit (Ambion). All
RNA samples (blood and spleen) were treated for removal of DNA contamination and
RNA was further purified by re-precipitation using ethanol precipitation. All RNA
samples were checked for RNA purity and integrity. RNA purity was evaluated using the
260/280 and 260/230 absorbance ratios; RNA samples with 260/280 and 260/230 values
of ≥1.8 were chosen. Further, RNA integrity was assessed using 1% RNA denaturing
agarose gels. We required clear sharp bands of 18S and 28S rRNA for all samples
compared to a control RNA sample to ensure intactness of RNA.
Microarray Platform and Design
We used Illumina mouse GW-6 v2.0 BeadChip; probes cover more than 45,200
transcripts per sample, targeting genes and known alternative splice variants. The probes
content is derived from the NCBI Reference Sequence (RefSeq) (Build 36, Release 22),
supplemented with probes derived from the Mouse Exonic Evidence Based
Oligonucliotide (MEEBO) set, as well as exemplar protein-coding sequences described in
the RIKEN FANTOM2 database.
We used RNA samples that passed quality control as detailed above and of
concentration ≥ 50ng/ul for cRNA synthesis using Illumina TotalPrep RNA amplification
kit (Ambion) according to manufacturer protocol. The basic outline of the procedure
involves reverse transcription of RNA to synthesize cDNA using oligo (dT) primer,
followed by in vitro transcription of purified dsDNA to synthesize amplified biotinylated
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cRNA (aRNA). We evaluated purified labeled cRNA using same methods as mentioned
above for RNA samples. cRNA samples of good quality were then used to hybridize to
Illumina mouseWG-6 v2.0 according to Illumina standard protocols.
This data set consists of arrays processed in four batches or groups, where groups
of 2, 4, 1, and 4 beadchips were scanned at a time. Samples from seven different ARIBXD strains were compared at 5 time points (0, 8, 12, 16 and 24 hours post infection)
belonging to two different tissues, blood and spleen. A single operator processed all
arrays using illumina protocol for hybridization, washing and scanning. All samples in a
group were labeled on one day and chips were scanned using BeadArray Reader.
Microarray Data Processing and Analysis
Pooled RNA samples from blood and spleens (n = 60 samples) were processed
using a total of 10 Illumina mouseWG-6 BeadChips. All chips passed quality control and
error checking. This data set was extracted and processed using the Bead Studio 3. We
applied 75th percentile normalization to all the samples and the resulting expression
values were analyzed for statistical significance of differences between susceptible and
resistant strains at different time points in the studied tissues.
Identification of Differentially Expressed Genes and Functional Pathways Analyses
We performed functional analyses of differentially expressed genes from our
genome-wide transcriptome analyses using Ingenuity pathways analysis (IPA)
(www.ingenuity.com). Each data set containing gene identifiers was uploaded into the
online application, and each gene was overlaid onto a molecular network developed from
information contained in the ingenuity pathways database. We chose IPA most
significant “Canonical Pathways”, which are pathways identified from the Ingenuity
Pathways Analysis library of pathways to be most significant to the data set. The
Canonical Pathways are displayed as y-axis in bar charts; x-axis displays the significance
in (–log (P-value)) where the higher the number the more likely the association is not by
chance. In addition a ratio is calculated for each pathway, which is the number of
differentially expressed genes divided by total number of molecules in this pathway.
Therefore, taller bars have more genes associated with the Canonical Pathway than
shorter bars. The significance of the association between the dataset and the pathways
was measured in two ways: (1) the ratio (described above) and (2) by Fisher’s exact test
with P < 0.001.
Cytokine Measurements and Analyses
We studied the kinetics of plasma cytokine production in selected highly resistant
and susceptible strains. Groups of 3–5 mice per strain per time point from selected highly
susceptible and highly resistant ARI-BXD strains, which were infected with 2 ± 1.5 x 107
CFU/mouse of a hypervirulent M1T1 GAS strain. In parallel, a control group of
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uninfected mice were used for collection of plasma for estimating normal levels of
cytokines in these selected ARI-BXD strains. We euthanized mice and collected blood
using cardiac puncture procedure into heparin-coated tubes. We separated plasma from
individual mice, added protease inhibitor cocktail to each plasma sample and stored
samples at -20ºC till further use. We measured cytokines levels in plasma of
representative 2 mice per strain of highly resistant (BXD48, 73 and 87) and highly
susceptible strains (BXD100, 77 and 97), with exceptions where we assayed more
samples from some strains as indicated in footnote of Figure 4-5. We analyzed data
collected for time points 8, 12, and 24 hours post-infection. We used a multiplex cytokine
ELISA kit from Millipore (Billerica, MA) to detect 4 cytokines: interleukin 6 (IL6), IL10,
tumor necrosis factor alpha (TNF), and gamma interferon IFNγ. The analyzed data
shown in Figures 4-5 to 4-9 are representive of susceptible and resistant groups, where 2
mice per strain (mentioned above) per time point were analyzed, with the exception of
BXD 97 at 8 and 12h we used 4 mice and for BXD77 we used 4 and 6 mice at 12 and 24
h respectively, and BXD87 at 8, 12 and 24 h 4 mice were used and one mouse at 8 hours
of BXD48. We collected far more plasna samples that are to be assayed. All other data
shown in Figures 4-5 to 4-9 are for 2 mice per strain (3 strains used) per time point (4
time points analyzed).
Prostaglandin Studies
We selected parental strains for studying the role of prostaglandins in modulating
differential susceptibility to infection. Mice (6-8 weeks-old mice of DBA/2J susceptible
parent strain and the C57Bl/6J resistant parent strain) were purchased from The Jackson
Laboratory (Bar Harbor, Maine). To test the effect of prostaglandins on differential
responses to GAS sepsis, we studied early systemic prostaglandin E2 (PGE2) production
(within the first 2 hours of infection) in 30 minute intervals (30, 60, 90 and 120 minutes)
following inoculation. We infected mice with 2 X 107 CFU/mouse of the hypervirulent
M1T1 GAS strain, and sacrificed 4 mice per strain per time point. Bacterial suspensions
used for infection of mice were prepared as detailed in Aziz et al. (2007). We collected
blood using a standard cardiac puncture procedure and dissected the spleens and
homogenized them using a tissue homogenizer, TH (Omni International, Marietta, GA) in
2 ml of PBS. Tissue homogenates were stored frozen at -20ºC and sent on dry ice to the
University of Michigan, Ann Arbor, MI. The homogenates were thawed then centrifuged
at high speed (13,000 RPM) for 5 min to remove particulates. PGE2 levels were
quantified in spleen homogenate supernatants using an enzyme-linked immunosorbent
assay (ELISA) PGE2 kit according to the manufacturer’s instructions (Assay Designs,
Ann Arbor, Michigan).
Statistical Analyses
We used ANOVA and t unpaired test to assess significance of differentially
expressed genes in either resistant or susceptible group at a given stage of infection
compared to its uninfected control group, using GeneSpring GX 11.0 (Agilent
technologies, Inc.). Normalization of microarray data is detailed above.
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We used Kolmogorov-Smirnov test to assess normal distribution of our cytokine
data, we found that our cytokine data was not normally distributed, and since the number
of samples in some of the tested groups was less than 10, we didn’t apply any
normalization methods. Since our data showed that samples had non-normal distribution,
we applied the non-parametric tests detailed below To assess statistical significance of
differences in levels of different cytokines across time points analyzed we used KruskalWallis test. We evaluated the statistical significance of levels of a given cytokine at a
given time point in resistant vs. susceptible strains by using Mann-Whitney test. In all the
statistical tests we performed, a P-value less than 0.05 was considered significant. All
data was analyzed using GraphPad Prism (La Jolla, CA).
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CHAPTER 5. ANALYSIS OF CELLULAR POPULATIONS MODULATING
DIFFERENTIAL RESPONSE TO SEVERE GAS SEPSIS
Summary
We have previously mapped quantitative trait loci (QTLs) associated with
differential susceptibility to severe GAS sepsis using advanced recombinant inbred (ARI)
ARI-BXD strains (Abdeltawab et al., 2008).We narrowed down these QTLs and parsed
candidate genes into pathways associated with severity to GAS sepsis. We then compared
pathways discovered through in vivo genome-wide association studies with those
discovered through genome-wide transcriptome analyses and found that they matched
quite well and even more interestingly, some of these pathways were interacting with
each other. Subsequently, we aimed to explore the role of the key genes in those
discovered pathways in modulating differential host responses to GAS sepsis (covered in
Chapter 4).
In this chapter, we examined the cellular differences between resistant and
susceptible strains to help us further elucidate cellular mechanisms underlying the
differentially expressed candidate genes in modulating the differential susceptibility to
GAS sepsis. To achieve this, we first aimed to examine and characterize differences in
immune cell populations of blood and spleen of selected resistant and susceptible strains
under normal physiological conditions and found that there were no significant
differences between the susceptible and resistant strains with respect to the numbers and
percentages of examined immune cells in both blood and spleen. This suggested that
inherent variations in percentages of immune cell population among the
immunophenotyped BXD strains were not linked to their differential susceptibility to
severe GAS sepsis. Accordingly, we aimed to examine the hypothesis that migratory and
functional differences rather than cellular availability might be a possible mechanism of
resistance.
Subsequently, we aimed to examine the possibility that differences in cellular
responses may account for the differential susceptibility to GAS sepsis in our mouse
model. Specifically, we wanted to test the hypothesis that effective innate responses in
the early stages of infection is directly associated with resolution of GAS infection, and
better outcome of GAS sepsis. We based our hypothesis on studies from our group and
other groups that showed that neutrophils (Voyich et al., 2004; Buchanan et al., 2006;
Nilsson et al., 2006; Soehnlein et al., 2008a; Navarini et al., 2009), macrophages
(Goldmann et al., 2004a; Thulin et al., 2006; Goldmann et al., 2009), NK cells
(Goldmann et al., 2005b; Takahashi et al., 2007) and dendritic cells (Loof et al., 2008;
Cortes and Wessels, 2009; Yong et al., 2009), each play an important role in
streptococcal infections according to the site and the stage of infection. We started our
cellular dissection by examining the role of neutrophils in differential susceptibility to
GAS sepsis. Neutrophils are dominant cells in circulation and thus mediate early innate
immune response. It has been shown that recruitment, migratory and functional defects in
neutrophils result in increased mortality post bacterial infection (reviewed in [Nauseef,
2007]).
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To examine the likely contribution of neutrophils in modulating differential
susceptibility in our GAS sepsis model, we first depleted neutrophils and assessed how
this may affect infection outcomes in susceptible vs. resistant ARI-BXD strains. We
depleted neutrophils using anti-mouse Ly-6G and Ly-6C (RB6-8C5) (Czuprynski et al.,
1994) 24h prior to infection and found that this rendered resistant BXD strains
susceptible. This was associated with an increased bacterial load in depleted mice vs.
control mice. The reversal of phenotype of resistant strains, while susceptibility was
exaggerated in susceptible strains, confirmed the key role of neutrophils in controlling
GAS sepsis.
We also depleted macrophages using clodronate liposome (Van Rooijen and
Sanders, 1994) in susceptible and resistant strains and found similar results with reversal
of phenotype of resistant strains and exaggerated susceptibility of the susceptible strains.
These results demonstrate the important role of both neutrophils and macrophages in
modulating differential host responses in GAS sepsis. We also examined the kinetics of
neutrophils and macrophages in the first 24 h post infection and found no significant
differences between susceptible and resistant BXD strains. However, peripheral blood
monocytes were significantly higher in susceptible strain at 16h post infection further
showing that even higher numbers of monocytes did not contribute to better outcome of
sepsis.
The above data suggested that the numbers of neutrophils and macrophages are
not the determinant of the outcome of infection as susceptible strains had an equal or
higher numbers of these cells as the resistant strains. Collectively, our data suggest that
functional and/or migratory differences in these cells play an important role in
modulating differential susceptibility.
Results and Discussion
Profiling of Blood Cell Populations across Selected Resistant and Susceptible
Strains Reveals Possible Migratory and Functional Differences Rather than Cellular
Availability as a Possible Mechanism of Individual Variations in Susceptibility to
Severe GAS Sepsis
Homeostasis is a dynamic system regulated by complex interactions between
environmental and genetic factors. Blood cellular percentages, platelet counts and
erythroid traits have been associated with several QTLs using both inbred and BXD
strains (Chen and Harrison, 2002; Peters et al., 2005; Ferreira et al., 2009) GAS has
multiple virulence factors that affect and interfere with host homeostasis, for example,
interruption of coagulation system (Tapper and Herwald, 2000; Frick et al., 2007), as one
of the causes of pathogenesis.
The parental strains of the BXD panel, C57Bl/6J and DBA/2J, show significant
differences in numbers and percentages of lymphocytes and granulocytes populations in
blood (Chen and Harrison, 2002; Kile et al., 2003; Petkova et al., 2008). Therefore, we
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wanted to examine if observed differential susceptibility to GAS sepsis was due to
differences in availability of immune cells. Hence, we aimed to explore differences in the
percentages of immune cells in the blood of selected highly resistant and highly
susceptible ARI-BXD strains prior to infection and/or any manipulation. Using complete
blood counts (CBC), we profiled five immune cells populations in blood (neutrophils,
monocytes, lymphocytes, eosinophils and basophils) of highly susceptible strains
(BXD100, BXD90, BXD75) and highly resistant strains (BXD73, BXD87 and BXD69),
Figures 5-1 and 5-2.
We found no significant differences between resistant and susceptible strains
indicating that differences in response to GAS sepsis is not due to differences in cellular
populations of susceptible strains vs. resistant strains. We also found that each strain
irrespective of its susceptibility had a unique percentage of different immune cell
populations, for example, neutrophil percentages (NE %) was variable among susceptible
strains ranging from 23–37 % while in resistant strains it ranged from 14.7–27 %.
Showing no significant differences between resistant and susceptible groups, indicating
that variability in number of cells is irrespective of their differential susceptibility, and
that differential response to GAS sepsis is not related to inherent differences in these
immune cells numbers.
Immunophenotyping Analyses of Cellular Population under Normal Physiological
Conditions in Spleen of BXD Strains Revealed No Differences in Cellular Numbers
or Relative Percentages among Susceptible and Resistant Strains
We immunophenotyped spleen cellular populations in selected resistant and
susceptible BXD strains. The spleen as a blood filtering lymphoid organ, is involved in
mounting immune responses to extracellular blood borne pathogens such as GAS
(Mebius and Kraal, 2005). We wanted to examine if there were any inherent differences
in number of immune cells in spleen due to strains variability. We found no significant
differences in the analyzed immune cell populations in spleen among highly susceptible
and highly resistant strains under normal physiological conditions (Figure 5-3).
Altogether, these data illustrated how different combinations of polymorphic
genes and recombinations, can result in a different manifestation from the ancestral
parent of these strains. However, in the current study, variations in numbers of immune
cells in both spleen and blood of selected highly resistant and susceptible strains were not
linked to differential susceptibility to severe GAS sepsis. Our data suggest that possible
migratory and functional differences rather than cellular availability as a possible
mechanism of differential susceptibility to severe GAS sepsis.
In vivo Manipulation of Cellular Populations in Susceptible and Resistant Strains:
Depletion of Gr-1+ Cells and Macrophages Rendered Resistant Strains Susceptible
To this extent we have established that the numbers of immune cells at
physiological state were not different between examined highly resistant and susceptible
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Figure 5-1. Differential blood count of selected susceptible and resistant BXD
strains.
We used 4–8 mice per sex, per strain, 8–12 weeks-old. The data show no significant
differences between resistant and susceptible strains. Since there were significant
differences in NE% between sexes of same strain (BXD69), we are showing males
separate from females for all the results. LY lymphocytes, NE neutrophils, MO
monocytes, BA basophiles, EO eosinophils. Significance based on Student t-test p <
0.01.
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Figure 5-2. Diagram showing a scheme for flow cytometric analysis of immune cell
populations in spleen employed in the current study.
We used CD19-FITC to characterize total B cells in spleens (panel A). To characterize
main subpopulations of T lymphocytes, we used a mixture of CD3-FITC, CD8-PE and
CD4-APC, we defined CD3+, CD4+ as T helper cells (panel B), and CD3+ CD8+ as T
cytotoxic cells (panel C). Natural killer cells were gated as CD3-, CD49b+, where CD49b
is a pan NK cells marker that is expressed on both parental strains NK cells. We
differentiated between granulocytes and macrophages based on granularity (side scatter
(SSC)) and CD11b staining as shown in panel E, where we gated on CD11b+ with high
granularity and designated this as total granulocytes (panel G) while CD11b+ cells with
lower granularity (SSClo) were assigned a separate gate and designated as macrophages
(panel F). Macrophages were then categorized based on their Gr-1 and CD11c expression
into resident and inflammatory macrophages (Mø) as shown in panel F. Total
granulocytes population (panel G) were then analyzed based on their Gr-1 and SSC into
neutrophils and eosinophils as indicated in panel G.

99

E

A

B

D
G
F
C

100

†

Figure 5-3. Immunophenotyping of spleen cellular populations in selected resistant
and susceptible BXD strains.
We used 3–8 mice per sex per strain; age 8–12 weeks old. There were no significant
differences in any of the analyzed cellular populations due to sex; therefore, data shown
in this Figure represents pooled males and females per strain. There were no significant
differences (P ≤ 0.01) between resistant and susceptible strains when comparing
different immune cell populations in spleen. NE neutrophils, Mø macrophages, EO
eosinophils, and NK natural killer cells. † NK cells were not analyzed for BXD73.

101

strains. Therefore, migratory and/or functional differences rather than cellular availability
may possibly account for the differential susceptibility to severe GAS sepsis. Therefore,
we aimed to dissect the role of neutrophils and macrophage in differential susceptibility
to severe GAS sepsis. We selected neutrophils (PMNs) and macrophages as our genomewide association studies and our transcriptome analyses suggested key roles for these two
cell populations in modulating severe GAS sepsis (Abdeltawab et al., 2008).
Neutrophils and macrophages play an important role in modulating host responses
to GAS sepsis (Goldmann et al., 2004a; Voyich et al., 2004; Medina and Lengeling,
2005). To dissect the role of these cells, we examined the effect of depleting them in vivo
on differential mice susceptibility to severe GAS sepsis. We selected highly susceptible
strains (BXD100 and BXD77) and highly resistant strains (BXD48 and BXD69) to test
the effect of depleting Gr-1+ cells on GAS sepsis severity and outcomes (Figure 5-4).
Two days prior to the infection, we quantified the PMNs in all mice, and then at
24 hours prior to the infection, we injected a group of mice i.v. with 200 g of antimouse Ly-6G and Ly-6C (RB6-8C5) antibody (Ab) which depletes Gr1+ cells within 1224 hours. This depletion only lasts for 48h at which point PMNs are replenished by the
bone marrow. In parallel, we injected a matching control group with isotypic control Ab
(purified rat anti-mouse IgG2b κ). To verify neutrophil depletion in the (RB6-8C5) Ab
treated group, we measured CBC/differential blood counts.
We then infected both groups with 107 CFU/mouse of hypervirulent M1T1 GAS
strain, and monitored their survival every 2 hours for the first 44 hours then every 8h till
day 6 post infection, when all surviving mice were sacrificed. We found that the Gr-1
depleted resistant mice were rendered susceptible; indicating the key role of Gr-1 cells
(PMNs and monocytes) in host defense against GAS sepsis. We found similar results
when we depleted macrophages using clodronate liposomes. Both studies emphasize the
role played by neutrophils and macrophages in resistance to severe GAS sepsis. Our
results indicated that the first 24 hours of infection are crucial in determining the outcome
of infection and the fate of the mice whether the mice will survive or succumb to the
infection. This conclusion is based on the finding that despite the fact that PMNs are
replenished at 48 hours post depletion and are increased in numbers this did not help
anymore in fighting the infection (Figure 5-4). Our results are in concordance with
(Goldmann et al., 2004b) where depletion of macrophages prior to or during the first 24 h
of infection affected mice susceptibility and that depletion of macrophages 48 hours post
infection had no effect on mice survival.Therefore, our next step was to examine the
kinetics of cellular populations in blood in the first 24 hours of infection in highly
susceptible and resistant strains.
To examine the kinetics of neutrophils and monocytes in blood post infection, we
measured percentages of these cells in susceptible and resistant strains at 8, 12 and 16 h
post infection. We found no significant differences between resistant and susceptible
strains (Figure 5-5). We also examined if there were any differences in further earlier
time points of infection (2 hours) at intervals of 30 minutes, and we again found that
there were no significant differences in numbers or percentages of neutrophils between
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Figure 5-4. Depletion of Gr-1+ cells in selected resistant and susceptible BXD strains
shows reversal of survival in response to GAS sepsis.
Summary of Gr-1+ depletion studies showing survival curves as percent survival on the
right hand side, where depleted group are in solid lines and control group injected with
isotypic control in dashed lines. Resistant strains were rendered susceptible, indicating
the beneficiary effect of NEUTROPHILs in modulating host response to severe GAS
sepsis. The bar graphs on the left represent percentage of neutrophils pre antibody
injection, 24 hours post antibody injection and 24h post infection with GAS.

103

Figure 5-5. Kinetics of neutrophils and monocytes at early time points post GAS
infection.
Susceptible and resistant strains were infected with 2 X 107 CFU/mouse of M1T1
hypervirulent GAS strain. We collected blood from 3–4 mice per strain per time point
and evaluated percentages of neutrophils and monocytes at selected time points post
infection. There were no significant differences in percentages of neutrophil at examined
time points between susceptible strains compared to resistant ones. Interestingly,
monocytes were higher at 16 h post infection in susceptible strains. Significance was
calculated using on Student’s t-test, with p ≤ 0.05 considered significant.
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resistant and susceptible strains at 30–90 minutes post infection. However, at 120 minutes
(2h) post infection susceptible strains had significantly higher numbers of neutrophils
(Figure 5-6).
Conclusions
In this chapter, we found that there were no significant quantitative differences in
the number of immune cells in blood and spleens of resistant and susceptible strains
under normal physiological conditions. This led us to investigate if neutrophils and
macrophages play a role in modulating differential response in GAS sepsis. We found
that depletion of both cell types prior to, or within 24 h of GAS infection rendered
resistant strains susceptible. We then examined the kinetics of neutrophils and monocytes
post infection in susceptible and resistant strains and found no significant differences in
numbers post infection. This suggested that numbers of neutrophils and monocytes
available may not be a major determinant factors of the outcome of infection as
susceptible and resistant strains had an equivalent numbers of these cells. Together our
data suggest that functional differences in these cells may play an important role in
modulating differential susceptibility.
This led us to initiate studies analyzing the role of neutrophils and pattern
recognition receptors, NOD like receptor family (NLR) and in particular Nlrp3 (Craven
et al., 2009; Harder et al., 2009; Munoz-Planillo et al., 2009), in modulating differential
response to bacterial sepsis. This work along with further in vitro functional assays are
being planned and outlined and will be a future direction for the project after completion
of the current dissertation.
Materials and Methods
Experimental Design of Immunophenotyping Studies
To characterize the main immune cell populations in blood and spleen of BXD
strains displaying differential susceptibility to GAS sepsis, we selected highly resistant
strains (BXD73, BXD69, and BXD87) and highly susceptible strains (BXD100, BXD90,
and BXD75). We collected blood and harvested spleens from 8–16 mice per strain, 8–12
weeks-old, age-matched males and females at physiological conditions. Where the mice
were housed in a pathogen-free colony in autoclaved pressurized individual ventilation
(PIV) cages (4 mice/cage) at the University of Cincinnati, Cincinnati, OH. The mice used
in the immunophenotyping studies were maintained on a 12 hours light dark cycle, and
were fed ad libitum sterile irradiated rodent chow (Harlan Teklad, Madison, WI). All
procedures involving mice were approved by the institutional animal care and use
committee (IACUC) at the University of Cincinnati.
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Figure 5-6. Comparison of the kinetics of neutrophils and monocytes numbers in
susceptible versus resistant strains during the first 2 hours post GAS infection.
Susceptible and resistant strains were infected with 2 X 107 CFU/mouse of M1T1
hypervirulent GAS strain. We collected blood from 3–4 mice per strain per time point
and evaluated percentages of neutrophils and monocytes at selected time points post
infection. There were no significant differences in percentages of neutrophil at examined
time points. Significance was calculated using on Student’s t-test, with p ≤ 0.05
considered significant.
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Differential Blood Counts
We measured numbers and percentage of different immune cells populations in
blood using automated complete blood counts (CBC) with differentials. We euthanized
age-matched (8–12 weeks-old) mice (n = 4–8 mice/sex/strain) and collected their blood
using cardiac puncture immediately into 0.5 M K2EDTA coated tubes. We performed
CBC with differentials using Hemavet 950 automated hematology analyzer (Drew
Scientific Inc, Oxford CT). We collected data for 5 immune cell populations:
lymphocytes, monocytes, eosinophils, basophiles and neutrophils across selected
susceptible and resistant ARI-BXD strains.
Flow Cytometric Analyses of Splenocytes
We used flow cytometric analysis to inspect percentages of different immune cell
populations in spleens. We harvested spleens from 8–16 mice/strain, age-matched (8–12
weeks-old) males and females belonging to the above-mentioned BXD strains. We
prepared single cell suspension of splenocytes using cell strainer method using a nylon
mesh 70 μm (BD Biosciences, San Jose, CA). During the following procedures,
splenocytes were kept on ice at all possible times. Cell suspensions were pelleted by
centrifugation at 400 xg for 5 minutes at room temperature. We discarded the
supernatants and lysed RBCs using 1X RBC lysis buffer (eBioscience, Inc, San Diego,
CA). We washed the cells twice with FACS buffer (phosphate buffered saline (PBS), 2%
fetal bovine serum (FBS) and 2 mM EDTA), and resuspended the cells in 10 ml of FACS
buffer. We counted the splenocytes single cell suspensions using hemocytometer and
brought the samples to a concentration of 107 cells/ml in FACS buffer.
We stained 106 cells with the following anti-mouse antibodies, CD19-FITC,
CD3-FITC, CD8-PE, CD4-APC, CD49b-PE, CD11b-FITC, CD11c-APC, Gr-1-PE (Ly6G and Ly-6C, RB6-8C5), and corresponding isotype controls (BD Biosciences, San
Jose, CA). Cell populations and cell surface markers used to identify these populations
are listed in Table 5-1. Data acquisition and preliminary analysis were done using BD
CellQuest Pro on a BD FACSCalibur flow cytometer (BD Biosciences). Detailed flow
cytometeric analyses were done using FlowJo software (Tree Star, Inc, Ashland, OR).
We used single color staining for CD19, and staining was analyzed using single
histogram statistics (Figure 5-1). We performed 2-color staining for NK cells (CD3 and
CD49b), we chose CD49b as an NK cell marker as it is a pan NK cells marker that is
expressed on both parental strains (B6 and D2) NK cells. We used 3-color staining for T
cells (CD3, CD4 and CD8) and myeloid cells (Gr-1, CD11b and CD11c). Figure 5-1
shows scheme of analysis of different cell populations.
Cellular Depletion Studies
We used anti-mouse Ly-6G and Ly-6C (RB6-8C5) antibody (Ab) for depletion of
Gr1 cells. We injected 8 weeks-old males belonging to highly susceptible and highly
+
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Table 5-1. Cell surface markers that were used to define spleen immune cells
populations characterized in the current study.
Cell Population
T cytotoxic cells (Tc cells)

Cell Surface Markers Used to
Define the Cell Population
CD3+, CD8+

T helper cells (Th cells)

CD3+, CD4+

B lymphocytes (B cells)

CD19+

Natural killer cells (NK cells)
Neutrophil granulocytes, leukocyte (PMNs)
Eosinophils (EO)

CD3-, CD49b+
CD11b+, SSChi, Gr-1hi
CD11b+, SSChi, Gr-1mid-low

Resident macrophage (Mø) & dendritic cells (DC) CD11b+, SSClow , Gr-1-, CD11c+
resistant strains with 200 ug/mouse of RB6-8C5 Ab (iv tail) injections (Czuprynski et al.,
1994). In parallel, we injected a control group of mice with 200 ug/mouse of isotypic
control Ab of purified rat anti-mouse IgG2b κ. We confirmed depletion by measuring
neutrophils in blood 24 hours post Ab injections. We infected control group and Gr-1+
depleted group with 107 CFU/mouse of hypervirulent M1T1 GAS strain. Bacterial
suspensions used for infection of mice were prepared as detailed in (Aziz et al.,
2007).We monitored mice survival every 2 hours for the first 44 hours until all depleted
mice expired and then every 8h till day 6 post infection when all surviving mice were
sacrificed. Similarly, we depleted monocytes and tissue macrophages using iv tail
injection of clodronate-loaded liposomes (CLLs) as previously described in (Van Rooijen
and Sanders, 1994). We followed same design for infection as above where control group
were injected with PBS-loaded liposomes.
Data Analysis and Statistical Analyses
We used FlowJo software (Tree Star, Inc, Ashland, OR) for analysis of flow
cytometry data. Statistical analysis and graphical presentation of flow cytometry and
CBC/differential data was done in GraphPad Prism (GraphPad Software, La Jolla, CA).
For granulocyte depletion studies, survival fractions were estimated using Kaplan-Meier
method and curves generated were compared using log rank test. In various experiments,
statistical significance was based on Student’s t-test, a P-value of ≤ 0.01 was considered
significant.
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CHAPTER 6. SUMMARY FUTURE DIRECTIONS AND CONCLUSIONS
Summary
In the studies outlined in this dissertation, we aimed to delineate host genetic
factors modulating differential susceptibility to severe GAS sepsis.
Our laboratory has previously found an association between variations in host
HLA-II alleles and the severity of disease outcomes. These findings were based on
extensive epidemiological studies, which were initiated based on two important findings.
First, the isolation of genetically identical GAS strains from both severe and non-severe
cases of GAS sepsis underscored the role of host variation in modulating outcome of
infection (Chatellier et al., 2000). Secondly, subsequent studies showed that there were
variations in the magnitude of inflammatory responses elicited by the same GAS
superantigens (SAgs) and that this correlated with the severity of GAS sepsis outcomes
(Norrby-Teglund et al., 2000). Because SAgs are presented to T cells by HLA-II
molecules, they hypothesized that host HLA-II allelic variations could be modulating the
observed differential response to the same GAS isolate (Chatellier et al., 2000).
Therefore, extensive epidemiological studies were undertaken to determine the
distribution of HLA-II haplotypes among patients with varying degrees of invasive GAS
infections. Kotb et al. (2002) found associations between certain HLA-II haplotypes and
high risk for STSS and that other haplotypes were associated with protection from STSS
and/or NF (Kotb et al., 2002; Kotb et al., 2003). These breakthrough studies were then
taken a step further to study mechanisms of interactions of the ternary complex of HLAII–SAgs–TCR in vivo and in vitro. Validation and dissection of the role of in HLA-II
variation in GAS sepsis were conducted using HLA-tg mice and bare lymphocyte
syndrome (BLS) cell lines expressing either high risk or protective HLA-II alleles (Nooh
et al., 2007). The intriguing HLA-II studies in our laboratory are providing us with new
exciting mechanistic data each day.
Despite the strong association between severity of GAS sepsis and host HLA-II
polymorphism, GAS sepsis is a complex trait disease, affected by multiple interacting
mechanisms. This elusive bacterium is rich in many other virulence factors, beside SAgs,
of which may interact with additional host factors, other than HLA-II, to modulate
disease outcomes. Therefore, we saw a great potential in adopting a systems approach to
explore additional host factors modulating the severity of GAS sepsis.
A systems genetics approach is a hypothesis-free approach made feasible due to
the coupling of powerful genetic and bioinformatics tools (Morahan and Williams, 2007;
Chesler et al., 2008). As detailed in the introductory chapter of this dissertation, ARIBXD strains, which were used as a genetic reference population in our studies, are a welldefined, genetically diverse mouse population. These strains are well defined as they are
heavily genotyped and their ancestral parents are fully sequenced (Williams et al., 2001;
Peirce et al., 2004; Shifman et al., 2006). This coupled with statistical analyses tools
offered by the WebQTL platform (Wang et al., 2003; Peirce et al., 2008) provides
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researchers, like myself, a great advantage of allowing us to easily link our measured
traits of interest with mice genotypes and map genetic loci associated with observed
differential response. The ARI-BXD strains, being genetically diverse, offer a huge
advantage of having a vast genetic pool for mapping studies. This is in contrast to
common inbred mice whose genetic pool is limited, thus in using ARI-BXD we are
trying to mimic the genetic diversity of the human population.
Systems genetics approaches are novel in GAS sepsis field, and have just been
recently employed in other infectious diseases (Hardy et al., 2001; Miyairi et al., 2007).
To take advantage of such approaches, we first aimed to carefully account for and to take
into consideration any non-genetic or environmental variations that might affect mice
differential response to GAS sepsis. Our analyses revealed that among the various
cofactors, age was the only significant cofactor that confounded differential response to
GAS sepsis (Aziz et al., 2007). This was predictable based on known effects of aging on
innate immune responses (Gomez et al., 2008) and in particular on those relating to
sepsis (Turnbull et al., 2009). Interestingly, a recent study has dissected such age-related
differences in immune responses in relation to severe GAS sepsis in mice (Goldmann et
al., 2010). Based on our studies, we standardized an age range for our mice to be between
40 to 120 days that reflects differential response and in later studies of dissecting the
mechanisms of differential susceptibility we used age range of 60 to 90 days.
We then mapped disease-associated traits of survival, bacteremia, and bacterial
dissemination to organs to 2 QTLs on Chr 2. The survival phenotype also mapped to an
additional QTL on Chr X (Abdeltawab et al., 2008). Excitingly, we had a strong cisacting QTL and the genes within these QTLs were polymorphic and associated with
immune response pathways which made biological sense. We then narrowed down our
QTLs using multiple bioinformatics tools including linkage analyses, SNP
polymorphism, gene ontology, and pathway analyses. We then validated selected key
genes within our candidate pathways by comparing gene expression levels (qPCR) in
selected infected vs. uninfected highly resistant and highly susceptible BXD strains.
Collectively our data suggested the involvement of two key pathways of IL1 and
prostaglandins in modulating differential susceptibility to GAS sepsis (Abdeltawab et al.,
2008). For the survival phenotype, we found that genes within all 3 QTLs (two on Chr 2
and one on Chr X) fell in the same or interactive pathways. In addition the QTL on Chr X
also harbors genes likely to be involved in host-mediated pathogenesis (e.g. thrombosis,
and coagulation). However, to further embrace our unbiased approach of systems
genetics and to dissect mechanisms of differential susceptibility to severe GAS sepsis, we
sought to compare genome-wide (GW) differential gene expression associated with
differential response at different stages of infection. We designed these experiments so
that we can gain insight into the dynamics of the host immune response during the
infection. We compared GW differential gene expression of infected vs. uninfected mice
of highly resistant and susceptible strains at selected times post infection.
We aimed to explore the basis of how mice react differently based on their genetic
differences, which modulated the outcome of infection into the observed differential

110

susceptibility. In addition, we aimed to delineate stages of the infection at which
divergence in response between susceptible and resistant strains occurs, i.e. stage at
which their fates are being decided. We were excited to find that the same or interacting
pathways were also pulled out with this GW transcriptome analysis approach (Chapter 4
in this dissertation). Moreover, we found that certain pathways were associated with
certain times post infection i.e. infection stage-specific. This was exemplified by changes
in the IL10 signaling pathways, which were only seen in resistant strains only at 8 h post
infection (in blood as studied “organ”). This will help us tremendously in understanding
the molecular mechanisms underlying each stage of the infection. To add to the
excitement, IL10 cytokine levels correlated with protection from disease severity, as IL10
levels were significantly higher in resistant strains (p < 0.01) at early times post infection.
Interestingly, we found significant differences between susceptible and resistant strains
only in levels of IL10 and IFN and at certain times post infection corresponding with the
expected time and role of each cytokine in sepsis modulation. The levels of IL10 were
significantly higher in resistant strains starting at 8 h but showed no differences at 24 h.
This suggests that IL10 may play an active role in regulating immune response within the
early stage of the infection.
This becomes exceedingly exciting, when taken together with our in vitro HLA-II
studies which showed that the protective HLA-II alleles induce high levels of IL10
production, suggesting an active suppression as mechanism of protection against STSS.
Further support was achieved via in vitro studies, where adding exogenous r-IL10 to
PBMCs isolated from individuals expressing high-risk HLA alleles decreased their SAginduced proliferative and cytokine responses. Meanwhile, adding anti-IL10 to PBMCs
isolated from individuals expressing protective HLA alleles increased their SAg-induced
responses (Nooh and Kotb in press). The IL10 story gets even far more exciting with our
microarray data on tissue samples from patients with severe and non severe GAS sepsis,
which showed the IL10 signaling pathways as top differentially expressed pathways
associated with disease outcomes (Kansal and Kotb in final preparation).
To further add to all the above exciting results, and to shape a bigger picture, our
prostaglandin studies revealed that high levels of PGE2 were associated with increased
severity of sepsis in inverse correlation with IL10 levels (chapter 4 in this dissertation).
This is in agreement with previous studies showing that PGE2 can down regulate the
production of IL10 and drives immune cellular responses towards an exaggerated Th17
inflammatory response (Boniface et al., 2009; Yao et al., 2009). However, it has been
shown that PGE2 effects are affected by its concentration, type of cells it is acting upon,
status of the relevant receptors activated and the site and stage of infection (Bos et al.,
2004; Tober et al., 2007; Sakata et al 2010.). Therefore, it seems that a very fine balance
of its concentration is required for an effective immune response. This led us to formulate
our hypothesis that PGE2 acts as a suppressor of IL10 production in susceptible strains,
where at high concentrations of PGE2, IL10 will be inhibited and Th17 inflammation
ensues with severe sepsis as an outcome. To test this hypothesis at a cellular mechanism
level, we first wanted to profile cellular population percentages across resistant and
susceptible strains under physiological conditions. In doing so, we wanted to account for
any quantitative differences in number of immune cells of resistant vs. susceptible strains
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prior to infection that might affect their differential response. We immunophenotyped
cells from blood and spleen of selected highly resistant and highly susceptible strains and
found no quantitative differences between these stains under normal physiological
conditions. Furthermore, there were no significant differences in number of neutrophils
post infection at selected times post infection.
Our finding of no significant differences in numbers of immune cells between
susceptible and resistant strains was very interesting, as it has been previously noted that
both qualitative and quantitative differences in neutrophils affect outcomes of infection
(Nauseef, 2007). However, an interesting recent study showed that in severe bacterial
infections including GAS infection, high bacterial loads induced depletion of bone
marrow neutrophils, as it triggered TLR2 activation leading to over-activation of immune
response mechanisms and blocking of recruitment of neutrphils to infectious abscess, as
bone marrow became depleted of neutrophils (exhausted bone marrow) (Navarini et al.,
2009).
Our data continue to point to the important role played by neutrophils and
macrophages in modulating the severity and outcomes of GAS sepsis. GAS has
developed specific mechanisms to evade killing by these two cellular populations. For
example, studies have shown invasive GAS strains to specifically develop mechanisms to
evade PMN killing. For example, GAS produces virulence factors that specifically impair
PMN chemotaxis, migration and function. C5a peptidase (ScpA) degrades host C5a while
IL8 degrading enzyme (ScpC) degrades host IL8 and thus impairing neutrophil
chemotaxis (Sjolinder et al., 2008; Gleich-Theurer et al., 2009). Another example of
GAS interfering with PMN killing mechanisms is Sda1, a potent DNase produced by
M1T1 (GAS strain under study). Sda1 dissolves neutrophil extracellular traps (NETs)
allowing the bacteria to escape the entrapment and killing by PMN (Aziz et al., 2004b;
Buchanan et al., 2006; Walker et al., 2007). Studies analyzing the role of macrophages in
modulating differential susceptibility to GAS, using transcriptome analyses of GAS
infected macrophages; found that GAS stimulates an “unusual” macrophage response. As
the transcriptional profiles were a mix of pro and anti-inflammatory response, including
profiles characteristic of both M1 and M2 macrophages (Goldmann et al., 2007).
Nonetheless, PMN and macrophages are in constant interplay, where in GAS sepsis,
PMN release antimicrobial LL37 and heparin binding protein (HBP), thereby increasing
the extravasations of inflammatory monocytes (Soehnlein et al., 2008b). Put together
with our results, we can hypothesize that functional and/or migratory differences in
neutrophils and/or monocytes between susceptible and resistant strains might modulate
their differential response to GAS sepsis.
In conclusion, we aimed to determine host immunogenetic factors modulating
differential host responses to GAS sepsis. To accomplish this aim, we employed systems
genetics approaches to study the genetic and molecular basis of host-pathogen
interactions leading to differential responses to GAS severe sepsis. We assessed
variations in traits associated with severity of GAS sepsis across a genetically diverse
reference population (ARI-BXD strains). We then performed genome-wide association
scans (GWAS), mapping differential susceptibility to QTLs on mouse Chr 2 and X.
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Combining genome-wide differential gene expression analyses with GWAS, and further
biomarker and cellular validations, indicated that PGE2 pathways and IL10 signaling
pathways modulate differential responses to GAS sepsis. In addition, our data suggested
that prostaglandin itself might act as a key modulator, controlling a network of genes
involved in innate immune response to GAS sepsis. We also showed using transcriptome
analyses and soluble biomarker analyses, that pathways involving activation of IL10
signaling and IL10 high levels were associated with resistance to infection. Our
contribution to the vertical growth of the GAS sepsis field is that we highlighted
interactions of prostaglandins and IL10 with networks of candidate genes affect host
differential susceptibility to severe GAS sepsis. Our future studies will be focused on
further dissecting the molecular mechanisms of the differential susceptibility, these are
outlined below.
Future Directions
Studies outlined in this dissertation have answered the original questions we
asked, and raised other questions for follow up in future studies. I would like to believe
that my studies helped in setting the foundation for future studies to answer some of the
raised questions. I believe that with the knowledge we gained from my studies and the
tools we are currently acquiring, answers to some of the raised questions are very
plausible in the near future. However, some questions might remain as open-ended
questions, which I hope we will someday answer to help us reach the laboratory mission
of moving from bench side to bedside and finding better therapeutics that take into
account individual variations and that incorporate the information generated to develop
more targeted interventions for this aggressive disease.
Dissection of Migratory and Functional Differences of Immune Cell Populations
between Susceptible and Resistant Strains
Our results strongly suggested that migratory and/or functional differences in
neutrophils and/or monocytes between resistant and susceptible strains are governing
differential response to GAS sepsis, as there were no significant differences in numbers
of immune cells of blood and spleen of differentially susceptible strains. Moreover,
comparison of neutrophil counts in susceptible and resistant strains post infection showed
no association with differential susceptibility. Studies of various GAS virulence factors
showed that several affect neutrophil recruitment, migration, and killing mechanisms
(Buchanan et al., 2006; Nilsson et al., 2006; Sjolinder et al., 2008; Sumby et al., 2008;
Zinkernagel et al., 2008; Lin et al., 2009; Alexander et al., 2010). Although these studies
gave us insight into how the bacteria affect neutrophil killing mechanisms, however, the
focus of these studies was to dissect bacterial virulence factors rather than to investigate
differences in host neutrophils killing mechanisms that can vary between resistant and
susceptible individuals.
I believe that studies to test our hypothesis of differences in migratory and
functional properties of PMNs and macrophage as a means of host differential
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susceptibility to GAS sepsis will give us great insight into mechanisms involved in
differential susceptibility to severe sepsis. To compare differences in functionality of
these cells, we will select highly susceptible and highly resistant BXD strains and isolate
neutrophils from blood and macrophages from peritoneum, spleen and bone marrow.
Then we will compare differences in phagocytic capacities, and production of reactive
oxygen species (ROS) and reactive nitrogen species (RNS). In addition, we will measure
effective bacterial killing by neutrophils/macrophages isolated from susceptible vs.
resistant mouse strains, as it has been shown that although phagocytosized, GAS can
survive intracellularly in APCs including neutrophils and monocytes (Medina et al.,
2003a; Medina et al., 2003b; Staali et al., 2006; Thulin et al., 2006).
Based on the mapped QTLs and genes associated with GAS severity as well as
our present neutrophil depletion studies, we are tempted to believe that the
neutrophils/macrophages of the resistant strains will have a better bactericidal activity
compared to the susceptible strains. In case we fail to observe expected differences in
their in vitro function, an alternate approach would be to test if there are differences in
the migration of these cells from lymphoid organs to periphery or vice versa following
infection. We will use several in vivo and in vitro methods to study neutrophil migration.
For studying in vivo migration of neutrophils, we will use mouse air pouch
technique. Air pouches will be formed on the back of susceptible and resistant BXD
mice by subcutaneous injection of sterile air. Mice will then be infected intravenously
with GAS and sacrificed at 1-4h post infection. The cells migrated in the pouches will be
collected in sterile PBS, and counted with a hemocytometer. Leukocyte subpopulations
will be distinguished by flow cytometry. Other studies have shown that neutrophils
accounted for 80-95% of accumulated cells (Ben Yebdri et al., 2009; Hattori et al., 2010;
Heissig et al., 2010). In vitro neutrophil transmigration assay will be carried out in a
Boyden chamber system. These studies should give us insight into the cellular
mechanisms modulating susceptible and resistant strains differential susceptibility to
GAS sepsis.
Analysis of Relationship of Prostaglandins and Modulation of Differential Response
to GAS
PGE2 acts as a fast acting, delicately balanced lipid mediator that can act as either
an immunosuppressor or immunoactivator depending on PGE2: a) concentration, b) cells
it is activating, c) combination of receptors being activated, d) nature of activation signal
and e) stage of infection (Bos et al., 2004; Tober et al., 2007; Sakata et al., 2010). PGE2
as an immunosuppressor promotes inflammation, induces IL6 and causes vasodilatation,
and vascular leakage; it can also reduce PMN migration and bacterial killing by
macrophages, by blocking production of reactive oxygen intermediates (ROI) (Aronoff et
al., 2004; White et al., 2005; Nakayama et al., 2006; Huang et al., 2007; Serezani et al.,
2007). However, recent studies have shown that it can be a regulator of that immune
inflammation (immunoactivator) by activation of Th1 differentiation and Th17 expansion
(Boniface et al., 2009; Yao et al., 2009; Sakata et al., 2010).
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If the fine balance of this mediator is disrupted, it can lead to serious pathological
consequences. For example alterations in the amounts of PGE2 are associated with high
risk of infection with HIV, cancer, and malnutrition (Lima et al., 2006; Anstead et al.,
2009; Greenhough et al., 2009). In promoting Th1 differentiation, PGE2 induces the
production of IFN and via its EP4 receptor; PGE2 inhibits production of IL10
exacerbating Th17 mediated inflammation (Boniface et al., 2009; Yao et al., 2009).
Excitingly, the outlined studies in this dissertation showed that susceptible stains had
higher levels of PGE2, and IFN and low levels of IL10 while the reverse was true for
resistant strains. Therefore, we hypothesize that PGE2 can act as a “switch”, wherein
susceptible strains PGE2 inhibits IL10 production, and increase IFN, exacerbating Th17
mediated inflammation. Meanwhile, in resistant strains, PGE2 is produced at controlled
levels, allowing Th1 and Th17 polarization and subsequent containment of infection. We
are even more interested in this interactive role of PGE2 and IL10 as our studies in the
HLA-tg mice have shown that IL10 mediates protection against severe GAS sepsis. In
addition, our genome-wide expression pathway analyses identified IL10 pathways being
up regulated in resistant strains at early time points (8h) associating high levels of IL10
with resistance to GAS sepsis and better outcomes of infection.
A likely applicable hypothesis is that PGE2 modulates differential susceptibility
on more than one level, by inhibiting IL10 production, increasing IFN levels, promoting
Th17 expansion but into exaggerated response and subsequent altering of neutrophils
and/or macrophages recruitment and functionality. However, further studies are needed to
dissect its role in each of these levels, therefore as a future direction of the work
presented herein, follow up studies dissecting the role of PGE2 in relation to IL10 in
modulating differential susceptibility would be quite interesting.
For these studies, to further explore the role of PGE2, one approach is to use
knockout mice of receptors relevant to PGE2 immune actions. PGE2 has four receptors,
prostanoid E receptor (EP) 1 through 4 (Narumiya et al., 1999; Breyer et al., 2001). EP2
and EP4 receptors are heavily involved in inflammatory and immune responses,
migration of antigen presenting cells (APC) and in cancer research (Kobayashi and
Narumiya, 2002; Greenhough et al., 2009). A large body of research on prostaglandins
associates the net action of PGE2 with the balance by which PGE2 activates “receptor
pairs”. For example, in blood pressure regulation, PGE2 can activate EP2/EP4 (leading to
vasodilatation) or EP1/EP3 (leading to vasoconstriction), depending on the balance it can
shift to one action or the other (Zhang et al., 2000).
Therefore, it would be interesting to test knockout mice of EP2 and EP4
receptors, which are involved in inflammatory and immune responses. We have two
knockout mice already in line for future studies on the role of PGE2, these are
microsomal prostaglandin E synthase 1 (mPGES1) and EP2 KO mice, which were made
in DBA/1J and B6 backgrounds respectively. In our ongoing collaboration with Dr.
Aronoff, of Univ. Michigan, we would like to determine how PGE2 might modulate
disease severity. I predict that EP2-KO mice would be resistant (as resistant as B6 or
more), but the main focus is to determine the mechanism of resistance, through functional
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assays, including phagocytosis, production of ROI, and bacterial killing (clearing of
bacteria) as detailed above.
Cytokine Profiling Associated with Susceptibility to GAS Sepsis
We have measured levels of selected cytokines in selected resistant and
susceptible strains and found that IL10 is a promising candidate modulator of severity of
sepsis as it was associated with differential response to GAS sepsis. I believe that a
carefully designed study can be initiated using levels of IL10 at 8 h and/or 12h, as both
time points had the highest correlation with disease severity (Figure 4-4), across BXD
strains and map differential responses due to cytokine level differences. We have
previously used survival, bacteremia and bacterial load in spleen as traits to map
differential severity of GAS sepsis and all these traits mapped to Chr 2 QTLs
(Abdeltawab et al., 2008). However, we have found that survival was the only trait that
mapped a QTL to Chr X. This suggested that genes within this QTL might be primarily
engaged in host-mediated pathogenesis, which we found true when we inspected this
QTL closely (data not shown).
Therefore, we are hoping that cytokine data will reveal QTLs associated with
modulation of cytokine response in GAS sepsis. We postulate that this might be a totally
different QTL, as it is known that complex interacting regulatory mechanisms govern
cytokine production in sepsis (reviewed in [Cohen, 2002; Rittirsch et al., 2008]). In
addition, IL10 is of particular interest due to results shown in this dissertation, where it is
correlated with better outcome of sepsis and is in inverse relation to PGE2 levels, another
mediator that can be used for mapping.
The association of GAS sepsis severity with multiple cytokines exerting their
effects temporally underscores the complexity of traits modulating severe GAS sepsis
and emphasizes the importance of the time of administration of appropriate cytokine
intervention to aid in the prevention of shock in severe GAS sepsis.
Analysis of the Role of Nod-like Receptors as a Candidate Pattern Recognition
Receptor Associated with Modulation of Differential Response to GAS Sepsis
It has been recently found that Streptolysin O (SLO) produced by GAS (Harder et
al., 2009) and hemolysin produced by Staphylococcus aureus (Craven et al., 2009)
activate nucleotide-binding domain (NOD) like receptor (NLR) pyrin domain containing
3 (NLRP3) inflammasome, indicating that GAS activation of the inflammasome was
independent of TLR signaling. NLRP3 inflammasome is involved in the regulation of
caspase-1, which in turn regulates the processing and secretion of IL1 cytokine family
including IL1ß and IL18, which are both parts of the pathways modulating susceptibility
to GAS sepsis which were found by both our genome-wide mapping and transcriptional
studies. NLR family acts as a pattern recognition mediating cytoplasmic recognition of
bacterial products (Ting et al., 2008; Ye and Ting, 2008). It will be particularly
interesting to study the role of the inflammasome in our current GAS model given the
growing connections and pointers that it might be associated with signaling pathways
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modulating observed differential response. We have started collaboration with Dr. Jenny
Ting, at UNC, where I will pursue this project as part of the immediate future directions
of my studies. In these studies we are going to use knockout mice of Nlrp3 and ASC
(Apoptosis-associated speck-like protein containing a CARD, also known as PYCARD),
both mediators have been associated with modulation of NLRP3 inflammasome
(reviewed [Cassel et al., 2009; Lamkanfi and Kanneganti, 2010]).
Concluding Remarks
The studies presented in this dissertation have helped shed some light on host
mechanisms of differential susceptibility to GAS sepsis. We were the first to find an
association between differential susceptibility to GAS sepsis and QTLs on mouse Chr 2
and X.Some studies have found associations between genes or QTLs on Chr 2 and
susceptibility to other infectious diseases (Appendix D), however none were for
differential susceptibility to GAS sepsis.We validated our mapped QTLs and parsed the
genes within those QTLs into pathways. This allowed us to explore plausible
mechanisms of differential susceptibility. The data suggested that prostaglandin might act
as a key modulator, controlling a network of genes involved in innate immune response
to GAS sepsis. In addition, pathways involving activation of IL10 production and
signaling (including PGE2) are likely to be associated with resistance to infection.
Despite differences between mouse and human immune systems (Mestas and Hughes,
2004), our results match beautifully with results obtained from human patients and its
validation using in vivo humanized HLA-tg mice. This demonstrates the strength of the
systems genetics approach employed and how comparisons of pathways rather than genes
can help us translate our findings from mouse to human.
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APPENDIX A. PRIMER SEQUENCES USED FOR QPCR AND THE RELATIVE
EXPRESSION LEVELS OF CANDIDATE GENES
This appendix contains two supplementary tables for Chapter 3:



Table A-1. Primer sequences used in quantitative PCR assays for candidate genes.
Table A-2. Relative expression levels of candidate gene list expressed as mean fold
difference between pre- and post-infection ± standard deviation (SD) in selected
resistant and susceptible strains.
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Table A-1. Primer sequences used in quantitative PCR assays for candidate genes.
Gene

Gene Description

Accession
Number

Forward 5’

Reverse 3’

Anapc2
Asb6
Edf1
Entpd2
Fbxw2
Garnl3
Gpr107
Hspa5
Il1
Il1rn
Mapkap1
Nfatc2

Anaphase promoting complex subunit 2
Ankyrin repeat and SOCS box-containing protein 6
Endothelial differentiation-related factor 1
Ectonucleoside triphosphate diphosphohydrolase 2
F-box and WD-40 domain protein 2
GTPase activating RANGAP domain-like 3
G protein-coupled receptor 107
Heat shock 70kD protein 5 (glucose-regulated protein)
Interleukin 1 alpha
Interleukin 1 receptor antagonist
Mitogen-activated protein kinase associated protein 1
Nfatc2 nuclear factor of activated t-cells, cytoplasmic,
calcineurin-dependent 2*

NM_175300
NM_133346
NM_021519
NM_009849
NM_013890
NM_178888
NM_178760
NM_022310
NM_010554.4
NM_031167
NM_177345
NM_010899

ctcaaggtggccctagagact
aggagcccctggatgatt
ccgcacaggccaagtcta
cagagaccacctgcaacca
caaagtcaagtctctcttgcaca
tccaccatgttgccatattc
cctgcagctctctcaggaag
ctgaggcgtatttgggaaag
ttggttaaatgacctgcaaca
tgtgccaagtctggagatga
accttgccgaggagaagag
caggaggacaccctgtgg

agagtgatgatgtcacatgtgttg
cagctccgtgaggaccag
aatggaatgctgcttgttctg
ggtctgctgtccgggtact
tcccaattggccaaatctt
caatgtggcgcttccttt
cacacccgatgtcgtcacta
cagcatctttggttgcttgtc
gagcgctcacgaacagttg
ttctttgttcttgctcagatcagt
gcgtcggactcgaagtacag
tcatctgctgtcccaatgaa

tgcaactgtcctctgccata
atctggagcccatggattt
cagagccaggacaggaagata
gtctggagcccagggaat
ggcagctcacagctcataga
gacgggtgaggacgtgtta
gcacactgctggtcatcaag
cccaggaaggagacagctt
aggtgcgctcatggtgtat
cagatcccagatctccactca

gtagcacatggggccaac
gcgttgtggtcatcaggaat
ttggctttgatcttctcagttg
gggcctttagctgtagagtgg
gccttctcatccacgaaatg
cgtccgtgatgggtataagc
acgtttcagcgcatcctc
aggtaggtcttgagggcactaat
caaccagctgcttaagtggtta
agcatggactcgggttacag

NM_001037177

Notch1
Noxa1
Phpt1
Phyhd1
Ppp2r4
Psmd5
Ptges
Ptges2
Rab14
Sh2d3c

Notch gene homolog 1 (Drosophila)
NADPH oxidase activator 1
Phosphohistidine phosphatase 1
Phytanoyl-CoA dioxygenase domain containing 1
Protein phosphatase 2A, regulatory subunit B
Proteasome (prosome, macropain) 26S subunit, non-ATPase, 5
Prostaglandin E synthase
Prostaglandin E synthase 2
RAB14, member RAS oncogene family
SH2 domain containing 3C

NM_001037178
NM_008714
NM_172204
NM_029293
NM_172267
NM_138748
NM_080554
NM_022415
NM_133783
NM_026697
NM_013781
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Table A-1. (Continued).
Gene

Gene Description

Sirpa
Traf1
Traf2
Tubb2c1
Ubadc1
Urm1

Signal-regulatory protein alpha
TNF receptor associated factor 1
TNF receptor associated factor 2
Tubulinbeta 2c
Ubiquitin associated domain containing 1
Ubiquitin related modifier 1 homolog (S. cerevisiae)

Accession
Number
NM_007547.2
NM_009421
NM_009422
NM_146116.1
NM_133835
NM_026615

Forward 5’

Reverse 3’

agggagcatgcaaaccttc
gagcacatcctgagcttgg
gctccttctgcctgacca
gctcctcttctacagctgttcc
gaacaacaaccagcagaacg
gagcgaccagagctgttcat

tttgatccggaggaggtaga
tctttttgagccagggtttg
agacacaggcagcacagttc
cgctgattacctcccagaact
tccaattcctcaggggatg
ggcatcattaatcagcacca

* Nfatc2 has three transcript variants; we designed a common assay for the three transcripts, and differentiating assays for each
isofrom. All assays showed similar results, shown are primers sets of common assay for the three transcript variants.
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Table A-2. Relative expression levels of candidate gene list expressed as mean fold difference between pre- and post-infection ±
standard deviation (SD) in selected resistant and susceptible strains.
Gene ID Gene
Genes down regulated in resistant group while up regulated in susceptible group
Anaphase promoting complex subunit 2
Anapc2
Ankyrin repeat and SOCS box-containing protein 6
Asb6
F-box and WD-40 domain protein 2
Fbxw2
G protein-coupled receptor 107
Gpr107
Interleukin 1 alpha
Il1
Interleukin 1 receptor antagonist
Il1rn
Mapkap1 Mitogen-activated protein kinase associated protein 1
NADPH oxidase activator 1
Noxa1
Phosphohistidine phosphatase 1
Phpt1
Prostaglandin E synthase
Ptges
Prostaglandin E synthase 2
Ptges2
RAB14, member RAS oncogene family
Rab14
SH2 domain containing 3C
Sh2d3c
Phytanoyl-CoA dioxygenase domain containing 1
Phyhd1
Ubiquitin related modifier 1 homolog (S. cerevisiae)
Urm1

Resistant

SD

Susceptible SD

0.551
0.573
0.930
0.866
0.739
0.851
0.732
0.270
0.229
0.417
0.913
0.704
0.162
0.806
0.834

0.022
0.482
0.384
0.481
0.045
0.384
0.199
0.164
0.133
0.101
0.553
0.268
0.102
0.727
0.625

1.475
2.300
1.159
2.196
54.687
55.909
1.189
1.086
0.714
5.046
1.456
1.411
1.009
1.288
1.277

0.691
1.801
0.268
0.758
0.011
0.274
0.460
0.151
0.155
0.679
0.122
0.711
0.389
0.288
0.309

Genes down regulated in both resistant group and susceptible groups
Ectonucleoside triphosphate diphosphohydrolase 2
pd2
Endothelial differentiation-related factor 1
Edf1
GTPase activating RANGAP domain-like 3
Garnl3
Nuclear factor of activated t-cells, cytoplasmic, calcineurin-dependent 2
Nfatc2
Proteasome (prosome, macropain) 26S subunit, non-ATPase, 5
Psmd5
Protein phosphatase 2A, regulatory subunit B
Ppp2r4
Ubiquitin associated domain containing 1
Ubac1
Tubulin beta 2c
Tubb2c

0.359
0.350
0.601
0.178
0.644
0.902
0.865
0.846

0.114
0.375
0.292
0.174
0.049
0.108
0.960
0.506

0.654
0.470
0.674
0.693
0.963
0.734
0.730
0.925

0.160
0.109
0.158
0.147
0.123
0.150
0.971
0.477
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Table A-2. (Continued).
Gene ID

Gene

Genes up regulated in both resistant group and susceptible group
Heat shock 70kD protein 5 (glucose-regulated protein)
Hspa5
Notch gene homolog 1 (Drosophila)
Notch1
Tnf receptor-associated factor 1
Traf1
Tnf receptor-associated factor 2
Traf2
Signal-regulatory protein alpha
Sirpa
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Resistant

SD

Susceptible SD

1.717
2.005
1.826
2.369
4.092

1.016
1.192
0.596
2.694
6.024

4.040
10.424
5.995
2.421
1.607

2.587
7.833
0.733
0.844
1.034

APPENDIX B. LIST OF GENES AND TRANSCRIPTS IN THE MAPPED LOCI
This appendix contains lists of genes and transcripts in the mapped quantitative
trait loci (QTLs) associated with differential susceptibility to severe group A
streptococcal (GAS) sepsis. Public access to an update list of transcripts is available
online at www.genenetwork.org under BXD published phenotypes, trait ID 10836. To
search for this trait ID, access the search databases page at the above link, use mice as
species, BXD as the group, phenotypes as type and BXD published phenotypes as
database, and then enter Abdeltawab as the search term and from the retrieved results
select trait ID 10836.
This appendix contains three tables:




Table B-1. Genes and their SNPs in mapped locus on Chr 2 between 22-34 Mb.
Table B-2. Genes and their SNPs in mapped locus on Chr 2 between 124-150 Mb.
Table B-3. Genes and their SNPs in mapped locus on Chr X between 50-100 Mb.
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Table B-1. Genes and their SNPs in mapped locus on Chr 2 between 22-34 Mb.
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Table B-1. (Continued).
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Table B-1. (Continued).

144

Table B-1. (Continued).
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Table B-2. Genes and their SNPs in mapped locus on Chr 2 between 124-150 Mb.

146

Table B-2. (Continued).
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Table B-2. (Continued).
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Table B-2. (Continued).
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Table B-3. Genes and their SNPs in mapped locus on Chr X between 50-100Mb.
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Table B-3. (Continued).
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Table B-3. (Continued).
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Table B-3. (Continued).
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Table B-3. (Continued).
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APPENDIX C. POLYMORPHISM ANALYSIS OF GENES AND TRANSCRIPTS
IN THE MAPPED LOCI
This appendix contains lists of single nucleotide polymorphism (SNPs) of genes
and transcripts in the mapped quantitative trait loci (QTLs) associated with differential
susceptibility to severe group A streptococcal (GAS) sepsis. The analysis was done on
selected highly susceptible and highly resistant strains, namely, BXD77, 97, 100 and 75
as highly susceptible strains. In contrast, BXD69, 73, 48 and 87 are highly resistant
strains, in addition, both parental strains B6 and D2 were included in this analysis. I
performed the analysis on May 1, 2010 using mouse phenome database (MPD)
employing the SNP wizard online tool at http://phenome.jax.org/SNP. The retrieved data
was based on several databases including; national center for biotechnology information
(NCBI) Mouse Build 37 (known as mm9), NCBI SNP database (dbSNP) build 128 and
the joint project of the European Molecular Biology Laboratory (EMBL), European
Bioinformatics Institute (EBI) and the Wellcome Trust Sanger Institute, (Ensembl) build
48. SNPs among BXD strains were based on Wellcome-CTC Mouse Strain SNP
Genotype Set (Shifman et al., 2006).
There are three tables in this appendix:




Table C-1. SNP analysis of genes in mapped locus on Chr 2 between 22-34 Mb.
Table C-2. SNP analysis of genes in mapped locus on Chr 2 between 125-150 Mb.
Table C-3. SNP analysis of genes in mapped locus on Chr X between 50-100 Mb.

The tables in this appendix contain the following abbreviations for SNP
functional classes retrieved:
Cn
Coding non-synonymous; SNP changes the amino acid/peptide,
Cs
Coding synonymous; SNP does not change the amino acid/peptide,
UTR Untranslated region, SNP is in non-coding interval of mRNA,
S
SNP is in a splice-site; first two or last two bases of intron (few),
I
SNP is in an intron, except first 2 and last 2 bases (see above splice-site SNP), and
L
Locus region; not assigned to a gene; can be in region of gene but not in
transcribed region; or may be in regulatory region.
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Table C-1. SNP analysis of genes in mapped locus on Chr 2 between 22-34 Mb.
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Table C-2. SNP analysis of genes in mapped locus on Chr 2 between 125-150 Mb.
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Table C-2. (Continued).
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Table C-2. (Continued).
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Table C-3. SNP analysis of genes in mapped locus on Chr X between 50-100 Mb.
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Table C-3. (Continued).
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Table C-3. (Continued).
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APPENDIX D. LIST OF PUBLISHED LOCI AND GENES ON CHROMOSOME 2
THAT ARE ASSOCIATED WITH DIFFERENTIAL SUSCEPTIBILITY TO
INFECTIOUS DISEASES
This appendix contains a list of quantitative trait loci (QTLs) and genes on Chr 2
that were found by published studies investigating susceptibility to infectious diseases
other than GAS sepsis, based on literature search on May 3, 2010. From the list below,
only one study used recombinant inbred (RI) mice strains (CXB-RI strains) (Thach et al.,
2001). Other retrieved studies used either F2 crosses or backcrossed of some strains of
interest.
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Table D-1. Diseases and mouse models associated with quantitative trait loci and genes located at Chromosome 2 loci mapped
in current study.
Disease
Neuroadapted Sindbis
virus (NSV)
Chlamydia trachomatis

Model and Strain Used
C57Bl/6J and Balb/cBy, CXB inbred
mice
C57Bl/6J and C3H/HeJ and F2 crosses
and congenic
C57BL/6N X C3H/HeN
(C57BL/6N X C3H/HeN) F1 X C3H/HeN
and (C57BL/6N X C3H/HeN) F1 X
C57BL/6N backcrosses
F2 crosses of (CcS-16 x BALB/c)

Candidate Genes/Loci
QTL on Chr 2 near D2Mit447
(60cM)
QTLs on Chr 2, 3 and 11

Immune response locus 2 (Ir2)

Candida albicans.

B10.LP-H-3 b and B10.CE(30NX) and
(B10.LP-H-3 b × B10)F1
[A/J x C57BL/6J] F2 crosses

Salmonella typhimurium
Listeria monocytogenes

(AcB61 x 129S6) F2 crosses
A/J and B6

Hemolytic complement (Hc or C5)
Hemolytic complement (Hc or C5)

Borrelia burgdorferi
(lyme disease)

Leishmania major

Leishmania donovani
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Bbaa15 locus and proximity of
markers D2Mit278 and D2Mit224

Lmr14

Hemolytic complement (Hc or C5)

References
(Thach et al., 2001)
(Bernstein-Hanley et
al., 2006)
(Roper et al., 2001)

(Havelkova et al.,
2006) (Zhang and
Matlashewski, 2004)
(Vladimirov et al.,
2003)
DeTolla 1980
(Tuite et al., 2004;
Tuite et al., 2005)
(Roy et al., 2007)
(Czuprynski et al.,
2003)
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